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Summary 
The mechanism by which certain carcinogens and radiation cause carcinogenesis is 
believed to be mediated by free radicals. It is increasingly proposed that reactive 
oxygen species (ROS) play a key role in human cancer development, especially as 
evidence is growing that antioxidants may prevent or delay the onset of some types 
of cancer. ROS have been shown to possess many characteristics of carcinogens. 
Mutagenesis by ROS could contribute to the initiation of cancer, in addition to being 
important in the promotion and progression phases. A substantial body of evidence 
has been produced that links the production of reactive oxygen radicals, and 
subsequently oxidative stress and damage, to pathogenesis of chronic diseases 
including cancer. Oxidative stress has been defined as an imbalance between 
oxidants and antioxidants in favour of the former, resulting in an overall increase in 
cellular levels of reactive oxygen species. Free radicals have been shown to be 
capable of damaging many cellular components such as DNA; proteins and lipids. 
Proteins can be damaged by oxygen radicals leading to a loss of both free radical 
scavenging enzyme activity and structural integrity, leading to compromised host 
antioxidant defense mechanisms and cell membrane structure, respectively. This 
eventually may culminate in neoplastic transformation. 
Environmental factors are recognized to play a major role in the etiology of various 
cancers that account for over 80% of human malignancies. Nitrosamines are formed 
by chemical reactions between nitrites and secondary amines or proteins. 
Nitrosamines exert their toxic and mutagenic effects by increased DNA damage and 
generation of reactive oxygen species. N-nitrosodiethylamine (NDEA) is a dialkyi 
nitrosoamine, belongs to the group of N-nitrosamines causing a wide range of 
tumors in all animal species and used as a carcinogenic agent to induce cancer in 
animal models. Exposure of man to N-nitrosamines occurs through consumption of 
products such as salt preserved food, tobacco, cosmetics, pharmaceutical and 
agricultural chemicals. In the present study it was found that NDEA treatment 
induced oxidative stress by significantly decreasing the activities of SOD, CAT, GR 
and GST in liver,lung and circulation along with a decrease in the level of glucose 
and uric acid in circulation. Hepatic,lung and plasma GSH content was found 
depleted with increased levels of MDA (lipid peroxidation). Levels of marker 
enzymes ALP, GOT and GPT in liver as well as ALP, SCOT and SGPT levels in 
circulation were also increased significantly. Further the role of stress on NDEA 
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induced oxidative stress was assessed. Increasing evidence suggests that 
psychological stress contributes to increased susceptibility to a number of diseases, 
including cancer. Psychological stress, via release of chemical mediators, can induce 
long-term changes in the organism resulting in an altered responsiveness of the 
organism to external carcinogens. Exposure to stress situations can stimulate 
abnormal production of reactive oxygen species that are involved in oxidative stress, 
which is capable of causing damage to various cellular constituents, such as DNA, 
proteins and lipids, leading to carcinogenesis .Although the evidence that stressful 
life events are related to the development of cancer is controversial, a number of 
human studies have correlated stressful life events with increased cancer risk and 
decreased survival probability. However, much attention has been paid to the 
possible influence of stress on prognosis in patients who already have cancer while 
very limited information is available on any possible direct role of stress on the 
development of neoplasia. The present investigation sought to evaluate the impact of 
chronic unpredictable stress on N-nitrosodiethylamine (NDEA) induced 
carcinogenesis. 
In order to model chronic stressful experiences, chronic unpredictable stress (CUS) 
paradigm (with varied type and timing of stressors) has been widely used to study 
the impact of stress on disease process in experimental animals. Exposure to CUS 
resulted in a significant decrease in the activities of superoxide dismutase (SOD), 
catalase (CAT), glutathione reductase (GR), gluatathione-S-transferase (GST) and 
glutathione (GSH) in liver and lung tissues as well as glucose, uric acid, SOD, CAT, 
GR and GST in circulation in comparison to untreated controls. This was 
accompanied with significantly increased levels of malondialdehyde (MDA) and 
marker enzymes ALP, GOT and GPT in liver, lung and circulation. Similar results 
were obtained by administration of NDEA. Moreover, when NDEA treated animals 
were pre-exposed to CUS there was marked increase in oxidative stress. This was 
reflected by a further decrease in the activities of antioxidant enzymes and other 
antioxidants as compared to NDEA aione or CUS alone treated animals. Levels of 
marker enzymes in liver and circulation were increased significantly with increased 
levels of MDA indicating an enhanced lipid peroxidation. 
NDEA has been shown to be metabolized by cytochrome P-450 IIEI (CYP 2EI) to 
its active ethyl radical metabolite, which could interact with DNA causing mutation 
Summary 
and carcinogenesis The toxic metabolites and ROS formed during its metabolism, in 
addition to causing oxidative stress, also result in oxidative DNA damage. In the 
present study, NDEA was found to induce DNA damage in lymphocytes, liver and 
lung cells of animals, in terms of increased DNA tail length, measured by alkaline 
comet assay. CUS enhanced the NDEA induced DNA damage in lymphocytes, liver 
and lung cells. CUS in addition to causing oxidative stress by itself enhanced the 
pro-oxidant effect of NDEA. Formation of oxidative stress-related molecules, 
increased lipid peroxidation with decreased activities of free radical scavenging 
enzymes may serve as the mediator to modulate tissue and cellular events 
responsible for NDEA induced carcinogenesis. 
Since free radicals are involved in initiation and promotion stages of carcinogenesis, 
one may expect that free radical scavengers should function as inhibitors in the 
neoplastic processes. Antioxidants have been shown to inhibit both initiation and 
promotion in carcinogenesis and counteract cell immortalization and transformation. 
A number of natural and synthetic antioxidants are known to retard chemical 
carcinogenesis in experimental animal models through chemoprevention. 
Chemoprevention is the use of one or several agents to prevent the occurrence of 
cancer. In this study two compounds -quercetin and melatonin and a medicinal plant 
extract of Podophyllum hexandrum rhizome were used to evaluate the effectiveness 
on NDEA induced carcinogenesis and the modulatory effect of chronic 
unpredticable stress on it. Quercetin,melatonin and podophyllum hexandrum 
rhizome extract (Phre) exerted their antioxidant role against NDEA induced 
carcinogenesis. This was assessed in terms of DNA damage, fluorescent studies and 
biochemical parameters. DNA damage, measured as increased DNA tail length, 
induced by NDEA was prevented largely when animals were supplemented 
with quercetin, melatonin or Phre. The biochemical events during pathological 
conditions are known to differ from their normal counter parts, which can be 
detected sensitively using fluorescent spectroscopy. NDEA induced carcinogenesis 
was detected from altered ratio of fluorescent intensity (FI 530nm/630nm) which is 
otherwise definite for a given normal tissue. This ratio was however, comparable to 
control values after treatment with quercetin, melatonin or Phre. The results of 
biochemical parameters showing decreased oxidative stress were also in line with 
those of comet assay and fluorescent studies, thus confirming the chemopreventive 
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properties of quercetin, melatonin and Phre against NDEA induced carcinogenesis. 
However, when animals were pre- exposed to chronic unpredictable stress the 
chemoprevention by these compounds was abolished and results were comparable to 
that of NDEA alone treatment. 
Chemotherapy is one of the mainstays of medical intervention for cancer. Although 
chemotherapy improves the survival rates of cancer patients, but the related toxicity 
is a major concern in the treatment of patients with tumours, particularly in those 
patients who are cured or achieve prolonged survival. Cisplatin is currently one of 
the most important cytostatic agents in the treatment of a wide range of tumours. 
Free radical mediated oxidative stress is one of the ways through which most of the 
chemotherapeutic drugs exert their cyotoxic effects. Antioxidants are compounds 
that can counteract free radicals and prevent them from causing tissue and organ 
damage. Administration of supplemental antioxidants - either dietary or 
pharmaceutical- concurrently with c>1otoxic regimens has been reported to cause 
modest decreases in treatment-related side effects. In the present study, we 
investigated the effects of supplementation with quercetin, melatonin and Phre on 
the therapeutic efficacy of commonly used anticancer drug (cisplatin) in NDEA 
treated mice both in presence and absence of chronic unpredictable stress. 
Quercetin,melatonin and Phre improved the chemotherapeutic efficacy of cisplatin 
against NDEA induced carcinogenesis. This was assessed in terms of DNA damage, 
fluorescent studies and biochemical parameters. DNA damage, measured as 
increased DNA tail length, in NDEA-cisplatin treated mice was prevented 
largely when animals were supplemented with quercetin, melatonin or Phre. The 
altered ratio of fluorescent intensity (FI 530nm/FI630nm) in NDEA -cisplatin 
treated animals which is otherwise definite for a given normal tissue was however 
comparable to control values after treatment with quercetin, melatonin or Phre. The 
results of biochemical parameters showing decreased oxidative stress were also in 
line with those of comet assay and fluorescent studies, thus confirming the 
chemoprotective properties of quercetin, melatonin and Phre against chemotherapy 
induced toxicities in NDEA administered animals. However, when animals were 
pre- exposed to chronic unpredictable stress the chemoprevention by these 
compounds was abolished and results were comparable to that of NDEA-cisplatin 
alone treatment. 
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Thus exposure to environmental chemicals like NDEA causes accumulation of large 
amount of free radicals by inducing oxidative stress and DNA damage. Chronic 
stress further exacerbates this condition thus putting an individual at an increased 
risk of developing cancer. 
For chemopreventive studies, quercetin, melatonin and a medicinal plant extract of 
Podophyllum hexandrum rhizome were found effective against NDEA induced 
carcinogenesis. However pre-exposure to chronic unpredictable stress was found to 
decrease their chemopreventive efficacy, thus playing an important role during 
cancer development as well as cancer chemoprevention. 
In chemotherapeutic studies the efficacy of cisplatin was significantly enhanced and 
the related toxicity was reduced by supplementation with quercetin, melatonin and 
Phre during NDEA carcinogenesis. Thus, it can be concluded that antioxidant 
compounds may be given as prophylactic/therapeutic supplements for reducing the 
treatment related side effects and enhancing the therapeutic efficacy of 
antineoplastic agents. This approach may be helpful in enhancing the quality of life 
of the cancer patients by limiting the oxidative stress associated with chemotherapy 
and by preserving the endogenous antioxidant defense systems. 
The present study has clearly demonstrate that prior exposure to CUS not only 
enhanced the cancer causing potential of NDEA through increased oxidative stress 
but also modulated the antioxidant potential of various antioxidants and 
chemotherapeutic efficacy of cisplatin either alone or in the presence of 
antioxidants. 
The experimental model currently employed might provide an insight at the most 
basic level of cell mutation, for investigating the effect of both physical and 
psychological stress on the etiology of NDEA induced carcinogenesis. This study 
may aid in the understanding of cancer initiation and can serve as a useful tool for 
further studies aimed at the development of interventions for disease prevention by 
identifying the relation between psychological factors and carcinogenesis. 
Modulation of stress induced oxidative stress should therefore be taken into 
consideration during cancer chemoprevention and chemotherapy as consideration of 
the influence of bio-behavioural factors provides a novel perspective for mechanistic 
studies and new therapeutic targets. Such interventions may include behavioural 
interventions alone or in combination with pharmacological approaches. 
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Introifuction 
The development of cancer in humans and animals is a multistep process involving 
complex array of cellular and molecular changes. Diverse numbers of exogenous 
and endogenous factors pave the way for onset and progression of cancer. The 
exogenous factors include nutritional habits, socio-economic status, lifestyle, 
physical agents (ionising and non-ionising radiation), chemical compounds and 
biological agents. Endogenous factors include immune system damage and 
inflammation caused by uncertain aetiology, genetic makeup, age, endocrine balance 
and physiological condition. 
Cancer initiation, progression and metastasis are intricate processes that depend on 
various steps including genetic alterations, growth/proliferation, vascularization, 
invasion, embolization, and survival/evasion of apoptosis. Epidemiological studies 
indicate that stress, chronic depression and lack of social support might serve as risk 
factors for cancer development and progression. Psychological distress can 
negatively influence multiple cancer relevant biological processes. A substantial 
source of evidences has been produced that implicate oxidative stress in many 
aspects of oncology, including formation of reactive oxygen and reactive nitrogen 
species by the major classes of carcinogens, cancer stages and oncogenic activation. 
The resulting disturbance of the pro-oxidant/antioxidant balance leads to a condition 
of oxidative stress, with subsequent oxidation of cellular components, activation of 
cytoplasmic/nuclear signal transduction pathways, modulation of gene and protein 
expression, and alteration of activities of DNA and RNA polymerase. Although the 
studies examining the effect of psychological stress on the production of ROS have 
yielded inconsistent results, it has been shown that exposure to stress situations can 
stimulate numerous pathways leading to increased production of free radicals. These 
free radicals, as already known, generate a cascade producing lipid peroxidation, 
protein oxidation, DNA damage and cell death which then contributes to occurrence 
of pathological conditions. Stress may also impair antioxidant defences, leading to 
oxidative damage, by changing the balance between oxidant and antioxidant factors. 
Since the involvement of oxidative stress in cancer induction and its subsequent 
development, and associated molecular mechanisms is becoming increasingly clear, 
the influence of stress-inducing conditions on cancer development has been the 
subject of several investigators, both at clinical and experimental level. However 
results are contradictory as both exacerbation and attenuation of tumor development 
Introduction 
has been reported by stress. In human studies main focus is on the field of 
psychosocial factors including stress on prognosis in patients who already have 
cancer, while very limited information is available on any possible direct role of 
stress in the development of neoplasia. Chronic unpredictable stress used in the 
present study is a classical method that has been used to study the impact of physical 
and psychological stress on disease process in experimental animals. 
To study various biological changes including DNA damage in carcinogenesis, 
mouse model of liver and lung carcinogenesis was employed in the present study 
using the carcinogen N-nitrosodiethylamine (NDEA). NDEA is carcinogenic in 
mouse, causing tumour formation in liver, lung, and nasal cavity, kidney, fore 
stomach, oesophagus, trachea, bronchi and respiratory tract depending on the dose 
and mode of administration. NDEA is metabolized by cytochrome P-450 HE! (CYP 
2Ei) to its active ethyl radical metabolite and other toxic metabolites causing 
oxidative stress, cellular injury and DNA damage due to the enhanced formation of 
free radicals. These free radicals produce other deleterious effects by directly or 
indirectly acting as secondary messengers for the primary free radicals and the toxic 
metabolites of NDEA which bind to nitrogen bases of DNA causing damage. 
Persistent DNA damage can result in either arrest or induction of transcription. 
induction of signal transduction pathways, replication errors, and genomic 
instability, all of which are seen in carcinogenesis. 
The essence of chemoprevention is intervention within this multistep carcinogenic 
process, prevention of initiational and promotional events associated with 
carcinogenesis. The approach may be the most direct way to reduce mortality and 
morbidity of cancer. Since free radicals are involved both in initiation and 
promotion of carcinogenesis, a number of natural and synthetic antioxidants are 
known to retard chemical carcinogenesis in the experimental animal models through 
chemoprevention. Protective antioxidant action imparted by many plant extracts and 
plant products make them a promising therapeutic drug for free-radical-induced 
pathologies. However, the prevention or cure of disease in almost every case 
depends on the response of host to the chemoprevention. It is widely believed that 
antioxidants help maintain human health by decreasing oxidative damage to key 
biomolecules. However, the antioxidant status in general and in vivo in particular 
has been shown to be modulated by exposure to stressful life events. Animal studies 
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have shown that exposure to rotational stress decreases the antitumor effects of 
chemotherapeutic drugs in terms of tumour burden, extent of metastasis and survival 
time. 
The present study has been carried out to assess the effect of chronic unpredictable 
stress (CUS) on the early stages of carcinogenesis in terms of measurement of in 
vivo antioxidant status and DNA damage in Swiss Albino Mice. The work has been 
divided into three parts. First part deals with the effect of stress on the antioxidant 
status of experimental animals exposed to chronic unpredictable stress via the 
measurement of alteration of various biochemical parameters considered as markers 
of oxidative stress such as the activities of superoxide dismutase (SOD), catalase 
(CAT), glutathione-S-transferase (GST) and the levels of glutathione (GSH), 
malondialdehyde (MDA), uric acid and glucose. The marker enzymes of liver 
function were also analyzed in both the liver tissues and circulation. Further studies 
were carried out to evaluate the effect of chronic unpredictable stress on the extent 
of DNA damage in peripheral blood lymphocytes, liver and lung cells as measured 
by single cell gel electrophoresis of untreated /treated mice. 
In the second part antioxidant compounds like quercetin, melatonin and the rhizome 
extract of Podophyllum hexandrum, a medicinal plant were used in the 
chemopreventive studies. The chemopreventive effects of these antioxidant 
compounds were evaluated on NDEA induced liver and lung carcinogenesis in the 
presence and absence of stress in terms of DNA damage, fluorescent studies and 
alteration of various biochemical parameters and antioxidant enzymes. 
In the third part chemotherapeutic studies of cisplatin, a commonly used anti-
neoplastic drug, both alone and in combination with the antioxidant compounds like 
quercetin, melatonin and ethanolic extract of rhizome of Podophyllum hexandrum 
were performed on NDEA induced liver and lung carcinogenesis in the presence and 
absence of stress in terms of measurement of all the above mentioned biochemical 
parameters, DNA damage, flourescent studies and functional markers ot 
treated/untreated mice. 
The experimental model currently employed might provide an insight at the most 
basic level of cell mutation, for investigating the effect of both physical and 
psychological stress on the etiology of NDEA induced carcinogenesis. This study 
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may aid in the understanding of cancer initiation and can serve as a useful tool for 
further studies aimed at the development of interventions for disease prevention by 
identifying the relation between psychological factors and carcinogenesis. Thus 
exposure of an individual to stress, physical or psychological, may increase the risk 
of cancer development. Modulation of stress induced oxidative stress should 
therefore be taken into consideration during cancer chemoprevention and 
chemotherapy. 
1^  il 
Literature 
^ - ^ 
Iffview of Literature 
2.1. Carcinogenesis 
Carcinogenesis or oncogenesis is literally the creation of cancer. It is a process by 
which normal cells are transformed into cancer cells. It is characterized by a 
progression of changes on cellular and genetic level that ultimately reprogram a cell 
to undergo uncontrolled cell division, thus forming a malignant mass. Cancer is a 
popular generic term for malignant neoplasms, occurring in all human and animal 
populations and arising in all tissues composed of potentially dividing cells. The 
basic characteristic of cancer is the transmissable abnormality of cells that is 
manifested by reduced control over growth and function leading to serious adverse 
effects on the host through invasive growth and metastases. Although progress has 
been made in reducing incidence and mortality rates and improving survival, cancer 
still accounts for more deaths than heart disease in persons younger than 85 years 
(Jemal et al., 2010). Studies conducted using animal models, "in vitro" studies and 
epidemiologic assays enabled investigators to conclude that neoplasic pathogenesis 
is a complex process which can be divided into three distinct stages, from an 
operational point of view. These are: initiation, promotion and progression 
(Gutierrez and Salsamendi, 2001; Trosko, 2001). Changes in the genome's structure 
occur across the three stages of neoplasic development (Pitot, 2001; Luch, 2005). 
Changes in gene expression also take place during the promotion stage, with 
selective proliferation of initiated cells and the development of pre-neoplastic cells 
(Grisham et al., 1984; Gutierrez and Salsamendi, 2001). During initiation and 
promotion, apoptosis and cell proliferation can occur at different rates, while 
remaining balanced. During progression, this balance is modified and from there 
malignancy arises (Mehta, 1995). 
PROMOTION 
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Fig.l. Carcinogenesis stages and the occurances involved in each one. 
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Carcinogenesis depends on inherited and acquired susceptibility factors, on exposure 
to initiation factors i.e., exogenous and endogenous factors and on promotion and 
progression factors (Walaszek et al., 2005). Exogenous factors includes nutritional 
habits, socio-economic status, lifestyle, physical agents (ionising and non-ionising 
radiation), chemical compounds and biological agents, growth factors (Pilot and 
Dragan, 1991; Barrett and Anderson, 1993; Minamoto et al., 2000; Lutz, 2002). 
Unhealthy lifestyle habits such as: excess alcohol consumption; inhalation of 
tobacco and related products; the ingestion of certain foods and their contamination 
by mycotoxins; are responsible for higher incidences of certain types of neoplasias 
in a number of population groups (Gomes-Cameiro et al., 1997; Witenburger, 1999; 
Gutierrez and Salsamendi, 2001). Endogenous factors include immune system 
damage and inflammation caused by uncertain aetiology, genetic makeup, age, 
endocrine balance and physiological condition (Cohen et al., 1991; Barrett and 
Anderson, 1993; Dewhirst et al., 2003; Ohshima et al., 2003., Ohshima et al., 2005). 
The mechanism by which certain carcinogens and radiation cause carcinogenesis is 
believed to be mediated by free radicals. It is increasingly proposed that reactive 
oxygen species (ROS) and reactive nitrogen species (RNS) play a key role in human 
cancer development (Cerutti, 1994; Routledge et al., 1994) especially as evidence is 
growing that antioxidants may prevent or delay the onset of some types of cancer 
(Byers and Perry, 1992; Diplock, 1994). ROS and RNS have been shown to possess 
many characteristics of carcinogens (Cerutti, 1994). Mutagenesis by ROS/RNS 
could contribute to the initiation of cancer, in addition to being important in the 
promotion and progression phases. ROS/RNS Cause structural alterations in DNA, 
e.g. base pair mutations, rearrangements, deletions, insertions and sequence 
amplification (von Sonntag, 1987; Dizdaroglu, 1993; Epe, 1993). ROS can produce 
gross chromosomal alterations in addition to point mutations and thus could be 
involved in the inactivation or loss of the second wild-type allele of a mutated proto-
oncogene or tumour-suppressor gene that can occur during tumour promotion and 
progression, allowing expression of the mutated phenotype (Cerutti. 1994). 
ROS/RNS also affect cytoplasmic and nuclear signal transduction pathways 
(Schreck et al., 1992; Burdon, 1995) and can lead to displacement of the inhibilorv 
subunit from the cytoplasmic transcription factor nuclear factor kB, allowing the 
activated factor to migrate to the nucleus (Schreck et al., 1992). These free radicals 
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also modulate the activity of the proteins and genes that respond to stress and which 
act to regulate the genes that are related to cell proliferation, differentiation and 
apoptosis (Cerutti, 1994; Sarafan and Bredesen, 1994; Burdon et a!., 1995). Damage 
to DNA by ROS/RNS appears to occur naturally, in that low steady-state levels of 
base damage products have been detected in nuclear DNA from human cells and 
tissues (Floyd et al., 1986; Ames, 1989; Musarrat and Wani,l994). 
2.2. Influences of stress on cancer relevant biological processes 
Stability in the internal environment of a living organism is the result of a complex 
equilibrium, which is constantly challenged by intrinsic or extrinsic forces, physical 
or psychological stimuli, known as stressors, which can endanger the survival of an 
individual. This tendency towards stability is called homeostasis. The term "stress" 
although having a very broad meaning, generally describes a state of disturbed 
homeostasis, harmony and equilibrium (Levine and Ursin, 1991; Weiner. 1992: 
Johnson et al., 1992). Stress can be classified as physical or psychological; of the 
two classes, psychological stress appears to be more potent stressor (Johnson et al. 
1992). Physical and psychological stressors experienced in combination could 
further exacerbate the stress response. A growing body of basic research and clinical 
studies suggest that stress and other psychosocial variables including low social 
support and chronic social isolation contribute to cancer progression and other 
disease states. 
Psychological distress can negatively influence multiple cancer relevant biological 
processes. Cancer initiation and progression is a complex set of processes that rel> 
on multiple steps including environmental exposures and behaviours, genetic 
changes, evasion of apoptosis, proliferation, escape from immune surveillance, 
vascularization, and metastases. There is emerging evidence that psychosocial stress 
can influence the course of disease at many points during this process (Antoni et al.. 
2006 b). Psychological distress is associated with health behaviours that ma> 
promote tumour growth and development. Distress states are associated with 
increased body mass index (BMl) and greater waist circumference (Wing et a!.. 
1991). Increased body weight, especially central adiposity, is associated with 
increased risk for breast cancer (Connolly et al., 2002). Psychological distress states 
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also relate to gene function. Psychological stress is associated with increased DNA 
damage and poorer DNA repair (Gidron et al., 2006;Flint et al., 2007) and DNA 
repair pathways are important in the etiology of breast cancer. 
Stress has long been associated with gastric and duodenal ulcers, hypertension, 
cardiovascular and cerebrovascular diseases, cancer and aging (Cooper, 1984, 1995; 
Csermely, 1998). Long-term exposure to stress has detrimental effects on several 
cell functions in many species, including humans (Kovacs e a.I, 1996). The 
influence of stress-inducing conditions on cancer development has been subject of 
several investigators, both at clinical and experimental levels (La Barba, 1970; 
Pradhan and Prabhati, 1974; Greer et al., 1979; Riley, 1981; Justice, 1985; Fox, 
1995; Croyle, 1998). Stress has been shown to markedly influence incidence, 
growth, and metastasis and rejection of chemically induced or implanted tumors 
(Amkraut & Solomon, 1972; Dechambre and Gosse, 1973; Benchfield et al., 1978; 
Goldman and Vogel, 1984; Laconi et al., 2000). However, results are contradictory 
in that both exacerbation and attenuation of tumor development has been reported by 
stress. Animal experiments have generally documented a positive association 
between the two variables (Sklar and Anisman, 1979; Sklar and Anisman, 1980; 
Steplewski et al., 1985; Matsukawa et al., 1997), although some studies have led to 
opposite conclusions (Amkraut and Solomon, 1972; Pradhan and Prabhati, 1974; 
Justice, 1985). For example, foot shock enhanced the growth of transplanted 
neoplastic cells in mice (Sklar and Anisman, 1979) and a similar pattern of results 
have been reported when psychosocial stress (isolation) was used in animals bearing 
grafted tumors (Dechambre and Gosse, 1973; Sklar & Anisman, 1980). Tumor 
rejection of rats receiving Walker 256 sarcoma and inescapable electric shock was 
lower than that seen in unstressed controls (Visintainer et al., 1982). Perhaps more 
interesting are reports indicating a beneficial effect of stress on tumor development. 
The size of virally induced sarcomas in mice was reduced when stress was elicited 
prior to virus inoculation, while an enhancing effect on tumor growth was seen when 
stress followed exposure to the virus (Amkraut and Solomon, 1972). In addition, 
significant inhibition in the growth and development of DMBA-induced mammary 
tumors was found by exposure of the animals to immobilization, electric shock and 
an overcrowding-sound situation (Pradhan and Ray, 1974; Bhattacharya and 
Pradhan, 1979; Ray and Pradhan, 1979). Animals exposed to electroconvulsive 
8 
(Review of Literature 
shock and cold showed better rejection and reduced growth of murine sarcoma and 
lymphoma tumors (Amkraut and Solomon, 1972; Benchfield, 1978). Among many 
factors, the intensity and duration of stress seem to play a major role. In experiments 
on tumor induction by DMBA, it was found that animals stressed after the injection 
of carcinogen had protective effect of stress whereas no protection was observed if 
stress began before first injection (Steplewski et al., 1985). 
It has also been considered that the ability of the organism to cope with stress is 
critical in determining its overall effect. Consistent with this proposition, escapable 
foot shock had no effect on the growth of transplanted tumors in mice, while 
inescapable shock increased tumor size under the same experimental conditions 
(Sklar and Anisman, 1979). Furthermore, the effect of inescapable shock was 
mitigated if mice received long-term shock treatment, suggesting a type ot 
adaptation to stress (Sklar and Anisman, 1979). The nature of the relationship 
between stress associated conditions and cancer has also been investigated in 
humans. However much attention has been paid to the possible influence of stress on 
prognosis in patients who already have cancer (Greer et al., 1979; Fox. 1981: 
Cassileth et al., 1985), while very limited information is available on any possible 
direct role of stress in the development of neoplasia, at any step (Fox, 1995). 
Various mechanisms have been considered as possible mediators of the effect of 
stress on neoplastic process, which include alteration in the immune and/or 
neuroendocrine system and in the antioxidant defense status (Boyd et al.. 1981; 
Steplewski et al., 1985; Banu et al., 1988; Wakikawa et al., 1997; Harada et al.. 
1997; Muqbil and Naheed, 2006). It shown that restraint stress can accelerate the 
onset of tumour formation and metastasis in female BALB/c mice treated 
intragastrically with DMBA (Melanie et al.,2010).Altered antioxidant status 
indicates production of reactive oxygen species such as peroxides, hydroxyl and 
superoxide anion radicals. There is accumulating evidence to indicate that stress can 
stimulate numerous pathways leading to an increased production of free radicals 
(Kovacs et al., 1996; Liu et al., 1996; Liu and Mori, 1999; Matsumoto et al., 1999; 
Olivenza et al., 2000; Zaidi et al., 2002; Muqbil and Naheed, 2006). It is well known 
that free radicals generate a cascade, producing lipid peroxidation, protein oxidation, 
DNA damage and cell death thus contribute to the occurrence of pathological 
conditions (Kovacs et al., 1996; Liu et al., 1996; Liu & Mori, 1999). 
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2.2.1. Stress and oxidative stress 
Currently, psychological distress has attracted attention with regards to its 
significant negative effects in treating various diseases, especially cancer (Andersen 
et al., 1998, Iribarren ,2005; Liu and Wang ,2005; Bultz and Carlson,2005) . There 
are a variety of stress induced hemodynamic changes that inhibit cellular immune 
responses and are relevant to cancer prognosis, e.g. NK cytotoxicity and T-cell 
responses (Andersen et al., 1998; Sieber et al.,1992; Kelly, 1999). The stressors can 
also induce myocardial ischemia and ventricular arrhythmias in patients with 
coronary artery diseases (Kawachi et al.,l996;Sant'anna et al.,2003) which 
associate with oxidative stress. It is thus suggested that psychological stress is 
associated with increased oxidant production and oxidative damage, and thus long-
term exposure to psychological stressors may enhance the risk of man} diseases 
(Kelly, 1999; Liu and Mori ,1999). Several animal stress models of various stressors 
such as immobilization, chronic unpredictable stress, burn shock and cold-restraint 
have been developed, and all cause oxidative lipid, protein and DNA damages in 
tissues ( Yoshikawa et al., 1987;Liu et al., 1996; Kovacs et al., 1996; Muqbil and 
Naheed, 2006;Hasan et al., 2010) . Based on the known pathophysiological effects 
of stress, it is plausible that associated increases in metabolism may lead to 
increased oxidant production and oxidative damage to cellular macromolecules. 
Chronic exposure to stress alters the prooxidant-antioxidant balance, which might 
lead to the development of various human pathological states (Stojilkovic et al., 
2005). A single short-term emotional pain stress produced a transient increase of the 
lipid peroxidation level (Taranova et al., 1994). Marked changes were observed in 
erythrocyte antioxidant enzymes SOD, CAT and GR and lipid peroxidation levels of 
rats exposed to acute, repeated and chronic restraint stress (Sahin et al., 2004). 
Moreover, different stress models are found to have different degrees of influences 
on enzymatic and non-enzymatic defense systems, protein oxidation and lipid 
peroxidation (Sahin and Gumuslu, 2004). Emotional stress induced by 24 h 
immobilization causes TBARS increase in the brain, liver and heart in Wistar rats 
(Sosnovskii et al.. 1992; Sosnovskii and Kozlov, 1992). Stress causes an increase in 
TBARS and protein carbonyl content and a decrease in the glutathione content 
suggesting stress does cause universal oxidative damage. Rats subjected to 30 min 
cold-immobilization stress show increased TBARS and conjugated dienes in the 
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liver, heart and stomach (Kovacs et al., 1996). The potentiation of lipid peroxidation 
by stress may be due to insufficiency of the protective systems (Aydin et al., 2005) 
as depletion of antioxidants and antioxidant enzymes by stress have been observed 
in different tissues of rats (Al-Qirim et al., 2002; Zaidi et al., 2005). To understand 
the role of antioxidant enzymatic defenses in ROS injury following immobilization 
stress, the effect on mRNA expression of antioxidant enzymes was examined. The 
mRNA levels of all antioxidant enzymes were markedly decreased in the liver, 
while no effect was observed in heart, lung and kidney (Oishi and Machida, 2002). 
Mice subjected to chronic unpredictable stress show increased TBARS and a 
decrease in the activities of antioxidant enzymes indicating oxidative stress in heart 
and brain. (Hasan et al., 20]0).Antioxidant defense status in peripheral tissues is 
thus influenced by immobilization and chronic unpredictable stress and tissue 
specific regulation mechanisms of antioxidants exist in rats and mice. 
2.2.2. Stress and DNA damage and repair 
One basic trigger of various diseases including cancer, heart disease and 
neurodegenerative diseases is damage to DNA integrity (Hoeijmakers, 2001). 
Indeed, DNA damage induced by oxidative stress and deficient DNA-repair may 
have etiological and prognostic roles in cancer (Musarrat et al., 1996), diabetes and 
atherosclerosis (Wu et al., 2004). Several studies have examined the effect of stress 
on DNA integrity as stress has been found to cause production of ROS resulting in 
oxidative stress and increased lipid peroxidation. Greater production of ROS has 
been shown to produce increases in oxidative DNA-damage (Kang, 2002), which is 
an important etiological and prognostic factor in various chronic illnesses (Wu et al., 
2004).The mechanisms that would account in part for the relationship between stress 
and tumor development may be damage to DNA or DNA repair (Glaser et al., 
1985). The levels of methyltransferase, a DNA repair enzyme induced in response to 
carcinogen alkylation damage, were significantly lower in spleens from stressed 
animals (Glaser et al., 1985). The studies conducted with animals showed that when 
stress was primarily repeated and not endured on a single occasion alone, it led to 
DNA-damage. The study by (Fischman et al., 1996) also demonstrates The generality 
of the effects of stress across stressors. The study by (Irie et al., 2000) demonstrated 
that DNA-damage may be elicited by non-toxic materials via classical conditioning. 
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Finally, the findings of (Bagchi et al., 1999) provide evidence that stress-induced 
DNA fragmentation may be reduced by protective agents, and this may have 
important clinical implications Several studies found relations between certain 
psychological outcomes such as anxiety-tension, depression and anger with DNA-
damage(Dimitroglou et al., 2003; Irie et al., 2001a, 2002, 2003, 2005). In human 
studies (Glaser et al.,1985) assessed the differences in DNA repair in lymphocytes 
and showed that lymphocytes from highly stressed humans had significantly poorer 
DNA repair when exposed to X-irradiation than those from lowly stressed subjects. 
The biomarker of oxidative damage to DNA, 8-OH-dG, is elevated in the liver 
nuclear DNA of rats subjected to psychological stress (Adachi et al., 1993). These 
data provide evidence for a direct pathway through which stress could play a role in 
the incidence of cancer. 
2.3. Chemical Carcinogenesis 
People are continuously exposed exogenously to varying amounts of chemicals that 
have been shown to have carcinogenic or mutagenic properties in experimental 
systems. Exposure can occur exogenously when these agents are present in food, air 
or water, and also endogenously when they are products of metabolism or 
pathophysiologic states such as inflammation. It has been estimated that exposure to 
environmental chemical carcinogens may contribute significantly to the causation of 
a sizable fraction, perhaps a majority, of human cancers, when exposures are related 
to life style factors such as diet, tobacco use etc. Chemically induced neoplasia is a 
multistep process involving DNA damage and cell proliferation. Chemical 
carcinogens impact on various stages of this process and function through 
mgjfffication of cellular and molecular events. On the basis of the apparent 
differences by which chemicals participate in the carcinogenic process, they may be 
defined as genotoxic or epigenetic (non-genotoxic) (Williams and Weisburger, 
1983). Genotoxic agents usually refer to chemicals that directly damage genomic 
DNA, which in turn can result in mutation and/or clastogenic changes. Such 
chemicals are fi-equently activated in the target cell and produce a dose-dependent 
increase in neoplasm formation (Pitot et al., 1981). In contrast, non-genotoxic 
compounds appear to function through non-DNA reactive or indirect DNA reactive 
mechanisms. Although much less is known about the exact mode of action of non-
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genotoxic carcinogens, they modulate cell growth and ceil death. Changes in gene 
expression and ceil growth parameters are paramount in the action of nongenotoxic 
carcinogens. These agents frequently function during the promotion stage of the 
cancer process (Kolaja and Klaunig, 1996). Two possible mechanisms have been 
proposed for the induction of cancer. In one, an increase in DNA synthesis and 
mitosis by a nongenotoxic carcinogen may induce mutations in dividing cells 
through misrepair. With continual ceil division, mutations will result in an initiated 
preneoplastic cell that may clonally expand to a neoplasm. In addition, nongenotoxic 
agents may serve to stimulate the selective clonal growth of already spontaneously 
initiated cells (Ames and Gold, 1990). In maintaining cell number within a tissue, 
equilibrium exists between cell proliferation and cell death. The cancer process thus 
is a result of an imbalance between cell growth and death. Experimental evidence 
supports an important role for reactive oxygen species in the cancer process. 
Increases in the reactive oxygen in the cell, through either physiological 
modification or through chemical carcinogen exposure, contribute to the 
carcinogenic processes. This may be via genotoxic effects resulting in oxidative 
DNA adducts or through modification of gene expression (Klaunig and Kamendulis, 
2004). There are plethoras of carcinogens, of which few are described below. 
Although oxidative stress is described herein as a unifying thread, other modes of 
action may also be involved. ROS are commonly generated by electron transfer. 
although non-electron transfer routes can also occur, e.g.. Radiation. The activity of 
peroxides and radiation provide compelling evidence for the important participation 
of oxidative stress. 
2.3.1. Radiation 
The specific types and levels of radiation that cause cancer remain a matter of 
speculation (Doll, 1998; Jaworowski, 1999; Marks, 1999). Each day, over a billion 
particles of radiation cross paths with a human body. In spite of the disputation, 
there is a strong correlation between radiation exposure (generally, wavelengths 
under 320 nm) and cancer (Fry and Ley, 1984). Radiation damage to DNA may 
come about either directly or indirectly. Non-melanoma skin cancers are the most 
common, and are thought to be brought on by excessive exposure to UV rays 
(Sarasin, 1999). Those with xeroderma pigmentosum syndrome - a rare disease 
wherein the skin contains very little repair or defense mechanisms - have very high 
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skin cancer incidences. Hence, DNA repair and defense are important in the 
promotion and progression of skin cancer. High-energy radiation, e.g., x-rays, 
gamma rays, and particle radiation, affect matter by breaking molecular bonds or 
ejecting electrons (ionization). When ionizing radiation impinges upon an aqueous 
environment, O-H bonds within water molecules break to form the highly reactive 
•OH moieties (Plumb et al., 1999). 'OH insults DNA primarily by abstracting H* at 
various places on the helix. This process leaves behind radical lesions, which can 
form various oxyl and peroxyl radicals by reacting with O2 or superoxide radical, the 
resultant peroxides can undergo Fenton type reactions (Rashid et al., 1999). 
Malonaldehyde, formed by oxidative degradation of the ribose portion of DNA, is a 
chief product in such a sequence, in addition to 8-OH dG. Since the proximate 
nuclear environment is aqueous, at low to average levels of radical scavengers, 'OH 
induced DNA damage is the predominant type caused by ionizing radiation (Plumb 
et al., 1999). The mechanistic picture is complicated by generation of cationic-type 
species that alkylate cellular constituents (Seifter et al., 1984). 
2.3.2. Peroxides 
Various peroxides have long been associated with carcinogenesis (Hix and Augusto, 
1999). More than forty years ago, hydrogen peroxide was reported to be an initiator 
(Kovacic, 1959). In fact, many carcinogens indirectly generate H2O2, which in turn 
brings about increased amounts of ROS (Kovacic, 1959). More recent 
experimentation has elucidated many specifics concerning H202-induced DNA 
damage (Korzets et al., 1999), including its role in tumor promotion, oncogene 
activation, and gap-junction disruption (Huang et al., 1999). Hydrogen peroxide has 
also been implicated in apoptosis by attacking regulatory proteins (Riou et al., 
1999). The cytotoxicity and tumor-promoting ability of benzoyl peroxide (BPO) 
have also been dealt v/ith (Gopalakrishna et al., 1999). BPO is involved in the 
oxidation of several key enzymes, including protein kinases, which may play an 
important mechanistic role in promotion. Tumors may be caused by tert-Butyl 
hydroperoxide by forming DNA adducts via reactive methyl radicals (CHS) (Hix 
and Augusto, 1999). Transition metal ions attached to the DNA are apparently 
involved in the radical sequence. Enzymatic and non-enzymatic cleavage of 
peroxides generates three predominant types of radicals: alkoxyl, peroxyl, and 
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hydroxyl. These ROS have been implicated in DNA cleavage (Adam et al., 1998) as 
well as oxidation of DMA bases (Simandan et al., 1998). 
2.3.3. Haloalkanes (HAs) 
Carbon tetrachloride (CCI4) and other haloalkanes (HAs) are widely used industrial 
solvents. The carcinogenicity and toxicity associated with CCI4 exposure is well 
established (Frezza et al., 1994; Brennan and Schiestl, 1998). Many HAs. including 
CC14, are procarcinogens that become activated via a sequence of redox reactions 
whereby CYP450 acts as the principal catalyst in the dehalogenation (Yao et al., 
1994). In a study involving '*0, several oxidative paths and oxidative species were 
verified and the isotope was found to be present in large amounts in lipids and other 
macromolecules, indicating oxidation (Hatch et al., 1988). 
CCI4 _S_^ CCir - ^ CI3C -22_»^13COO- -tL_»Ci3C00H »Oxy Radicals 
Metabolism ofCCM 
Most carcinogens or their metabolites appear to interact directly with DNA as an 
important component in the oncogenic sequence. The radicals generated, during 
metabolism, in the immediate vicinity of the nucleic acids then effect chain scission, 
HA activity is marked by an ability to penetrate biological membranes (Ludek et al.. 
1998). Research involving HAs dealt with their effects on enzyme signaling 
(Roghani et al., 1987), tissue repair proteins and oncogenes (Camandola et al.. 
1999), including induction of human proto-oncogenes in transgenic mice 
(Tsunematsu et al., 1994). Studies with CHCI3 (Brennan and Schiestl, 1998) and 
CBr4 (DeGroot & Noll, 1989) indicate activity resembling that of CCI4 while 
BrCH2CH2Br and CCI4 were found to be synergistic (Camandola et al.. 1999). 
2.3.4. Aromatic amines 
(i) Hydrocarbon Types 
A detailed review incorporates a large body of knowledge concerning aromatic 
amines and their link to cancer (Vineis and Pirastu, 1997). Human exposure is 
primarily through various dyes, rubber, and oil industries, agricultural settings, and 
tobacco smoke. There are numerous case studies linking naphthylamine and 
benzidine to bladder cancer. It is proposed that bladder cancer in smokers comes 
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about primarily through exposure to ArAs, not PAH or other smoi<e byproducts. 
Twenty carcinogenic ArAs and ten noncarcinogenic ones were analyzed using real-
time, organ specific testing (Sasaki et al., 1999). Of the twenty, aniline, benzidine, 
many of their derivatives and other aromatic amines damaged DNA. Nine of the ten 
non-carcinogenic amines exhibited no adverse effects. Ring size of aromatic amines 
is directly related to their potency (Shapiro et al., 1998). Larger ring adducts 
intercalate and bind DNA grooves, which can distort the helical shape and inhibit 
repair. Some studies also suggest a role for ROS in aromatic amines carcinogenicity 
(Loftetal., 1999). 
(ii) Heterocyclic Types (Cooked Foods) 
Pyrolysis of food can create several types of heterocyclic amines, many of which are 
suspected in carcinogenesis (Adamson et al., 1996;Schut and Synderwine. 1999). 
They are generated primarily by reactions of amino acids in meats, and the amount 
produced depends upon the duration and temperature of cooking (Zheng et al.. 1998; 
Skog et al., 1998). Carcinogenic mechanisms involve ring epoxidation to form a 
phenol, or a multi-step process beginning with N-hydroxylation by CYP450 to 
create the RNHOH moiety which is esterified to RNHOCOR by N-acetyi transferase 
(NAT) (Manson and Benford, 1999). The two most prevalent heterocyclic amines in 
cooked foods are the imidazoquinoxaline (Ryu et al., 1999) and the imidazopyridine 
(Nagao et al., 1998). Exposure to former causes DNA damage and overexpression of 
oncogenes (Ryu et al., 1999), and later induces guanine specific DN.A adducts 
(Totsuka et al., 1996). 
2.3.5. Aromatic hydrocarbons 
Exposure to monocyclic (Wiemels et al., 1999) and polycyclic aromatic 
hydrocarbons (PAHs) is intimately linked to cancer incidence (Boffetta et al.. 1997). 
The chemicals are commonly found in industrial settings, diesel exhaust, foods and 
cigarette smoke (Schoket, 1999). Monocyclic and PAHs are procarcinogens; various 
endogenous entities, including CYP450, oxidize the rings to the active forms which 
are implicated in DNA binding and oxidative stress. PAH potency rises as the 
number of aromatic rings increases (Till et al.. 1999), whereby the larger adducts 
may interfere to a greater extent with various repair processes. Dibenzopyrene 
(DBP), a six-ringed aromatic hydrocarbon, is a more potent carcinogen than 
16 
(Rfview of Literature 
dimethylanthracene (3 rings) or benzopyrene (5 rings) (Arif et a!., 1999). Several 
endogenous moieties can be involved as catalysts in their metabolism, including 
CYP450, which can oxidize the rings to various epoxides. Since the repeated 
application of the carcinogenic PAHs alone results in production of tumors, many of 
which are malignant carcinomas (Shubik, 1950), they are considered complete 
carcinogens (Berenbium, 1974). Complete carcinogens carry out both initiating and 
promoting functions. When used in both initiating and promoting stages, they yield a 
higher incidence of carcinomas than does initiation with a PAH and promotion by 
TPA (Shubik, 1950). It was suggested that malignant tumor formation results from 
two or more carcinogen-induced mutations and that the role of promotion is to 
enlarge the size of the target cell population available for the second mutation 
(Hennings et al., 1983). Papillomas induced by repeated carcinogen application arise 
from significantly more cells than those induced by the carcinogen promoter 
sequence (Reddy and Fialkow, 1983) 
2.3.5.1. Metabolic activation of PAHs 
PAHs are ubiquitously distributed carcinogens in the environment and their 
carcinogenic potentials have been extensively studied in experimental animal 
models (Conney, 1982). PAHs acquire carcinogenecity only after they have been 
activated by xenobiotic-metabolizing enzymes (Phase I enzymes) to highly reactive 
metabolites capable of attacking cellular DNA. Cytochrome P450 (CYP) enzymes 
are central to the metabolic activation of these PAHs to epoxide intermediates, 
which are converted with the aid of epoxide hydrolase to the ultimate carcinogens, 
diol epoxides(Shimada & Kuriyama, 2004) . Historically, CYPlAl had been 
thought to be the sole enzyme responsible for the metabolic activation of most of the 
carcinogenic PAHs to reactive electrophiles in mice, rats, and rabbits (Conney. 
1982). However, recent studies have established that CYPlBi also activates PAHs 
to reactive metabolites at rates similar to or even higher than CYPlAl in 
experimental animals and humans. As a further cause of concern, human CYPIBI 
has also been shown to metabolize 17p-estradiol to a 4-hydroxylated product, a 
chemical considered to cause breast cancer in women (Spink et al., 1998). Both 
CYPlAl and IBI are expressed mainly in extrahepatic organs and thus make a 
major contribution to the incidence of cancers in these organs, when PAHs and other 
carcinogens are ingested into an animal's body (Shimada et al., 1996). PAHs induce 
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several xenobiotic metabolizing enzymes, including CYPIAl and IBI. through the 
aryl hydrocarbon receptor. Many studies have demonstrated that most carcinogenic 
PAHs are activated by the combined actions of CYPs and epoxide hydrolases to 
highly reactive diol-epoxides that initiate cell transformation (Gelboin. 1980; 
Conney, 1982). For a number of PAHs, including 7,12-dimethylbenz (a) anthracene 
(DMBA) the ultimate carcinogen is a so-called bay-region dihydrodiol epoxide, 
produced during cellular metabolism (Kapitulnik et al., 1978; Slaga et al., 1984). 
Biological systems have developed methods for dealing with electrophilic 
xenobiotics produced during Phase-J metabolisms; they are generally classified as 
Phase-ll enzymes . Many antioxidants and anticarcinogenic compounds that block 
the toxic and neoplastic effects of carcinogen share in common the ability to elevate 
levels of Phase-II detoxification enzymes, i.e., glutathione-S-transferases (GSTs). 
quinone reductase, and UDP-glucuronosyltransferases (Wattenberg, 1992: Hanausek 
et al., 2003; Walaszek et al., 2004). Substantial evidences have accumulated to 
suggest that induction of Phase 11 enzymes is a causal mechanism for protection, 
since these enzymes divert ultimate carcinogens from reacting with critical cellular 
macromolecules (Prochaska et al., 1992). 
2.4. N-Nitrosamines 
Nitrosamines are compounds having the general structure: 
where Rl and R2 are alkyl or aryl groups. Nitrosamines are present in water, soil 
and air. They can be found contaminating food, feeding stuff (where they create the 
highest risk for health), drugs, cosmetics, and pesticides (Hecht, l997;Hecht and 
Hoffman,1988; Osterdahl,1990 ) Nitrosamines are absorbed by skin, airways and the 
alimentary tract (Low, 1974) . There is evidence that nitroso compounds may be 
generated in vivo from nitrites or nitrates and primary, secondary and tertiary 
amines in organs of people who apparently were not exposed to these compounds 
(Brendler et al., 1992;Hinuma etal.,1990) 
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Human exposure to a wide range of N-nitrosocompounds occurs from diet, tobacco 
smoking, work place and drinking water (Bartsch and Spiegelhalder,1996; Tricker 
and Preussmann,1991) which are the major source of exposure in the general 
population( Tricker, 1997). Nitrate and nitrite are added to meat and fish for the 
purpose of preservation, as colour fixatives and as flavouring. Ingestion of nitrite 
and nitrate can result in the endogenous formation of nitroso compounds, 
particularly in the presence of nitrosatable precursors, such as primary amines, in the 
acidic condition of the stomach (Lin et al., 2002).Preformed exogenous nitrosamines 
are found mainly in cured meat products, smoked preserved foods, foods subjected 
to drying by additives such as malt in the production of beer and Whiskey, pickled 
and salty preserved foods ( Tricker and Preussmann, 1991) Available data suggest 
that nitrosamines are found more frequently and at higher concentration in Asian 
foods than in Western foods (Hotchkiss,1989).Nitrosamines are comparatively 
stable under conditions present in organisms, before being subjected to degradation 
to biologically active derivatives (Pr2ezdziecki,1980; Lake et al.,1982; Huang et 
al.,1992;). Nitrosamines reach the liver by the blood stream. In the liver 
microsomes, enzymes are present which are responsible for reactions of the first and 
second phase of biotransformation of nitrosocompounds. In the first phase of 
biotransformation of nitrosamines, hydroxylation and dealkylation are the main 
reactions. In the second phase, the products of the first phase undergo transformation 
to polar metabolites by the action of specific enzymes which conjugate them with 
glucuronic or sulfuric acids or aminoacids or glutathione. Enzymes of the first and 
second phases of biotransformations were detected not only in liver but also in the 
intestine, kidney, lungs, brain, skin and placenta (Przezdziecki,1980;Hinuma et al. 
1990;). Biotransformation reactions are catalyzed by microsomal enzymes 
dependent on cytochrome P-450, i.e. a set of hemoproteins catalyzing the activation 
of molecular oxygen and transfer of oxygen to lipophilic molecule of the xenobiotic 
(Hanke,1980; Labuc and Archer,1982; Lutz,1984; Hiroshi et a!., 1992). 
Nitrosamines are excreted partially in urine and exhaled in air. Remaining 
nitrosamines are degraded to carbon dioxide by active intermediates (Nikonorow 
and Urbanek, 1987). Active intermediates are very important fiom the toxicological 
point of view as many of them have carcinogenic activity. 
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2.5. N-Nitrosodiethylamine (NDEA) 
N-Nitrosodiethylamine (NDEA), also known as diethylnitrosamine or DEN, is a 
slightly yellow liquid with a boiling point of 175-1 77°C. It is soluble in water, 
ethanol, diethyl ether and organic solvents. 
Its chemical structure is 
CH, CH, \ 
N N =--=0 
CH3 CH, 
NDEA has had extensive use as an experimental carcinogen. NDEA has been found 
in a variety of products that would result in human exposure, including mainstream 
and sidestream tobacco smoke meat , whiskey, cured meats, salami, millet flour 
and dried cuttle fish (Brunnemann and Hoffmann, 1978; Hoffmann et al., 1980;Sen 
et al.. 1980; Loeppky, 1999) .The International Agency for Research on Cancer 
review (lARC 1978, 1982, 1987) concluded that NDEA was carcinogenic in all 
animal species tested. There are many NDEA bioassays and target organ studies in a 
variety of animal species and strains, including a large dose/response study in rats by 
the British Industrial Biological Research Association (BIBRA). 
NDEA is metabolized primarily in the liver by cytochrome P450 to ethyl-
acetoxyethyl-nitrosamine. This intermediate can be conjugated by the phase 11 
enzymes to a non toxic compound or it can produce ethyldiazonium ion that directly 
ethylates cellular macromolecules (Muzio et al; 1999). Metabolic activation of 
NDEA by cytochrome P450 enzymes is responsible for its cytotoxic, mutagenic and 
carcinogenic effects. Instrumental to them is the increased in ROS production 
caused by NDEA (Bansal et al;2000) .N-nitrosodiethylamine has been suggested to 
cause oxidative stress and cellular injury due to the enhanced formation of free 
radicals. (Ramakrishnan et al., 2006; Valko et al., 2006). NDEA has been shown to 
be metabolized to its active ethyl radical metabolite, and the reactive product 
interacts with DNA causing mutation which would lead to carcinogenesis (Anis et 
al;2001). 
The putative mechanism of NDEA-DNA adduct formation is shown in Fig.2. DNA-
adduct formation proceeds through an ethyl diazonium ion intermediate and 
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evolution of N2 (Michejda et al., 1982; Singer and Grunberger, 1983). Since this is a 
relatively simple and rapid alkylation mechanism, NDEA may produce DNA 
adducts in any tissue with appropriate activating P450 isozymes. Nitrosamine 
alkylation in each organ reflects the local level of bioactivation capacity, since the 
diazonium ion is too reactive to be transported to other organs in significant 
amounts. Additionally, P450 isozymes are responsible for detoxification of NDEA, 
thereby adding to the complexity of the biotransformation. After NDEA is bio 
activated to an electrophilic ethyl diazoniumion, it undergoes reaction with 
nucleophiles, including DNA bases, to form adducts. (Saenger, 1984). 
•s. P4S0 *Nv 
N — N = 0 » N—N-0 
CHjCH,-^ o„f<ADPH cHaCH^ 
^2 
NOEA OH 
CHjCHj 
CHjCH, — N^ ^  N + OH*-^-
+DNA 
H-
N — N = O + CH,CHO 
CHjCM, — DNA • N2 • HjO 
DNA Adducts 
Fig. 2. Biotransformation of NDEA and mechanism of DNA-formation. 
2.6. Oxidative stress and reactive oxygen species 
Oxidative stress occurs in a cell or tissue when the concentration of reactive oxygen 
species (ROS) generated exceeds the antioxidant capability of that cell (Sies,199l). 
ROS can be produced both endogenously and exogenously (Figure 3). Endogenous 
oxidative stress can be the result of normal cellular metabolism and oxidative 
phosphorylation. The metabolism of substances by the P450 enzyme system 
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generates oxygen free radicals through normal or futile cycling mechanisms (Parke 
and loannides, 1990). Exogenous sources of ROS can also impact on the overall 
oxidative status of a cell. Drugs, hormones, and other xenobiotic chemicals can 
produce ROS by either direct or indirect mechanisms (Trush and 
Kensler,1991;Halliwell, 1996). Alternatively, oxidative stress can also occur when 
there is a decrease in the antioxidant capacity of a cell. Non enzymatic antioxidant 
levels (vitamin E,vitamin C, glutathione, etc.) and enzymatic antioxidant levels 
(superoxide dismutase,glutathione peroxidase, and catalase) in the cell can be 
decreased through modification in gene expression, decreased in their uptake in the 
diet, or can be overloaded in ROS production, which creates a net increase in the 
amount of oxygen free radicals present in the cell (Vuillaume, 1987;Barber and 
Harris,!994;). Several human chronic disease states including cancer have been 
associated with oxidative stress produced through either an increased free radical 
generation and/or a decreased antioxidant level in the target cells and tissues (Trush 
and Kensler, 1991; Rice-Evans and Burdon, 1993) . A role for reactive oxygen 
radicals in the etiology of cancer is supported by epidemiologic studies. Specifically 
these epidemiologic studies illustrated the protective role for antioxidants against 
cancer development (Ames, 1983; Willett and MacMahon,l984) and a correlation 
between tumour induction and the intake of high concentrations of transition metals 
such as iron, which facilitate the production of free radicals (Nelson, 1992; Stevens 
and Nerishi,1992). The formation of oxidative stress may result in damage to critical 
cellular macromolecules including DNA, lipids, and proteins. Oxidative DNA 
damage may participate in ROS-induced carcinogenesis (Breimer, 1990). A 
common form of damage is the formation of hydroxy I ated bases of DNA. which are 
considered an important event in chemical carcinogenesis (Breimer, 1990. 
Chaudhary et al.,1994) . This adduct formation interferes with normal cell growth by 
causing genetic mutations and altering normal gene transcription. Several different 
pathways by which oxidative DNA damage leads to mutations have been proposed, 
including chemical modification of nucleotide moieties in DNA causing alteration in 
their hydrogen bonding, exacerbation of polymerase-specific hot spots. 
conformational change in the DNA templates, and the induction of a DNA 
polymerase conformation that is error prone (Feig et al., 1994). Formation of 8-
hydroxy-2'-deoxyguanosine (8-OHdG) [an oxidative modification of DNA produced 
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by hydroxylation in the C-8 position of deoxyguanosine residues by the hydroxy! 
radical (Floyd ,1990)] has been used as a measurement of oxidative DMA damage. 
A substantial body of evidence has been produced that links the production of 
reactive oxygen radicals, and subsequent oxidative stress and damage, to the 
pathogenesis of age-related and chronic diseases including cancer (Vuillama, 1987; 
Trush and kensler, 1991; Witz, 1991; Guyton «& Kensler, 1993). Reactive oxygen 
species (ROS) are derived from the metabolism of molecular oxygen (Halliwell, 
1999). Molecular oxygen (dioxygen) has a unique electronic configuration and is 
itself a radical. The addition of one electron to dioxygen forms the superoxide anion 
radical (02') (Miller et al., 1990). Superoxide anion, arising either through 
metabolic processes or following oxygen "activation" by physical irradiation, is 
considered the "primary" ROS, and can further interact with other molecules to 
generate "secondary" ROS, either directly or prevalently through enzyme-or metal 
catalyzed processes (Vaiko et al., 2005). These include singlet oxygen ('O2), 
hydrogen peroxide (H2O2), and the highly reactive hydroxy I radical (OH). The 
deleterious effects of oxygen are said to result from its metabolic reduction to these 
highly reactive and toxic species (Buechter, 1988). ROS normally exist in all 
aerobic cells in balance with biochemical antioxidants. Oxidative stress occurs when 
this critical balance is disrupted because of excess ROS, antioxidant depletion, or 
both (Scandalios, 2002). To counteract the oxidant effects and to restore redox 
balance, cells must reset important homeostatic parameters. ROS are not always 
harmful metabolic byproducts; when tightly regulated, ROS can act as intracellular 
signaling molecules (Klein & Ackerman, 2003). ROS can be produced by both 
endogenous and exogenous sources. In living cells, the major sources of endogenous 
ROS are hydrogen peroxide and superoxide anion, which are generated as by 
products of cellular metabolism such as mitochondrial respiration (Nohl et al.. 
2003). Alternatively, hydrogen peroxide may be converted into water by the 
enzymes catalase or glutathione peroxidase. Variability or inductive changes in the 
expression of these enzymes can significantly influence cellular redox potential. 
ROS can cause tissue damage by reacting with lipids in cellular membranes, 
nucleotides in DNA (Ahsan et al., 2003), sulphydryl groups in proteins (Knight, 
1995) and cross-linking/fragmentation of ribonucleoproteins (Waris & Alam. 1998). 
The relatively unreactive superoxide anion radical is converted by superoxide 
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dismutase (SOD) into H2O2, which in turn take part in the "Fenton reaction", with 
transition metal ion (copper or iron) as catalysts, to produce the ver> reactive 
hydroxyl radical (Aruoma et al., 1989; Halliwell & Gutteridge, 1990; Haliwell and 
Gutteridge, 1992; Halliwell, 1993). ROS can be produced by a host of exogenous 
processes. Environmental agents including nongenotoxic carcinogens can directly 
generate or indirectly induce ROS in cells (Rice-Evans and Burdon, 1993). The 
induction of oxidative stress and damage has been observed following exposure to 
xenobiotics of varied structure and activities (Klaunig et al., 1997). 
EndOBanous sources 
C^ochriMne P4S0 
Exoganous sources 
UVHght 
tonizftig racflatkm 
bfiflammatory cytokines 
Pat)K>g«ns 
Oxidative stress 
Damage to Nucleic acicte, 
Proteins a ndUplfls 
CtifMnosomal inst8l>l%, 
MuUitkMrts 
Loss of (M'ganeile functkms, 
Memlu^ne ctemage 
Cancer 
Fig.3. Pathways illustrating the sources of reactive oxygen species and its role in the 
development of cancer. 
2.6.1. Generation of ROS: 
During the earliest periods of life on earth, living organisms were chiefly anaerobic 
(Sahnoun et al., 1997). As evolution took place in the presence of steadily increasing 
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amounts of atmospheric oxygen, life forms adopted numerous mechanisms to 
defend against, as well as utilize, the reactivity of the molecule. The marked activity 
can be attributed to the propensity of molecular oxygen to form various radical 
species. The formation of ROS is guided by external and internal agents, e.g., 
irradiation, exogenous chemicals, and endogenous entities, e.g., phagocytes and 
enzymes, such as cytochrome P450 mono-oxygenases (CYP450). Likewise, creation 
of ROS can be ebbed or reversed in the presence of certain agents, e.g., antioxidants 
and various enzymes, including superoxide dismutase (SOD), glutathione reductase 
(GR) and catalase (CAT). Aerobic life, as we know it, might be viewed as a contest 
between the formation and deactivation of ROS. In this light, oxidative stress can be 
defined as a state wherein this process becomes unbalanced. CYP 450, a chief 
enzyme in many oxidative processes, manipulates molecular oxygen, with the help 
of a reducing agent (designated RH2 in reaction 1), in order to monooxygenate a 
targeted substrate (Halliwell and Gutteridge, 1999). Usually, the oxidation is helpful 
to the organism, e.g., hydroxylation of Phenobarbital, leading to detoxification and 
excretion. However, as in the case of aromatic hydrocarbons, carbon tetrachloride 
and others, CYP 450 oxidative metabolites can be harmful. 
Substrate-H + 02+RH2 • Substrate-OH + R + H2O (1) 
Mono-oxygenation of substrate by cytochrome P450 
Molecular oxygen often undergoes a single electron reduction to form the 
superoxide radical anion (SO") (Hauptmann and Cadenas, 1997). The production of 
superoxide occurs mostly within the mitochondria of a cell (Cadenas and Sies. 
1998). The mitochondrial electron transport chain is the main source of ATP in the 
mammalian cell and thus is essential for life. During energy transduction a small 
number of electrons "leak" to oxygen prematurely, forming the oxygen free radical 
superoxide (Valko, 2004; Kovacic, 2005). In vivo, SO' can be converted to various 
oxidative species, including: peroxides and various oxy radicals, namely hydroxyl 
(OH), peroxyl (ROO) alkoxyl (RO). Such entities, including SO" itself can cause 
several internal anomalies, including: enzyme inactivation, lipid and protein 
peroxidation, and DNA oxidation (Halliwell and Gutteridge, 1999). Superoxide 
radical is usually neutralized by enzymatic conversion to the less reactive, non-
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radical hydrogen peroxide via SOD (reaction II). Tliis activity is often observed 
occurring along the mitochondrial electron transport chain. 
2O2" +2H^ • H2O2 + O2 (11) 
Dismutation of superoxide 
Hydrogen peroxide, which has various duties and metabolic fates, can be Fenton 
catalyzed to form one of the most powerful ROS, the hydroxyl radical (reaction III). 
The Fenton reaction is part of a net transformation called the Haber-Weiss reaction, 
whereby superoxide and molecular oxygen undergo redox cycling with a catalyst, 
usually iron, (reaction IV). The redox state of the cell is largely linked to an iron 
(and copper) redox couple and is maintained within strict physiological limits. It has 
been suggested that iron regulation ensures that there is no free intracellular iron; 
however, in vivo, under stress conditions, an excess of superoxide releases "free 
iron" from iron containing molecules. The release of iron by superoxide has been 
demonstrated for [4Fe-4S] cluster containing enzymes of the dehydratase-lyase 
family (Liochev and Fridovich, 1994). The released Fe^^ can participate in the 
Fenton reaction, generating highly reactive hydroxyl radical. Thus under stress 
conditions, 02'" acts as an oxidant of [4Fe-4S] cluster-containing enzymes and 
facilitates OH production from H2O2 by making Fe^ "^  available for the Fenton 
reaction (Leonard et al., 2004; Valko et al., 2005). Processes like these compel 
organisms to limit the presence of catalytic entities like metals. 
Fe(ll) + H2O2 • Fe(lII) + HO-+ HO" (III) 
Fenton reaction 
Fe (III) + O2" • Fe(II) + O2 
Fe (II) + H2O2 • Fe(IlI) + HO" +H0-
02' + H2O2 • H 0 + 0 H - + 0 2 (IV) 
Haber-Weiss reaction 
The hydroxyl radical is the neutral form of the hydroxide ion. The hydroxy! radical 
has a high reactivity, making it a very dangerous radical with a very short in vivu 
half-life of approx. 10"^ s (Pastor, 2000). Thus when produced in vivo OH reacts 
close to its site of formation. 
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Catalase keeps the level of hydrogen peroxide in check via reactions that form water 
and molecular oxygen (reaction V). In addition, glutathione (GSH), which reacts 
with hydrogen peroxide to form water and oxidized glutathione (GSSG), can act in a 
variety of ways to combat radical formation (Halliwell and Gutteridge, 1999). Many 
other species, including metals, metal chelators, cofactors, antioxidants, singlet 
oxygen, and enzymes are involved in these redox transformations. 
2H2O2 • 2H2O + O2 
Decomposition of hydrogen peroxide by catalase 
Additional reactive radicals derived from oxygen that can be formed in living 
systems are peroxyl radicals (ROO"). The simplest peroxyl radical is HOO, which is 
the protonated form (conjugate acid; pKa ~ 4.8) of superoxide and is usually termed 
either hydroperoxyl radical or perhydroxyl radical. With this pKa value, only -0.3% 
of any superoxide present in the cytosol of a typical cell is in the protonated form 
(De Grey, 2002). It has been demonstrated that hydroperoxyl radical initiates fatty 
acid peroxidation by two parallel pathways: fatty acid hydroperoxide (LOOH)-
independent and LOOH dependent (Aikens and Dix, 1991). The LOOH-dependent 
pathway of HO2" initiated fatty acid peroxidation may be relevant to mechanisms of 
lipid peroxidation initiation in vivo (Valko et al., 2007). 
2.6.2. Oxygen radicals and lipid peroxidation: 
Initiation of lipid peroxidation in a membrane or polyunsaturated fatty acid is due to 
the attack of any species that has sufficient reactivity to abstract hydrogen. 
Lipid-H+ OH •Lipid +H2O 
Since hydrogen atom has only one electron this leaves behind an unpaired electron 
on the carbon atom. The carbon radical in a polyunsaturated fatty acid tends to be 
stabilized by a molecular rearrangement to produce a conjugated diene. which 
rapidly reacts with O2 to give a hydroperoxy radical. 
Lipid+ O2 •Lipid-02 
(After molecular rearrangement) 
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Hydroperoxy radicals abstract hydrogen atoms from other lipid molecules - this is 
the propagation stage of lipid peroxidation and so continues the chain reaction of 
lipid peroxidation. The hydroperoxy radical combines with the hydrogen atom that it 
abstracts to give a lipid hydroperoxide R-OOH (Halliwell and Gutteridge, 1984) 
Lipid-02 + Lipid-H • Lipid-02 H + Lipid 
Pure lipid hydroperoxides are fairly stable at physiological temperatures and a major 
role of transition metals is to catalyze their decomposition. Many metal complexes 
that can do this are present in vivo. They include simple complexes of iron salts with 
phosphate ion or phosphate esters such as ADP. Haem, hemoglobin, peroxidase, 
cytochrome P-450, other cytochromes and non-haem iron proteins are also effective 
(O'Brien, 1969; Kaschnitz and Hatefi, 1975; Gutteridge, 1977; Aust and Svingen, 
1982). All these should contribute to the propagation of lipid peroxidation in 
membranes in vivo. A reduced iron compound can react with lipid hydroperoxides 
(lipid-OaH), in a similar way to its reaction with H2O2 to give alkoxy (lipid-O) 
radicals. 
Lipid-02H + Fe^*-complex • Fe^^ -complex + OH' + lipid-O' 
(Fenton reaction) 
With an iron (III) compound a peroxy (lipid- O2.) radical will form: 
Lipid-OaH + Fe^ "^ -complex • lipid- O2. + H^ + Fe^^-complex 
Both alkoxy and peroxy radicals stimulate the chain reaction of lipid peroxidation by 
abstracting further hydrogen atoms. 
2.6.3. Lipid peroxidation and carcinogenesis: 
Lipid peroxidation generates a constellation of products among which are reactive 
electrophiles such as epoxides and aldehydes (Esterbauer, 1985; Janero, 1990). The 
major aldehyde product of lipid peroxidation other than Malondialdehyde (MDA) 
(Mamett, 1999) is 4-hydroxy-2-nonenal (HNE) (Valko et al., 2006). MDA is 
mutagenic in bacterial and mammalian cells and carcinogenic in rats (Mukai and 
Goldstein, 1976). It is highly electrophilic as well as nucleophilic and reacts not only 
with cellular nucleophiles but leads to self-condensation to form MDA oligomers 
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(Golding et.al., 1989). The dimer of MDA is approximately equipotent to 
monomeric MDA as a mutagen (Riggins and Marnett, 2001). MDA reacts with 
nucleic acid bases at physiological pH to form adducts to dG, dA and dC (Fig.4) 
(Setoeta!., 1981;Nairetal., 1984; Marnett etal., 1986; Stone et.al., 1990a,b). 
DNA 
HO' H 
MDA Mi6 MiA MiC 
Fig 4. Generation of monomeric adducts from MDA reaction with DNA. 
In addition, MDA can attack amino groups on the protein molecule to form both 
intramolecular cross links and also cross-links between different protein molecules. 
HCOCH2CHO + protein / 
\ 
NH2 
NH2 
-NH — 
'N = 
Intramolecular 
- C H 
:CH ' 
cross-
CH 
link 
HCO.CH2.CHO + 2 Protein NH2 
Protein • • N H C H ^ C H - •CH: rN -Protein 
Intramolecular cross-link 
Enzymes that require -NH2 or —SH groups for their activity are usually inhibited 
during lipid peroxidation e.g., the glucose-6-phosphate enzyme found in liver 
microsomal fractions is inhibited as its -SH groups are attacked. HNE and other low 
molecular weight products of lipid peroxidation have been shown to inhibit protein 
synthesis and to interfere with the growth of bacteria and animal cells in culture 
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(Halliwell and Gutteridge, 1999). The production of MDA and its reactions with 
DNA and proteins provides a link between lipid peroxidation and genetic disease. 
Furthermore, DNA adduction by IVIDA correlates to alterations in cell cycle control 
and gene expression in cultured cells (Ji et.al., 1998). Thus lipid peroxidation must 
be considered significant endogenous source of DNA damage and mutations that 
contribute to human genetic diseases including cancer. 
2.6.4. Oxidative DNA damage and carcinogenesis: 
Damage to DNA by ROS has been widely accepted as a major cause of cancer 
(Ames, 1983). In a given cell, an estimated 10^  oxidative lesions per day are formed 
(Fraga et al., 1990). Over 100 oxidative DNA adducts have been identified (Von 
Sonntag, 1987; Dizdaroglu, 1992; Demple and Harrison, 1994). ROS can directly 
produce single- or double-stranded DNA breaks, purine, pyrimidine, or deoxyribose 
modifications, and DNA cross-links. Persistent DNA damage can result in arrest or 
induction of transcription, induction of signal transduction pathways, replication 
errors and genomic instability, all of which are seen in carcinogenesis (Marnett. 
2000; Valko et al., 2006). Division of cells with unpaired or misrepaired damage 
leads to mutations. Human studies support the experimentally based notion of 
oxidative DNA damage as an important mutagenic and apparently carcinogenic 
factor (Loft & Poulsen, 1996). The majority of mutations induced by ROS appear to 
involve modification of guanine, causing G—>T transversions (Higinbotham et al.. 
1992; Demple et al., 1994; Denissenko et al., 1996; Lunec et al., 2002). If it occurs 
in critical genes such as oncogenes or tumor suppressor genes, initiation/progression 
can result (Ames et al., 1993). Indeed, these species can act at several steps in 
multistage carcinogenesis. It is now assumed that ROS are involved in both the 
initiation and progression of cancer (Moller et al., 1998). Because of the multiplicity 
of DNA modifications produced by ROS, it has been difficult to establish the 
frequency and specificity of mutations by individual oxygen radical induced lesions. 
Some of these modified bases have been found to possess mutagenic properties. 
Therefore, if not repaired they can lead to carcinogenesis. Studies show that 
although all the four bases are modified by ROS, mutations are usually related to 
modification of GC base pairs, while that of AT base pair rarely leads to mutations 
(Retel et al., 1993). These mutations are usually base pair substitutions, whereas 
base deletions and insertions are less frequent. In human tumors. G to I 
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transversions are the most frequent mutations in the p53 suppressor gene (Brash et 
a!., 1991; Hollstein et al., 1991; Harris & HoUstein, 1993). Using single stranded 
DNA template in a sensitive forward mutation system, various mutations, including 
tandem double CC^TT substitution have been observed in DNA treated with 
oxygen free radicals (Reid and Loeb, 1993). Elevated levels of modified bases in 
cancerous tissue may be due to the production of large amount of H2O2, which has 
found to be characteristic of human tumor cells (Szatrowski & Nathan, 1991; 
Olinski et al., 1998). Initiation of cancer in humans by ROS is further supported by 
the presence of oxidative DNA modifications in cancer tissue (Ames et al., 1993: 
Poulsen et al., 1998). Many forms of reactive oxygen species are capable of forming 
oxidized bases. The hydroxyl radical in particular has been shown to produce a 
number of oxidized DNA lesions (Mamett, 2000). The reactivity of the hydroxyl 
molecule is such that its migration in the cell is limited and thus reacts quickly with 
cellular components (Sies, 1985). For the hydroxyl radical to react and oxidize 
DNA, it must be generated adjacent to the nucleic acid material. Hydrogen peroxide 
(H2O2), a precursor to hydroxyl radical, is less reactive and more readily diffusible 
and thus more likely to be involved in the formation of oxidized bases (Guyton and 
Kensler, 1993; Barber and Harris, 1994). Peroxynitrite, another strong cellular 
oxidant, is formed from the coupling of nitric oxide and superoxide (Beckman et al.. 
1990; Koppenol et al., 1992). As with H2O2, peroxynitrite is diffusible between cells 
and is taken up by active transport mechanisms into cells (Radi, 1998). Equally 
important to the induction of mutation by reactive oxygen species is the fact that 
nitric oxide and superoxide are produced in activated macrophages, and as such, it is 
likely that peroxynitrite is formed in proximity to these cells. The DNA damaging 
capability of peroxynitrite may therefore help to explain the reported association 
between inflammation and mutation (Mamett, 2000). 
Oxidation of guanine at the C8 position results in the formation of 8-
hydroxydeoxyguanosine (0H8dG), probably the most studied oxidative DNA 
adduct. This oxidative DNA lesion results in site-specific mutagenesis, is mutagenic 
in bacterial and mammalian cells, and produces G-» T transversions that are wideh 
found in mutated oncogenes and tumor suppressor genes (Shibutani et al., 1991: 
Moriya, 1993; Hussain and Harris, 1998). In addition, reactive oxygen species can 
react with dGTP in the nucleotide pool to form 0H8dG. Therefore, it is postulated 
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that during DNA replication, 0H8dG in the nucleotide pool will be incorporated 
into DNA opposite dC or dA on the template strand, resulting in A:T to C.G 
transversions (Cheng et al., 1992; Demple and Harrison, 1994). 0H8dG also 
produces dose-related increases in cellular transformation, which can be prevented 
by antioxidants, further supporting the role of 0H8dG in the carcinogenic process 
(Zhang et al., 2000). Other oxidative DNA lesions, such as 8-oxo-adenine, thymine 
glycol, 5-hydroxy-deoxycytidine, as well as several uracil analogs, have been shown 
to be mutagenic (Wang et al., 1998; Kreutzer and Essigmann, 1998). In summary, 
oxidized DNA bases appear to be mutagenic and capable of inducing mutations that 
are commonly observed in neoplasia. 
2.6.5. Oxidative stress and cell growth regulation 
A role for reactive oxygen species production and oxidative stress has been 
proposed for both the stimulation of cell proliferation and for cell deletion by 
apoptosis (Burdon, 1995; Slater et al., 1995) The mechanisms for the involvement of 
oxidative stress in the induction of the cell proliferation and apoptotic processes are 
not known, but clearly do not involve a universal mechanism. The effects of reactive 
oxygen species and oxidative stress within cells appear to be cell specific and 
dependent upon the form as well as the intercellular concentration of reactive 
oxygen species. Thus, the involvement of reactive oxygen species in cell growth 
regulation is complex, and dependent on a number of cellular and biochemical 
parameters (Klaunig and Kamendulis, 2004). 
Reactive oxygen species function to induce cell proliferation during the tumor 
promotion stage of carcinogenesis (Cerutti, 1985; Bickers & Athar, 2006). Both 
H2O2 and superoxide anion induce mitogenesis and cell proliferation in several 
mammalian cell types (D'Souza et al., 1993). Furthermore, a reduction in cellular 
oxidants via supplementation with antioxidants such as superoxide dismutase. 
catalase, P-carotene, and flavonoids inhibits cell proliferation in vitro (Alliangana, 
1996). Oxidative stress also modulates apoptosis. High concentrations of reactive 
oxygen species trigger an apoptotic signaling pathway, resulting in cell loss 
(Dypbukt et al., 1994). A num.ber of endogenous substances (prostaglandins, and 
lipid hydroperoxides), redox cycling compounds (quinones, adriamycin). and 
growth factors (transforming growth factor P and tumor necrosis factor a) induce 
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apoptosis via the generation of reactive oxygen species (Sandstrom et ai., 1994; 
Aoshima et al., 1997). Antioxidants such as N-acetyl cysteine (NAC), glutathione, 
and dithiothreitol inhibit the apoptotic process, further supporting the link between 
reactive oxygen species induction and apoptosis (Sandstrom et al., 1994). Although 
no single mechanism explains the increased cell proliferation and/or inhibition of 
apoptosis observed following conditions that favor increased cellular oxidants, 
mounting evidence is emerging that links reactive oxygen species with altered 
expression of growth regulatory genes. 
2.7. Antioxidants 
Exposure to free radicals from a variety of sources has led organisms to develop a 
series of defense mechanisms (Cadenas, 1997). These in vivo defense mechanisms 
against free radical-induced oxidative stress involve: (i) preventive mechanisms, (ii) 
repair mechanisms, (iii) physical defenses, and (iv) antioxidant defenses (Valko et 
al., 2007). Enzymatic antioxidant defenses include superoxide dismutase (SOD), 
catalase (CAT) and glutathione peroxidase (GPx). They are considered as primary 
antioxidant enzymes, since they are involved in the direct elimination of active 
oxygen species. Glutathione-S-transferase (GST), glutathione reductase (GR) and 
glucose-6-phosphate dehydrogenase (G6PD) are secondary antioxidants which help 
in the detoxification of reactive oxygen species by decreasing peroxide levels (e.g.. 
GST) or by maintaining a steady supply of metabolic intermediates like glutathione 
and NADPH for the primary antioxidant enzymes. The non-enzymatic small 
molecules include sulphydryl compounds such as glutathione (GSH) ascorbic acid, 
flavonoids and other antioxidants (Sun, 1990). Under normal conditions there is a 
balance between both the activities and the intracellular levels of these antioxidants. 
This balance is essential for the survival of organisms and their health. 
2.7.1. Biochemistry of antioxidant enzymes 
Superoxide Dismutase (SOD) (E. C 1.15.1.1) 
SOD was first discovered by McCord and Fridovich in 1969 (McCord and 
Fridovich, 1969). The enzyme is believed to be present in all oxygen metabolizing 
cells but lacking in most obligate anaerobes, presumably because its physiological 
function is to provide a defense against the potentially damaging reactivities of the 
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superoxide radical (02') generated by aerobic metabolic reactions (McCord et a!.. 
1971). This enzyme catalyzes the reaction 
Of + 02- • H2O2 + O2 
Four different forms of SOD have been found to date (Fridovich, 1974): two 
containing copper and zinc, one manganese and one iron. CuZnSOD is found in the 
cytosol of most eukaryotic cells (Fridovich, 1975), a different form of CuZnSOD is 
found in extracellular fluids (Marklund, 1982; Marklund, 1984). MnSOD is located 
in the mitochondrial matrix as well as in bacteria, while FeSOD is present in many 
aerobic bacteria (Fridovich, 1974). FeSOD and MnSOD share considerable 
homology, they are very different from CuZnSODs except in their activity (Banister 
et al., 1987). Diminished amounts of MnSOD have been found in almost all the 
tumors examined. Lowered amounts of the CuZnSOD have been found in many, but 
not all tumors. At the same time tumors have been shown to produce superoxide 
radicals, therefore, diminished enzyme activities along with radical production may 
lead to many of the observed properties of cancer cells (Oberley and Buettner, 
1979). Numerous studies in cultured cells suggested that MnSOD might function as 
a new type of tumor suppressor gene (Amstad et al., 1997; Zhao et al., 2001; Zhao et 
al., 2002). 
Catalase (CAT) (E.C 1.11.1.6) 
Catalase is one of the oldest known enzymes; it was named by Loew in 1901 (Percy. 
1984). The enzyme catalyzes the reaction 
2H2O2 •2H2O + O2 
Most aerobic cells contain this enzyme. In animals, CAT is present in all major body 
organs, being especially concentrated in liver and erythrocytes. At the subcellular 
level, CAT is found mostly in peroxisomes (80%) and cytosol (20%) (Sun, 1990). 
Most purified catalases have been shown to consist of four protein subunits, each of 
which contains a beam group bound to its active site (Halliwell and Guttendge. 
1990). Catalase activity is found to be low in many animal tumor cell lines (Bozzi et 
al., 1976). Animal studies have also shown lower CAT activity in tumor than in 
normal tissue (Tisdale and Mahmoud, 1983). 
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Glutathione-S-Transferase (GST) (E.C 2.5.1.18) 
GSTs are a family of enzymes that utilise glutathione in reactions contributing to the 
transformation of a wide range of compounds, including carcinogens, xenobiotics, 
therapeutic drugs and products of oxidative stress (Valko et al., 2007). They were 
originally observed in the catalysis of the first step in the formation of the 
mercapturic acids (Booth et al, 1961). GSTs occur in substantial quantities in liver 
and other mammalian tissues e.g., erythrocytes and intestines (Marcus et al., 1978). 
A large number of studies have established an association between cancer incidence 
and various disorders of GSH-related enzyme functions, alterations of GSTs being 
most frequently reported (Pastore et al., 2003). 
Glutathione Reductase (GR) (E.C 1.6.4.2) 
GR was initially observed in livers from various animals by Hopkins and Elliot in 
1931 (Hopkins and Elliot, 1931) and later isolated from ox, sheep and rabbit liver by 
Mann in 1932 (Mann, 1932). The enzyme catalyses the reaction: 
GSSG + NADPH + H* • 2GSH + NADP^ 
The enzyme is found in cytosol and mitochondria. GR can also catalyse reduction of 
certain mixed disulphides, such as that between GSH and coenzyme A. Glutathione 
avtivity has been found to be variable in different tumors, however it was found to 
be lowered in most of them. In a wide variety of mouse tumors, GR activities were. 
in general, lower in the tumors as compared to corresponding normal tissues 
(Tisdale and Mahmoud, 1983). 
Glutathione (GSH) 
Glutathione, the most abundant low molecular-weight thiol in mammalian cells, is 
present in reduced (GSH) and oxidized (GSSG) forms (Meister and Anderson. 
1983). The main protective roles of glutathione against oxidative stress are: (i) 
glutathione is a cofactor of several detoxifying enzymes against oxidative stress, 
e.g., glutathione peroxidase, glutathions transferase and others; (ii) GSH participates 
in amino acid transport through the plasma membrane; (iii) GSH scavenges 
hydroxyl radical and singlet oxygen directly, detoxifying hydrogen peroxide and 
lipid peroxides by the catalytic action of glutathione peroxidase; (iv) GSH is able to 
regenerate the most important antioxidants, vitamin C and E, back to their active 
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forms; glutathione can reduce the tocopherol radical of vitamin E directly, or 
indirectly, via reduction of semidehydroascorbate to ascorbate (Masella et al.. 2005). 
The capacity of GSH to regenerate the most important antioxidants is linked with 
the redox state of the glutathione disulphide-glutathione couple (GSSG/2GSH) 
(Pastore et al., 2003). This ratio is normally closely regulated. Disruption of this 
ratio is involved in several cellular reactions involved in signal transduction and cell 
cycle regulation under conditions of oxidative stress (Schafer and Buettner, 2001). It 
is therefore presumed that decreased GSH would contribute to cell death only when 
oxidative stress becomes prolonged, and cellular systems are not sufficient to 
counteract the reactive oxygen species mediated insult (Estrela et al., 2006). 
Since free radicals are involved in both initiation and promotion stages of 
carcinogenesis, one may expect that free radical scavengers should function as 
inhibitors in the neoplastic processes. Much data has been accumulated on this topic. 
Antioxidants have been shown to inhibit both initiation and promotion in 
sscarcinogenesis and counteract cell immortalisation and transformation (Sun. 
1990). 
2.8. Chemoprevention 
The term chemoprevention was first introduced by Sporn, 1976. in contrast to 
chemotherapy, when he referred to the prevention of development of cancer both by 
natural forms of vitamin A and its synthetic analogues. This strategy seems to be 
promising for reducing cancer incidence both in well-defined high-risk groups of 
people and also in the general population. Chemoprevention is now defined as the 
use of specific agents to suppress or reverse carcinogenesis (Greenwald and Kelloff 
1996). Primary prevention of cancer is one of the key approaches to the control of 
cancer. It includes (i) avoiding exposure to known cancer-causing agents, (ii) 
enhancement of host defence mechanisms, (iii) chemoprevention (Kakizoe. 2003). 
Cancer chemoprevention may target various processes as proposed by Kellof et al.. 
(1996) e.g., prevention of carcinogen binding to DNA, enhancement of DNA repair, 
scavenging of oxygen radicals etc. 
2.8.1. Antioxidants in Cancer Prevention 
In the last few years, there has been growing interest in the role played by oxidative 
reactions in human diseases. Since oxidative stress is generally perceived as one of 
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the major causes for the accumulation of mutations in the genome, antioxidants are 
believed to provide protection against cancer. A number of natural and synthetic 
antioxidants are known to retard chemical carcinogenesis in experimental animal 
models, and epidemiological studies suggest that a diet rich in plant products 
containing natural antioxidants may be deterrent to carcinogenecity (Sardas. 2003). 
The mechanisms of the anticarcinogenic effects of antioxidants are not fully 
understood. However, the evidence available so far suggest that the most plausible 
mechanism for the anti-carcinogenic activity of antioxidants are: (1) scavenging of 
reactive oxygen species, free radicals and electrophiles; (2) possible attenuation of 
the formation of activated carcinogenic species by phase 1 biotransformation 
enzymes and; (3) enhancement of detoxification of electrophiles by inducing phase 
11 detoxification enzymes such as GST and quinone reductase (Sardas, 2003). 
Carcinogens administered to animals are absorbed from the gastrointestinal tract or 
from the site of administration, and are then distributed throughout the body and 
metabolised in tissues including the liver and target sites. They are detoxified or 
activated enzymatically, and activated metabolites or ROS then covalently bind to 
cellular macromolecules thus causing DNA or cellular damage followed by 
carcinogenesis (Ito and Hirose, 1989). Antioxidants can modify the carcinogenic 
process at different stages, including (1) alteration of the metabolic activation of a 
precarcinogen by (a) inhibition of the activating enzyme or (b) alteration of the 
metabolic pattern of the carcinogen via selective enzyme induction; (2) prevention 
of the reaction between the ultimate carcinogen and DNA by (a) direct interaction 
with the carcinogenic species, (b) increased detoxication by antioxidant-inducible 
enzymes, or (c) competition between carcinogen and antioxidant in the binding 
process (Wattenberg, i978a, b, 1981). 
In the process of finding the most efficient agents for better prevention and cure of 
cancer many natural as well as synthetic antioxidants have been studied. Two such 
antioxidants; quercetin and melatonin and a medicinal plant extract of podophyllum 
hexandrum, have been extensively studied for their antioxidant properties against 
different cancers and were used in this study as well. 
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2.8.2. Melatonin (N-acetyl-5-methoxy-tryptamine) 
HaC^O 
HN.,^.CH3 T 
O 
Melatonin is the main (indole) hormone of the pineal gland synthesised from 
tryptophan predominantly during the night (Arendt, 1995). Melatonin is critical for 
the regulation of circadian and seasonal changes in various aspects of physiology 
and neuroendocrine function (Arendt, 1995; Pevet et al., 2002). Since 1993, when 
potent antioxidant properties of melatonin were discovered (Tan et al., 1993), many 
studies have confirmed the ability of melatonin to protect DNA from free radical 
damage. It was shown to be a very efficient scavenger of free radicals and was found 
to be more effective than other well known antioxidants such as glutathione and 
vitamin E (Musatov et al., 1998; Fieri et al., 1994)). Rieter et al (1995) reported that 
melatonin is a potent quencher of hydroxyl radicals. Melatonin in vitro directly 
scavenges OH (Tan et al., 1993), H2O2 (Barlow-Walden et al., 1995), singlet 
oxygen (Qi et al., 2001) and inhibits lipid peroxidation (Fieri et al., 1994). Likewise, 
melatonin can stimulate a number of antioxidative enzymes including SOD (Antolin 
et al., 1996), GFx (Fablos et al., 1998), GR (Urata et al., 1999) and catalase 
(Barlow-Walden et al., 1995). It has been shown that melatonin enhances 
intracellular glutathione levels by stimulating the rate-limiting enzyme in its 
synthesis, y-glutamylcysteine synthase, which inhibits the peroxidative enzymes 
(Fierreflche and Laborit, 1995). There is evidence that melatonin stablizes 
microsomal membranes; thereby probably helping them resist oxidative damage 
(Karbownik et al., 2001). It has also been shown to increase the efficiency of the 
electron transport chain and, as a consequence, to reduce electron leakage and the 
generation of free radicals (Reiter et al., 2001). It was shown that melatonin reduced 
the formation of 8-hydroxy-2'-deoxyguanosine more effectively than some classic 
antioxidants (Qi et al., 2001). Thus melatonin acts as a direct scavenger of free 
radicals with the ability to detoxify reactive oxygen species and indirectly increasing 
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the activity of the antioxidative defence systems (Reiter et a!., 2001; Qi et al., 2001; 
Tan et al., 2002). These properties allow melatonin to preserve macromolecules 
including DNA, protein and lipid from oxidative damage resulted from ionising 
radiation and chemical carcinogen exposure. Being both lipophilic and hydrophilic, 
melatonin may play an important role in the antioxidant defence system in all cells 
and tissues of the body (Reiter et al., 1995). 
The role of the pineal gland in tumor development has been under intensive study 
during the last years (Blask, 1993; Bartsch et al., 2001; Vijayalaxmi et al 2002; 
Bartsch and Bartsch, 2006). In cancer patients the morphological signs of pineal 
function is found to decrease and disturbances in the circadian secretion pattern of 
melatonin were observed (Vijayalaxmi et al 2002; Bartsch and Bartsch, 2006). The 
inhibitory effect of melatonin is well established in relation to mammary tumors 
(Cos et al., 2000; Cos et al., 2001; Sanchez-Barcelo et al., 2003) and colon cancer 
(Anisimov et al., 1997; Anisimov, 2001). There are few data on the effect of 
melatonin on tumors of other localizations. 
2,8.3. Quercetin 
HCK/''^=::5^v/ 
OH O 
Quercetin (3,3',4',5,7-pentahydroxyflavone) is an important dietary flavonoid, 
present in different vegetables, fruits, seeds, nuts, tea, and red wine (Formica and 
Regelson ,1995;Beecher et al.,1999; Hollman and Katan,1999) .Quercetin is 
considered an excellent free-radical scavenging antioxidant owing to the high 
number of hydroxyl groups and conjugated pi orbitals by which quercetin can 
donate electrons or hydrogen, and scavenge H2O2 and superoxide anion (Heijnen ,et 
al 2001). The reaction of quercetin with superoxide anion leads to the generation of 
the semiquinone radical and H2O2 (Metodiewa et al., 1999). Quercetin also reacts 
with H2O2 in the presence of peroxidases, and thus it decreases H2O2 levels and 
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protects cells against H202 damage. The study of Quercetin as potential 
chemopreventer is assuming increasing importance considering its involvement in 
the suppression of many tumor-related processes including oxidative stress, 
apoptosis, proliferation and metastasis. Quercetin has also received greater attention 
as pro-apoptotic flavonoid with a specific and almost exclusive activity on tumor 
cell lines rather than normal,non-transformed cells (Lugli et al., 2009).Cancer cells 
are extremely sensitive to quercetin induced apoptosis. These differences between 
normal and cancerous cells may result from different signaling pathways (Gupta and 
Panda,2002; Kuo et al.,2004;Lugli et al.,2005; Ma et al.,2005; Kim et al.,2008; 
Chien et al., 2009; Shan et al.,2009 Jung et al.,2010).Quercetin triggers apoptosis via 
the mitochondrial pathway, through the loss of mitochondrial membrane potential, 
the subsequent release of cytochrome c from mitochondria to cytosol, and the final 
activation of caspases, such as caspase-3 and caspase-7 (Lee et al.,2006; Yang at 
al.,2006;Chien et al.,2009) 
2.8.4. Podophyllum hexandrum 
Antioxidants of plant origin with free-radical scavenging properties have great 
importance as therapeutic agents in several diseases caused due to oxidative stress 
(Ramchoun et al., 2009). Plant extracts and phytoconstituents are found effective as 
radical scavengers and inhibitors of lipid peroxidation (Yildirim et al.,2001; Dash 
et al.,2007).Plants also have a long history of use in the treatment of cancer 
(Hartwell, 1982) and it is significant that over 60% of currently used anti-cancer 
agents are derived in one way or another from natural sources, including plants, 
marine organisms and micro-organisms (Newman et al.,2003;Cragg et al., 2005). 
Two clinically active agents, etoposide (VM 26) and teniposide (VP 16-213). which 
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are semi-synthetic derivatives of the natural product, epipodophyllotoxin (an isomer 
of podophyllotoxin), may be considered as being more closely linked to a plant 
originally used for the treatment of cancer (Lee and Xiao, 2005). The Podophyllum 
species (Podophyllaceae), Podophyllum peltatum Linnaeus (commonly known as 
the American mandrake or Mayapple), and Podophyllum emodii Wallich from the 
Indian subcontinent, have a long history of medicinal use, including the treatment of 
skin cancers and warts. The major active constituent, podophyllotoxin,was first 
isolated in 1880, but its correct structure was only reported in the 1950s. Application 
of podophyllum resin 25% solution is efficacious in producing significant short-term 
resolution of HIV related oral hairy leukoplakia (Cobb,1990; Gowdey et al.. 1995). 
Podo-phyllatoxin has been used as a precursor to semi-synthetic anti-cancer drugs 
like etoposide, teniposide and etopophos. These compounds have been used for the 
treatment of lung and testicular cancers as well as certain leukemias (Stahelin and 
Wartburg, 1991; Imbert, 1998).The oxidative stress induced by CC14 in liver,lung 
and renal tisssues has been reduced by ethanolic extract of P.hexandrum by 
strengthening the antioxidant defense system and by scavenging free radicals in 
rats.( showkat et al.,(a)2010; showkat et al., (b)2010) 
2.9. Chemotherapy with cisplatin 
Cl>^ ^ N H 3 
Pt 
Chemotherapy is one of the mainstays of medical intervention for cancer. The 
interest in platinum based antitumor drugs dates back to the 1960s with the 
serendipitous discovery by (Rosenberg et ai.,1965) showing the inhibition of cell 
division by platinum complexes. Cisplatin has been used effectively in the 
chemotherapy of recurrent brain tumours and intracranial germ cell tumours (Spence 
et al., 1992). The cure rate for testicular cancer is now greater than 90% when 
tumors are promptly diagnosed (BosI and Motzer, 1997). The optimal manner of 
administering the drug is not established, although investigators have used various 
schedules such as bolus injection (Hayes et al., 1977), prolonged infusion (Loo et 
al., 1978), and fractional daily usage (Einhorn and Donohue, 1977). Cisplatin is a 
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neutral, water-soluble, coplanar complex. The drug enters the cell by either passive 
diffusion or active uptake and is converted to its active form through sequential 
thermal ligand exchange in an aquation reaction replacing its chloride ions with 
water or hydroxyl groups (Singh and Turro, 2004). Treatment of tumor cells with 
cisplatin provokes several responses including membrane peroxidation (Sugiyama et 
al., 1989), dysfunction of mitochondria (Brady et a!., 1990), inhibition of protein 
synthesis and DNA damage (Kharbanda et al., 1995). 
A mechanism by which cisplatin exerts its cytotoxicity is through the generation of 
ROS (Auersperg et al., 1998). The drug is able to generate reactive oxygen species, 
such as superoxide anion and hydroxyl radical. Masuda et al. (1994) found cisplatin-
induced generation of active oxygen radicals in a cell-free system. Along with its 
usage several inconvenient side effects are included that need to be dealt with 
carefully in order to maximize antitumor activity and minimize toxicity A number of 
rescue agents such as mesna, WR-2721, diethyldithiocarbamate and thiosulfate, 
selenium and bismuth subnitrate have also been used to control cisplatin toxicity; 
however, the exact role of these agents is not well understood, and they are yet not 
routinely being used in Pt chemotherapy (Reedijk, 1999). Intrinsic or acquired 
resistance, its toxicity towards healthy cells (Zhang and Lippard, 2003), reduction of 
antioxidant plasma level and generation of free radicals in normal cells (Weijl et al., 
1998; Yoshida et al., 2003) limit the organotropic profile of the drug. 
2.10. Chemotherapy and antioxidant supplementation 
Antineoplastic agents have been shown to produce oxidative stress in patients who 
receive these drugs during cancer chemotherapy (Sangeetha et al.,1990;Faber et 
al.,1995; Erhola et al.,1996;Weijl et al.,1998) This is evident by the elevation of 
lipid peroxidation products; the reduction of total radical-trapping capacity of blood 
plasma;the reduction in plasma levels of antioxidants and the marked reduction of 
tissue glutathione levels that occurs during chemotherapy.( Conklin,2004). There are 
considerable in vitro and animal data showing that vitamin C and other antioxidants 
can protect cells against radiation and chemotherapy.3-5 (Sonneveld, 1978; 
Witenberg et al.,1999; Greggi et al,2000;).lt seems likely that they would therefore 
reduce treatment-related toxicities and there are promising, although not 
unequivocal, data that this indeed is the case. ( Legha,1982; Mills, 1988; 
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larussi,1994; Pace et al,2003; Weijl et al.,2004)Antioxidant supplements are useful 
in conjunction with chemotherapy because they enhance the efficacy of the 
chemotherapy, as well as alleviate toxic side effects, allowing patients to tolerate 
chemotherapy for the full course of treatment and possibly at higher doses 
(Conklin,2004). One of the main mechanisms of chemotherapy drugs against cancer 
cells is the formation of reactive oxygen species (ROS), or free radicals. Drugs with 
free radical mechanisms include but are not limited to alkylating agents (e.g., 
melphalan, cyclophosphamide), anthracyclines (e.g.,doxorubicin, epirubicin), 
podophyllin derivatives (e.g., etoposide),platinum coordination complexes (e.g., 
cisplatin,carboplatin) and camptothecins (e.g. topotecan, irinotecan).Unfortunately, 
these ROS often are the source of serious side effects, as well.. Oxidative stress 
interferes with cellular processes that are necessary for antineoplastic agents to exert 
their optimal cytotoxicity on cancer cells, and modest levels of oxidative stress have 
been shown to reduce the cytotoxicity of anticancer drugs.( Lee and 
Shacter,1999;Shacter et al,2000) Thus, the formation of ROS that occurs when 
anticancer drugs are administered may diminish the effectiveness of the treatment. 
In addition, since some side effects caused by antineoplastic agents appear to be 
prevented by certain antioxidants, administering these supplements during 
chemotherapy may diminish the development of side effects as well as improve the 
response to therapy. This contention is supported by many preclinical and some 
clinical studies.( Lamson and Brignall ,1999; Conklin,2000) 
Cisplatin [cis-diamminechloroplatinum (II)] (CDDP) is a potent antineoplastic agent 
used for the treatment of a wide range of cancers (Saad et al., 2004; Wang et al.. 
2004). Oxidative stress is one of the most important mechanisms involved in CDDP-
induced toxicity. The biochemical basis of cisplatin toxicity is believed to relate to 
free radicals generated in these tissues (Ravi et al 1995).Indeed, several antioxidants 
have been tested, with limited success, as potential agents to ameliorate the 
destructive actions of this chemotherapeutic drug (Ravi et al 1995). 
The study of Qu as potential chemopreventers, or for chemotherapy, is assuming 
increasing importance, considering its high toxicity for cancer cells, along with its 
relatively scarce effects on normal, non-transformed cells (Lugli et al.,2009). 
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Melatonin, a hormone of the pineal gland has been known to be a chemopreventive, 
anticancer agent in in vitro studies and experimental animal models (Cos et al., 
2005). In pharmacological amounts, melatonin effectively reduces oxidative stress 
through several mechanisms (Martinez et al. 2005). Considering the low toxicity of 
melatonin and its ability to reduce the side effects and increase the efficacy of drugs, 
its use as a combination therapy with anticancer agents seems important and worthy 
of pursuit. 
Natural polyphenolics are reported to contain several biologically active 
flavonoides, polyphenols and podophyllotoxin glycoside, and the like that might 
contribute toward enhancing DNA repair (Gao et aI.,2006).The therapeutic efficacy 
of podophyllum hexandrum is predominantly attributed to their properties of free 
radical scavenging, reduced lipid peroxidation (Gupta et al.,2007), transient metal-
chelation (Kumar and goel,2000) and protection to endogenous defense enzymes 
(Gupta et al.,2007) and to cellular DNA. 
2.11. Stress and chemoprevention 
Epidemiological (Fox, 1981; Locke, 1982; Temoshok and Fox, 1984) and 
experimental (Sklar and Anisman, 1980; Sklar and Anisman, 1981) evidence 
suggest that stress and ability to cope with stress may play a role in disease 
processes as well as cure. Psychosocial stressors have been associated with reduced 
efficacy of cancer therapies (Lichtman et al., 1987; Waxier-Morrison et a!.. 1991). 
Other studies have shown that reducing the impact of life-stressors through 
psychosocial intervention or social support may extend survival time and decrease 
the toxic side effects of chemotherapy (Burish et al., 1987; Grossarth andEysenck. 
1989). In support of these data, recent animal studies have shown that exposure to 
rotational stress decreases the anti tumor effects of chemotherapeutic drugs in terms 
of tumor burden, extent of metastasis and survival time (Pressin et al., 1991; Giraldi 
et al., 1992; Giraldi et al., 1994). Several factors appear to play a role in mediating 
stressor-induced alterations in the effectiveness of chemotherapy treatments. 
including tumor size and growth rates, hormone levels, and/or immune function, or 
an interaction among these factors (Corbett et al., 1978; Armitage, 1992; Bassukas 
and Schultze, 1993; Boddy and Idle, 1993; Maclean and Longenecker, 1994). So far. 
many stressors have been evaluated for their possible effect on chemoprevention and 
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chemotherapy. (Perissin et al.,199])investigated the influence of stress on the effects 
of the antitumor cytotoxic drug cyclophosphamide and the selective non-cytotoxic 
antimetastatic agent razoxane. In mice bearing Lewis lung carcinoma the application 
of rotational stress significantly decreased the magnitude of the effects of both 
drugs. Further studies showed that the curative action of cyclophosphamide was 
abolished when animals were subjected to restraint stress. The application of 
restraint stress, which by itself has no effects on survival, completely abolished the 
increase in survival time caused by the treatment with cyclophosphamide (Zorzet et 
al., 1998).Within a conceptualized framework of stress and disease,bio-behavioral 
factors are understood to influence multiple aspects of tumor growth including 
apoptosis, angiogenesis, invasion,and immunological escape to the metastatic 
cascade (Antoni et al.,2006).As one example, transferring laboratory mice from 
group housing to social isolation accelerates growth of induced tumors and 
attenuates the effects of chemotherapy (Grimm et al.,1996, Kerr ,1997).Although 
many studies have been carried out to determine the impact of stress on 
chemotherapy, less data is available to-date on the relevance of psychological 
factors in determining the outcome of cancer chemoprevention. 
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3.1. Materials 
Chemicals 
Acetone 
BSA 
CDNB 
Cisplatin 
DMBA 
Dexamethasone 
Dichloromethane 
DTNB 
EDTA 
Ethidium bromide 
Glutathione (reduced & oxidized) 
Glycine 
Histopaque 1077 
HBSS 
Hydrogen peroxide 
Low melting point agarose 
Melatonin 
Methanol 
N-nitrosodiethylamine 
NADPH 
pNPP 
p-nitrophenol 
Pyrogallol 
Quercetin 
Sodium chloride 
Sodium hydroxide 
Source 
Sisco Research Laboratory, Mumbai 
Sisco Research Laboratory, Mumbai 
Sisco Research Laboratory, Mumbai 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Himedia, India 
Sisco Research Laboratory, Mumbai 
Sisco Research Laboratory, Mumbai 
Sigma Chemical Co., USA 
Sisco Research Laboratory, Mumbai 
Sisco Research Laboratory, Mumbai 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Qualigens laboratories. Bangalore 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Qualigens laboratories. Bangalore 
Sigma Chemical Co., USA 
Sisco Research Laboratory, Mumbai 
Sisco Research Laboratory, Mumbai 
Sisco Research Laboratory, Mumbai 
Sisco Research Laboratory, Mumbai 
Sigma Chemical Co., USA 
Sisco Research Laboratory, Mumbai 
Sisco Research Laboratory, Mumbai 
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Sodium acetate 
Succinic acid 
Sulphosalicylic acid 
TBA 
TCA 
TPA 
Tris 
Sisco Research Laboratory, Mumbai 
Sisco Research Laboratory. Mumbai 
Qualigens Laboratories, Bangalore 
Himedia, India 
Sisco Research Laboratory, Mumbai 
Sigma Chemical Co., USA 
Sisco Research Laboratory, Mumbai 
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3.2. Methods 
3.2.1. Experimental animals 
Six-eight week male Swiss albino mice weighing 35±5g used for this study were 
purchased from Jamia Hamdard University, New Delhi, India. The animals were 
acclimatized for 1 week and maintained under standard housing condition with 12 h 
light and dark cycle. The food in the form of dry pellets (Ashirwad Industries, 
Chandigarh, India) and water were available ad libitum. The institutional research 
Committee approved all animal procedures and the study has been conducted 
according to the principles of (CPCEA) Committee for the Prevention and Control 
of Experimental Animals, an Indian national body enacting the ethical rules for 
performing the research on experimental animals. 
3.2.2. Chronic Unpredictable Stress (CUS) 
The CUS protocol is a modification of published procedures (Katz et al.,l981;Lu et 
al.,2006; Willner et al.,1987) The CUS sequence consisted of different types of 
stressors presented randomly, two per day, over a period of 15 days as outlined in 
table 1. All procedures were carried out in isolated rooms adjacent to the housing 
room, requiring minimal handling or transport of the mice. After each stressor. 
animals were placed in clean cages with fresh bedding and returned to the housing 
facility. Control animals were left undisturbed until the time of the experiment with 
the exception of daily cleaning of the cages and weekly weighing. 
Specific details of the CUS procedure are as follows: for restraint stress, mice were 
placed in a restraining device made of Plexiglas and flexible nylon, which was 
closed using two Velcro strips, thus restricting movement but allowing free 
respiration and air circulation. The shaking procedure was carried out by placing six 
mice in a cardboard box atop a lab shaker set to produce 220 back-and-forth 
movements (approximately 2-inch sideways deflection) per min. Warm swim and 
cold swim were accomplished by placing the mice in a cylindrical tank (60 cm 
heightSO cm diameter) filled with water to a 30 cm depth at 25 or 18°C. 
respectively. High-density housing was achieved by placing 6 mice per cage. For 
cold isolation stress, the animals were placed individually in home cages at 4°C. Wet 
bedding was performed by putting 400 ml tap water in the home cage. Tail pinching 
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involved placing the mice in the previously described restraining device, and 
applying a clothespin 1 cm from the base of the tail. 
Table l.Chronic Unpredictable Stress Procedure 
Days Stressor Time 
Day 1 
Day 2 
Day 3 
Day 4 
Day 5 
Day 6 
Day? 
Day 8 
Day 9 
Day 10 
Day 11 
Day 12 
Day 13 
Day 14 
Day 15 
1 -hr restraint stress 
30 min cold room (4°C) 
1 -hr shaking/crowding 
5 min cold water swim 
4-hr wet bedding 
Lights on over night 
3-hr high density housing 
5 min warm water swim 
2-hr restraint stress 
30 min cold room (4°C) 
6-hr isolation 
Lights on over night 
5 min cold water swim 
16-hr food and water deprivation 
2-hr restraint stress 
I -hr shaking/crowding 
4-hr high density housing 
lights on over night 
4-hr wet bedding 
16-hr food and water deprivation 
3-hr restraint stress 
2-hr isolation 
5min cold water swim 
1 - hr min shaking/crowing 
10 min tail pinch in restrainer 
1 -hr shaking /crowing 
2-hr restraint stress 
3-hr high density housing 
24-hr fod and water deprivation 
08:00 a.m 
11: OOp.m 
ll:00a.m 
03:00 p.m 
09:00 a.m 
06:00 p.m 
10:00 a.m 
06:00 p.m 
08:00 a.m 
03:00 p.m 
10:00 a.m 
07:00 p.m 
09:00 a.m 
03:00 p.m 
10:00 a.m 
02:00 p.m 
08:00 a.m 
07:00 p.m 
09:00 a.m 
04:00 p.m 
ll:00a.m 
05:00 p.m 
08:00 a.m 
11:00 a.m 
09:00 a.m 
04:00 p.m 
11:00 a.m 
04:00 p.m 
08:00 a.m 
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3.2.2.1 A nimal treatment 
For stress treatment mice were exposed to chronic unpredictable stress protocol for 
15 days as shown in table 1 and N- nitrosodiethylamine (NDEA) was dissolved in 
normal saline and given to mice by oral gavage once a week for 3 weeks for a total 
of three doses. 
3.2.3. Experimental Design 
To evaluate the effect of chronic unpredictable stress (CUS) on N-
nitrosodiethylamine (NDEA) induced carcinogenesis animals were divided into four 
groups of 12 mice each and following treatment schedule was adopted: 
Group I: animals served as normal controls. 
Group II (CUS alone): animals were exposed to CUS for consecutive 15 days just 
before termination of the experiment. 
Group III (NDEA alone) animals were treated with NDEA (100 mg/kg body 
weight) p.o (postoral) once a week for three weeks. 
Group IV (Prestress-NDEA) animals were pre- exposed to 15 days of CUS 
followed by NDEA treatment as in group 111. 
Six mice from each group were sacrificed after a period of 12 weeks following 
NDEA administration; blood, lung and liver samples were collected and subjected to 
biochemical estimations. Further the remaining six mice from each group were 
sacrificed and their liver, lung and blood tissues were subjected to DNA damage 
studies by single cell gel electrophoresis (comet assay). 
3.2.4. Collection of plasma and Preparation of tissue homogenates 
Blood samples were collected in heparinised tubes by cardiac puncture and 
centrifuged at 2500 g at 4°C for 10 minutes to collect the plasma. Liver and lung 
tissues were rapidly removed and washed in ice cold sterile physiological saline, 
weighed portion of liver and lung were homogenized in chilled 0. IM phosphate 
buffer pH 7.4 using glass Teflon homogenizer and volume adjusted to give 10% w/v 
homogenate. The homogenates were centrifuged at 10,000 g for 15 mins at 4° C to 
remove cellular debris. The supematants were stored at -20°C C for the biochemical 
analysis. 
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3.2.5. Biochemical estimations 
3.2.5.1. Superoxide dismutase (SOD) (E.C.1.15.1.1) 
Superoxide dismutase was assayed on the method based on the ability of superoxide 
dismutase to inhibit the auto-oxidation of pyrogaliol (Marklund & Markiund, 1974). 
Reaction mixture in a final volume of 3.0 ml containing 0.05ml of enzyme source 
with 2.85 ml of 0.05M tris-succinate buffer pH 8.2 was incubated at 25°C for 20 
mins. The reaction was initiated by the addition of 0.1ml pyrogaliol (8nm) and 
change in optical density was measured for 3 mins at 412 nm. A reference set 
containing 0.05ml distilled water instead of sample solution, was run 
simultaneously. Results were expressed as enzyme units/mg protein. One enzyme 
unit is defined as the amount of enzyme required to cause 50% inhibition of 
pyrogaliol auto-oxidation per 3 ml of assay mixture. 
3.2.5.2. Catalase (CAT) (E.C. 1.11.1.6) 
Catalase activity was determined by the method of Claiborne (1985). Briefly the 
reaction mixture consisted of 2.0 ml phosphate buffer (0.1 M, pH 7.4), 0.95 ml 
hydrogen peroxide (0.019 mM) and 0.05 ml of homogenate (10% w/v) in a final 
volume of 3.0 ml. Changes in absorbance were recorded at 240 nm for 3 mins. 
'Catalase activity was calculated as nmol H2O2 consumed min"' mg"' protein. 
3.2.5.3. Glutathione-S-transferase (GST) (E.C2.5.1.1.18) 
GST activity was assayed by the method of Habig et al., (1974) using CDNB as 
substrate. The cuvettes in a final volume of 3.0 ml contained 0.2M phosphate buffer, 
pH 6.5, 1 mM glutathione, ImM CDNB and 0.1 ml homogenate. The change in 
absorbance at 340 nm was recorded at room temperature against blank containing all 
the reactants except the enzyme source. Calculation was made using millimolar 
extinction coefficient value of 9.6 mM'' cm"' and specific activity was expressed as 
nmoles CDNB conjugate formed per minute per mg protein. 
3.2.5.4. Glutathione reductase (GR) (E.C. 1.66.4.2) 
GR was assayed according to the method of Carlberg & Mannervik (1975). This 
enzyme catalyzes the NADPH dependent reduction of glutathione disulfide to 
glutathione. The reaction m.ixture in a final volume of 2.0 ml contained 1.65 ml of 
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0.125 M phosphate buffer, pH 7.4; 0.2 ml of 0.1 mM NADPH and 0.05ml of ImM 
GSSG. The reaction was initiated by the addition of 0.1 ml of enzyme to the cuvette 
and the oxidation of MADPH was followed spectrophotometrically at 340 nm after 
30-sec intervals for 3 mins. The activity was expressed as nmoles of NADPH 
oxidized per minute per mg protein. 
3.2.5.5. Reduced glutathione (GSH) 
The level of reduced glutathione was determined by the method of Jollow et al., 
(1974). A 1.0 ml supernatant (10% w/v) was mixed with I.O ml sulphosaiicyiic acid 
(4% w/v). The samples were incubated at 4°C for atleast 1 h and then centrifuged at 
1200g for 15 min at 4°C. The reaction mixture contained 0.4 ml of the filtered 
sample; 2.2 ml phosphate buffer (O.IM, pH 7.4) and 0.4 ml of DTNB (4 mg/ml) in a 
total volume of 3.0 ml. The yellow color developed was read immediately at 412 
nm. The GSH concentration was calculated as micromol/mg protein. 
3.2.5.6. Lipid Peroxidation (LPO) 
The rate of lipid peroxidation (LPO) was determined according to the method of 
Beuge & Aust (1978) by estimating MDA formed with TBA. The reaction mixture 
containing 0.5 ml homogenate (10% w/v) and 1ml of 0.67% TBA and 30% TCA 
(1:1) was taken in a test tube and heated for 20 mins at 100 °C in a boiling water 
bath. The contents were then centrifuged at 5000g for 15 mins and 1.0 ml of clear 
pink colored supernatant was withdrawn. The intensity of developed color was 
measured at 535 nm. For quantitation, molar extinction coefficient of 1.56 x 10^ M'' 
cm-1 for MDA-TBA colored complex was used and results expressed as nanomoles 
of malondialdehyde formed per mg protein. 
3.2.5.7. Uric acid 
Uric acid level was measured using commercial kit (Span diagnostics Ltd. India). 
The method is based on the principle that uric acid in alkaline medium reduces 
phosphotungstic acid to 'tungsten blue' which can be measured 
spectrophotometrically at 660 nm. Briefly, the reaction mixture contained 150 
microiitre of plasma mixed with 1.5 ml of pre-incubated f-eagent i (co.ritaining 
sodium carbonate). For color development, 1.5 ml of reagent 2 (containing sodium 
tungstate, lithium sulphate and phosphoric acid) was added to the mixture. The 
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contents were allowed to stand at room temperature for 15 mins and read at 660nm 
against purified water. Absorbance of the standard (containing 5mg/dL of uric acid 
and an all other reagents except the plasma) was measured followed by the test. 
Values were expressed as mg uric acid/dL of plasma. 
3.2.5.8. Glutamate Pyruvate Transaminase (GPT)/Alanine transaminase (ALT) 
(E.C 2.6.1.2) 
GPT in plasma and liver samples was determined using commercial kit (Span 
diagnostics ltd. India). GPT (ALT) catalyses the following reaction 
a- Ketoglutarate + L-Alanine ^''^ ^ L-Glutamate + Pyruvate 
This method is based on the principle that pyruvate so formed is coupled with 
DNPH to give the corresponding hydrazone, which gives brown color in alkaline 
medium, measured spectrophotometrically. Briefly the reaction mixture contained 
0.05 ml of enzyme source mixed with 0.25 ml of pre-incubated buffered alanine. 
The contents were incubated at 37^ C for 30 mins and mixed with DNPH reagent. 
2.5 ml of solution 1 (prepared by diluting 1 ml of 4N sodium hydroxide to 10 ml 
with distilled water) was added after 20 minutes and read at 505 nm against purified 
water. From a standard curve, GPT was calculated and expressed as units/ml. 
3.2.5.9. Glutamate Oxaloacetate Transaminase (GOT)/Aspartate transaminase 
(AST) (E.C2.6.1.1) 
GOT was measured using commercial kit (Span diagnostics ltd. India). The 
principle behind the method is that the transaminase catalyses the reaction 
a- Ketoglutarate + L- Aspatate J22I • L- Glutamate + Oxaloacetate 
and the oxaloacetate so formed reacts with 2, 4-DNPH to give brown colored 
hydrazone in alkaline medium which can be measured colorimetrically. The reaction 
mixture contained 0.05 ml of enzyme source mixed with 0.25 ml of pre-incubated 
buffered alanine. The contents were incubated at 37° C for 60 mins and mixed with 
DNPH reagent. 2.5 ml of solution 1 was added after 20 mins and read at 505 nm 
against purified water. From a standard curve, GOT was calculated and expressed as 
units/ml. 
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3.2.5.10. Glucose 
Plasma glucose level was measured using commercial kit (Span diagnostics Ltd. 
India). The method is based on the principle that Glucose oxidase (GOD) oxidizes 
glucose to gluconic acid and hydrogen peroxide. In presence of enzyme peroxidase, 
released hydrogen peroxide is coupled with phenol and 4-aminoantipyrene (4-AAP) 
to form colored quinoneimine dye which is measured at 505 nm. 
Glucose + O2 + H2O Glucose oxidase Gluconic acid + H2O2 
H2O2+ Phenol + 4-AAP Peroxidase ^ Quinoneimine dye + H2O 
Briefly, the test mixture contained 20 microlitre of plasma mixed with 1.5 ml of 
working glucose reagent. The contents were incubated at Zl^ C for 10 mins. 1.5 ml 
of distilled water was added and read at 505 nm against blank (containing all 
reagents except glucose standard and plasma). Absorbance of the standard 
(containing glucose standard and an all other reagents except the plasma) was 
measured followed by the test. Values were expressed as mg glucose/dL of plasma. 
3.2.5.11. Alkaline phosphatase (E.C 3.1.3.1) 
The activity of alkaline phosphatase was determined according to the method of 
Shah et al., (1979). The assay mixture contained 1.4 ml of assay buffer (50 mM 
glycine, 36 mM NaCl and 45 mM NaOH, pH 10.5) and 0.1 ml of enzyme. The 
reaction was started by adding 0.015 ml of 0.6 M pNPP. The contents were 
incubated at 3(fC for required time period and the reaction was stopped by adding 
0.05 ml of 5N NaOH. The yellow color developed was read at 405 nm against 
reagent blank. The activity was calculated from standard p-nitrophenol curve and 
expressed as units/mg protein. 
3.2.5.12. Protein 
The protein content in all the samples was estimated according to the method of 
Lowry et ai. (1951), using bovine serum albumin as standard. An aliquot of protein 
sample was diluted with distilled water to a final volume of 1 ml. To this, 5 ml of 
alkaline copper reagent (freely mixed 98 ml of 2% sodium carbonate in 0.1 M 
sodium hydroxide, 2.0 ml of 0.5 % copper sulphate and 1 % sodium potassium 
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tartarate) was added and the solution was kept at room temperature for 10 mins. 
Color was developed by the addition of Folin-Ciocalteau reagent and the intensity of 
blue color was measured after 30 mins at 660 nm. The result was expressed as mg 
protein/e tissue or/ml plasma. * —j , -^  
3.2.6. Comet assay «/- T ^ S ^ ^ ^ ^ ^ ^ ' 
( Ace. N<j ) 
3.2.6.1. Preparation of cells for comet assay "f, < J 
x jCf " ' - " ' -^. , ^ 
Lymphocyte Isolation ^ "*'''" ' '^i^' '*' ' 
Immediately after each sacrifice the heparinised blood was suitably diluted in PBS 
(Ca"*~^ and Mg^ free). Lymphocytes were isolated using Histopaque 1077. The 
isolated cells were finally suspended in RPMl 1640. 
Isolation of Liver and Lung cells 
A small lobe of liver was minced thoroughly, with a blade and the tissue mass was 
suspended in ice-cold solution of HBSS. After centrifugation cells were suspended 
in RPMl 1640. Same procedure was followed for lung tissues. The viability of cells 
was assessed using trypan blue exclusion test (Pool-Zobel et al., 1993). 
3.2.6.2. Alkaline comet assay 
Comet assay was performed under alkaline conditions essentially according to the 
procedure of Singh el al., (1988) with slight modifications. Fully frosted 
microscopic slides precoated with 1.0 % normal melting agarose at about 50° C 
(dissolved in Ca^ "^  and Mg "^"^  free PBS) were used. Around 10,000 cells (isolated 
from blood, liver and lung) were mixed with 75 |al of 1.0 % Low melting point 
agarose (LMPA) to form a cell suspension and pipetted over the first layer and 
covered immediately by a cover slip. The slides were placed on a flat tray and kept 
on ice for 10 min to solidify the agarose. The cover slips were removed and a third 
layer of 0.5 % LMPA (75(il) was pipetted and cover slips placed over it and allowed 
to solidify on ice for 5 min. The cover slips were removed and the slides were 
immersed in cold lysing solution containing 2.5 M NaCl, 100 mM EDTA, 10 mM 
Tris, pH 10 and I % TritonX 100 added just prior to use for a minimum of 1 hour at 
4 C. After lysis slides were left for 30 min in alkaline electrophoretic solution 
consisting of 300 mM NaOH, 1 mM EDTA, pH >13, to allow DNA unwinding and 
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expression of alkali labile sites as DNA breaks. Using a power supply (Techno 
Source India Pvt. Ltd. India) electrophoresis was performed at 4^ C in field strength 
of 0.7 volts/cm and 300 mA current. All these steps were performed under dim light 
to avoid additional DNA damage due to stray light. The slides were then neutralized 
with cold neutralization buffer (0.4 M Tris, pH 7.5), stained with 75 1^ EtBr (20 
Hg/ml) and covered with a cover slip. The slides were placed in a humidified 
chamber to prevent drying of the gel and analyzed the same day. 
Slides were scored using an image analysis system (Komet 5.5, Kinetic Imaging, 
Liverpool, U.K) attached to an Olympus (CX41) fluorescent microscope and a 
COHU 4910 (equipped with a 510-560 nm excitation and 590 nm barrier filters) 
integrated CC camera. Comets were scored at lOOx magnification. Images from 50 
cells (25 from each replicate slide) were analyzed. The parameter taken to assess 
cellular DNA damage was tail length (migration of DNA from the nucleus, ^m) and 
was automatically generated by Komet 5.5 image analysis system. 
3.2.7. Chemopreventive studies 
3.2.7.1. Preparation ofQuercetin solution 
Quercetin was dissolved in normal saline and given to mice by oral gavage at a 
concentration of 10 mg/kg body weight. 
3.2.7.2. Preparation of melatonin solution 
Melatonin was dissolved in normal saline and given to mice by oral gavage at a 
concentration of 5mg/kg body weight. 
3.2.7.3. Collection and Processing of Medicinal Plant Material 
Live plant material of Podophyllum hexandrum Royle (syn. Podophyllum emodi 
Wall) family ( Berberidaceae) was collected from the high-altitude regions of 
Sonmarg and shopian (>3000 m), Kashmir Himalayas, Jammu and Kashmir, and 
transplanted under natural conditions at the Department of Biochemistry ,University 
Of Kashmir,Srinagar . The plant material was authenticated by a plant taxonomist 
from the Centre of Plant Taxonomy, University of Kashmir, Srinagar. Plant 
rhizomes were washed thoroughly with running tap water to remove extraneous 
material and dried under partial shade. The dried rhizome samples were powdered 
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and transferred to a Soxhlet apparatus and consecutively extracted with 70% ethanoi 
for a minimum of three times over 24-72 h using a proportionate amount of solvent. 
The pooled filtrates were concentrated by solvent evaporation in a rotary evaporator 
and dried. The dried powder was used for chemopreventive studies 
3.2.7.4. Podophyllum hexandrum rhizome extract administration 
The dried powder of Podophyllum hexandrum rhizome was dissolved in normal 
saline and a chemopreventive concentraiion of 20 mg /kg body weight was 
administered by oral gavage to mice. The dose administered as mg/kg b.w. of 
experimental animal refers to the dried powdred extract of rhizome of P. 
hexandrum. 
The chemopreventive effect of quercetin, melatonin and medicinal plant extract of 
Podophyllum hexandrum rhizome was evaluated on NDEA treated mice that were 
pre exposed to chronic unpredictable stress. The prophylactic effect of these 
compounds was evaluated in terms of biochemical parameters and extent of 
prevention of NDEA induced DNA damage in the presence and absence of stress. 
Swiss albino mice Six to eight week old (35 ±5g) were used in the study. The 
experimental animals were acclimatized for one week under standard laboratory 
conditions and given commercial pellet diet (Ashirwad industries, Chandigarh. 
India) and water ad libitum. All experimental protocols adhered to the guidelines of 
the Animal Welfare Committee of the university. 
Animals were divided into nine groups of 12 animals each and following treatment 
schedule was adopted: 
Group I: animals served as normal controls. 
Group II (NDEA alone): NDEA at a dose of 100 mg/kg body weight) was given 
p.o. (postoral) once every week for a total of 3 doses. 
Group III (pre-stress NDEA): animals were first exposed to 15 days of Chronic 
unpredictable stress (CUS) followed by NDEA treatment as in group II. 
Group IV (NDEA-Qu): Animals received the same dose of NDEA as in group II 
and in addition they were daily orally administered (p.o) quercetin (lOmg /kg body 
weight) starting with NDEA administration to the end of the experiment. 
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Group V (pre-stress NDEA-Qu): animals were first exposed to CDS followed by 
the same treatment as in group IV. 
Group VI (NDEA-MIt): Animals received the same dose of NDEA as in group II 
and in addition they were daily orally administered (p.o) melatonin (5mg /kg body 
weight) starting with NDEAadministration to the end of the experiment. 
Group VII (pre-stress NDEA-MIt): animals were first exposed to CUS followed 
by the same treatment as in group VI 
Group VIII (NDEA-Phre) Animals received the same dose of NDEA as in group II 
and in addition they were daily orally administered (p.o) Podophyllum hexandrum 
rhizome extract (20mg /kg body weight) starting with NDEA administration to the 
end of the experiment. 
Group IX ( pre-stress NDEA-Phre) animals were first exposed to CUS followed 
by the same treatment as in group VIII 
Melatonin was applied no less than 3hrs before switching off the lights.Six mice 
from each group were sacrificed after a period of 12 weeks following NDEA 
administration; blood, lung and liver samples were collected and subjected to 
biochemical estimations. Further the remaining six mice from each group were 
sacrificed and their liver, lung and blood tissues were subjected to DNA damage 
studies by single cell gel electrophoresis (comet assay).FIuorescent studies were also 
done on blood samples of animals from all the groups. 
3.2.7.5. Comet assay 
Comet assay was performed under alkaline conditions essentially according to the 
procedure of Singh et al., (1988) as described under section 3.2.6.2. 
3.2.7.6. Biochemical parameters 
All the biochemical estimations discussed under section 3.2.5. were done 
accordingly. 
3.2.7.7. Fluorescent studies: 
Fluorescent spectral analyses were done according to the method of Karthikeyan et 
al., (1999). 2 ml of analytical grade acetone was added to the known amount of 
plasma from all the groups, vortexed and centrifuged a 5000 rpm for 10 mins.The 
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clear supernatants were then subjected to fluorescent spectral analysis al 400 nm 
excitation using a spectrofluorometer and the emission spectra were scanned from 
430 nm to 700 nm. The experiments were repeated thrice and data obtained were 
statistically analyzed. 
3.2.8. Chemotherapeutic studies 
3.2.8.1. Preparation ofCisplatin solution 
Cisplatin was dissolved in normal saline and given to mice (p.o) at a concentration 
of 1.5 mg/kg body weight consecutively after 15 days. (2 doses per month).The 
animals were pre hydrated with normal saline prior to drug administration. 
The Chemotherapeutic effect of cisplatin alone and in combination with antioxidant 
compounds (quercetin, melatonin and Podophyllum hexandrum rhizome extract) 
was performed on NDEA treated mice both in presence and absence of chronic 
unpredictable stress (CUS). Animals were divided into eleven groups of 12 mice 
each and the following treatment schedule was adopted: 
Group I: animals served as controls. 
Group II (NDEA alone): NDEA at a dose of 100 mg/kg body weight) was given 
p.o. once every week for a total of 3 doses. 
Group III (pre-stress NDEA): animals were first exposed to Chronic unpredictable 
stress (CUS) followed by NDEA treatment as in group II. 
Group IV (NDEA-Csp): After 12 weeks of NDEA treatment (as in group II) 
animals were intraperitonealy administered cisplatin (1.5 mg/kg body weight) 
consecutively after 15 days (2 doses per month) for 6 weeks. 
Group V (pre stress-NDEA-Csp): After 12 weeks of pre-stress NDEA treatment 
(as in group III) animals were intraperitonealy administered cisplatin (1.5 mg/kg 
body weight) consecutively after 15 days (2 doses per month) for 6 weeks. 
Group VI (NDEA-Csp-Qu): animals received the same treatment as in group IV, 
followed by daily p.o administered of quercetin (lOmg/kg body weight) until the end 
of experiment. 
Group VII (pre-stress NDEA-Csp-Qu): animals were first exposed to CUS 
followed by the same treatment as in group VI 
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Group VIII (NDEA-Csp-Mlt): animals received the same treatment as in group IV, 
followed by daily p.o administered of melatonin (5mg/kg body weight) until the end 
of experiment. 
Group IX (pre-stress NDEA-Csp-Mlt): animals were first exposed to CUS 
followed by the same treatment as in group Vlll. 
Group X (NDEA-Csp-Phre). animals received the same treatment as in group IV, 
followed by daily p.o administered of podophyllum hexandrum rhizome extract 
(20mg/kg body weight) until the end of experiment. 
Group XI (pre-stress NDEA-Csp-phre): animals were first exposed to CUS 
followed by the same treatment as in group X. 
Melatonin was applied no less than 3hrs before switching off the lights. Six mice 
from each group were sacrificed after a period of 18 weeks following NDEA 
administration; blood, lung and liver samples were collected and subjected to 
biochemical estimations. Further the remaining six mice from each group were 
sacrificed and their liver, lung and blood tissues were subjected to DNA damage 
studies by single cell gel electrophoresis (comet assay).Fluorescent studies were also 
done on blood samples of animals from all the groups. 
3.2.8.2. Collection of plasma and Preparation of tissue homogenates 
Plasma and tissue homogenates was isolated as described under section 3.2.4. 
3.2.8.3. Comet assay 
Comet assay was performed under alkaline conditions essentially according to the 
procedure of Singh et al., (1988) as described under section 3.2.6.2. 
3.2.8.4. Biochemical parameters 
All the biochemical estimations discussed under section 3.2.5 were done 
accordingly. 
3.2.8.5. Fluorescent studies 
Fluorescent studies were performed according to the method of Karthikeyan et al.. 
(1999) as described under section 3.2.7.7. 
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3.2.8.6. Statistical analysis 
Statistical analysis was done using student's t test to examine statistically significant 
differences. Analysis of variance was performed using one-way ANOVA. P values 
< 0.05 were considered statistically significant. 
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Control 
Control animals did not receive any treatment during the experimental period, 
however, they were handled at the same time as other experimental animals and 
were deprived of food and water during the application of chronic unpredictable 
stress to the treatment groups. They were subjected to the measurement of all 
biochemical parameters to assess the alteration in treated groups after 
comparison. TBARS (Thiobarbituric Acid Reactive Substances) levels were 
measured in liver, lung and plasma of mice along with the activities of antioxidant 
enzymes SOD, CAT, GST and GR. Moreover, GSH levels were also measured in 
liver, lung and plasma besides marker enzymes of liver function, ALP, GOT and 
GPT were measured in liver tissues. Circulatory antioxidants, glucose and uric acid 
were assessed along with SGOT, SGPT and ALP levels. The levels of antioxidant 
and marker enzymes were found higher in the liver tissues than in circulation. 
Effect of chronic unpredictable stress (CUS) on antioxidant status 
Both the antioxidant status and other biochemical parameters were altered by CUS 
exposure. Animals exposed to chronic unpredictable stress experienced altered 
antioxidant status as well as altered levels of other biochemical parameters. Hepatic, 
lung and plasma MDA levels were found to be increased significantly (p<0.05) in 
stressed animal as compared to controls (figs 1, 2 and 3). Decreased hepatic, lung 
and plasma GSH content was observed in these animals (figs 4. 5 and 6) with 
decreased activity of antioxidant enzymes SOD, CAT, GST and GR (table 2, 3 and 
5) when compared with that of control animals (p<0.05). This was accompanied by 
significantly increased (p<0.05) levels of marker enzymes GOT, GPT and ALP in 
liver tissues (table 4). The alterations in the circulatory antioxidants as well as 
biochemical markers of stressed animals were comparable with that of tissue levels. 
Significantly decreased (p<0.05) levels of circulatory glucose, uric acid, SOD, CAT, 
GR and GST (Table 5 ) were observed in these animals while the levels of SGOT. 
SGPT and ALP were significantly increased (p<0.05) as compared to untreated 
control animals (Table 6). 
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Effect of NDEA administration on antioxidant levels 
The effect of oral administration of NDEA (100 mg/kg body weight) once weekly 
for three weeks on hepatic and lung antioxidant enzymes is tabulated in table 2 and 
3. The activities of antioxidant enzymes SOD, CAT, GST and GR were significantly 
decreased (p<0.05) as compared to controls. NDEA decreased the hepatic and lung 
GSH content (p<0.05) with concomitant increase (p<0.05) in lipid peroxidation (figs 
1, 2, 4 and 5). Biochemical markers of liver function were also found to be altered. 
Significantly increased levels (p<0.05) of GOT, GPT and ALP in liver (Table 4) 
were observed in the NDEA treated animals as compared to untreated controls. 
Similar alterations were found in circulatory parameters of NDEA treated animals as 
shown in table 6. Levels of circulatory antioxidants, uric acid and glucose as well as 
SOD CAT, GST and GR were found to be decreased significantly (p<0.05) when 
compared with controls.(Table5) The decreased antioxidant levels were 
accompanied with significantly increased (p<0.05) levels of SCOT, SGPT and ALP 
in these animals, shown in table 5 and 6. 
Antioxidant status in pre-stress NDEA 
Animals exposed to chronic unpredictable stress followed by NDEA treatment 
resulted in altered levels of antioxidant enzymes and biochemical parameters which 
were significantly different fi-om controls as well as NDEA alone or CDS alone 
treated groups. Hepatic, lung and plasma MDA levels were increased significantly 
(figs 1, 2 and 3) as compared to controls (p<0.05), CUS alone (p<0.05) as well as 
NDEA alone (p<0.05) with concomitant decrease in GSH content (figs 4, 5 and 6). 
Antioxidant enzymes SOD, CAT, GST and GR were decreased significantly in 
hepatic and lung tissues as compared to control, CUS alone and NDEA alone, as 
shown in table 2 and 3 while marker enzymes GOT, GPT and ALP in liver(Table 4) 
were increased significantly (P<0.05). 
Plasma antioxidant levels were further decreased in NDEA treated animals on pre-
exposure to chronic unpredictable stress (Table 5) while SCOT. SGPT and ALP 
were increased significantly (Table 6) as compared to control (p<0.05) and NDEA 
treated (p<0.05) animals. 
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DNA damage studies 
The induction of DNA damage following exposure to chronic unpredictable stress 
and NDEA doses, alone and in combination was evaluated in lymphocytes, liver and 
lung cells of control and treated animals. The extent of DNA damage was measured 
in terms of migration of DNA from nucleus by various treatments. 
Chronic unpredictable stress for 15 days damaged the lymphocyte, liver and lung 
cell DNA to significant extent as depicted by significant migration of DNA or 
change in tail length of DNA (fig 7-9 and table 7). 
Effect of NDEA on DNA damage 
NDEA induced DNA damage in lymphocytes, liver and lung cells as depicted by 
significantly enhanced tail lengths (p<0.05) (Table 7). However, DNA damage was 
pronounced in the liver and lung cells (fig 7-9) because liver and lung are target 
organs of the carcinogen administration. 
DNA damage in pre-stress NDEA 
Animals exposed to chronic unpredictable stress followed by NDEA treatment 
resulted in increased DNA damage which was significantly different from controls 
as well as NDEA alone or CUS alone treated groups. Liver cell, lung cell and 
lymphocyte DNA damage was increased significantly as compared to controls 
(p<0.05), CUS alone (p<0.05) as well as NDEA alone (p<0.05) (table 7 and fig 7-9) 
treated animals. 
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Table 2: The hepatic levels of free radical metabolizing enzymes in mice exposed 
to CUS alone, NDEA alone and pre stress-NDEA treatments. 
Groups 
SOD 
Units/mg 
protein 
CAT 
Units/mg 
protein 
GST 
Units/mg 
protein 
GR 
Units/mg 
protein 
Control 553.92±8.4I 27.30±1.42 594.10±9.60 0.277±0.0I 
CUS alone 399.3I*±7.70 18.6r±1.23 424.53*±9.23 O.I25'±0.004 
NDEA alone 275.40* ±8.50 ]5.22*±0.81 329.2r±9.50 0.082*±0.005 
*#. . * # , Prestress-NDEA 227.40 "±6.22 9.11 "±0.43 219.62 "±9.!I 0.045 "±0.003 
Each value represents the mean ± SEM of 6 animals. 
* P< 0.05 when compared to control group. 
* P< 0.02 when compared to CUS alone and NDEA alone treated groups. 
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Table 3: The lung levels of free radical metabolizing enzymes in mice exposed to 
CUS alone, NDEA alone and pre stress-NDEA treatments. 
Groups 
Control 
CUS alone 
NDEA alone 
Prestress-NDEA 
SOD 
Units/mg 
protein 
519.71±8.71 
306.81* ±7.90 
256.73*±9.80 
199.71 **±6.91 
CAT 
Units/mg 
protein 
18.50 ±0.71 
12.40*±0.81 
8.0r±0.42 
4.05**±0.30 
GST 
Units/mg 
protein 
333.82±9.81 
224.62*±9.71 
182.10*±6.31 
126.40*''±4.60 
GR 
Units/mg 
protein 
0.339±0.04 
0.124*±0.01 
0.057*±0.013 
0.026'''±0.0l 
Each value represents the mean ±SEM of 6 animals 
* P< 0.05 when compared to control group 
# P< 0.02 when compared to CUS alone and NDEA alone treated groups 
66 
^fsulisl 
Table 4: Levels of liver function enzyme GOT, GPT and ALP in stressed, NDEA 
and pre stress NDEA treated mice. 
Groups 
Control 
CUS Alone 
NDEA Alone 
Prestress-NDEA 
GOT 
lU/Liter 
46.40±2.12 
60.22* ±2.91 
83.61* ±2.21 
10^2***1.32 
GPT 
lU/Liter 
28.73±1.32 
40.12* ±2.81 
95.7r±1.53 
129.21** ±2.31 
ALP 
mg/ml 
8.83±0.53 
13.81* ±0.52 
19.62*±1.12 
34.42 *^± 1.02 
Each value represents the mean± SEM of 6 animals 
* P< 0.05 when compared to control group 
" P< 0.02 when compared to CUS alone and NDEA alone treated groups 
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control CUS alone NDEA abne 
Treatment Groups 
R-estress-NDBA 
Fig 1. The effect of CUS alone, NDEA alone and CUS on NDEA administration in 
terms of hepatic levels of MDA. 
Values are mean ± SEM of 6 animals. 
* P< 0.05 when compared to control. 
P< 0.02 when compared to CUS alone and NDEA alone treated groups 
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Fig 2. The effect of CUS and NDEA, alone and in combination on the lung levels 
of malondialdehyde (MDA). 
Values are mean ± SEM of 6 animals. 
* P< 0.05 when compared to control. 
*P< 0.02 when compared to CUS alone and NDEA alone treated groups 
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Fig 3. The effect of CUS and NDEA, alone and in combination on the plasma 
levels of malondialdehyde (MDA). 
Values are mean ± SEM of 6 animals. 
* P< 0.05 when compared to control. 
*P< 0.02 when compared to CUS alone and NDEA alone treated groups 
71 
140 
120 
S 100 ^ 
I 
^ 80 
5 60 • 
E 
20 -
control 
^fsuUsI 
*# 
I V H > V , ^ ^ ^ ^ ^ 
" ^ v ^ ••*«-•</• 
CDS alone NDEA alone Restress-
rOEA 
Treatnnent Groups 
Fig 4. The hepatic GSH content in stressed, NDEA treated and pre stress-NDEA 
treated mice. 
Values are mean ± SEM of 6 animals. 
* P< 0.05 when compared to control. 
P< 0.02 when compared to CUS alone and NDEA alone treated groups 
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Fig 5. The lung GSH content in stressed, NDEA treated and pre stress-NDEA 
treated mice. 
Values are mean ± SEM of 6 animals. 
* P< 0.05 when compared to control. 
*P< 0.02 when compared to CUS alone and NDEA alone treated groups 
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Fig 6. The plasma GSH content in stressed, NDEA treated and pre stress-NDEA 
treated mice. 
Values are mean ± SEM of 6 animals. 
* P< 0.05 when compared to control group. 
P< 0.02 when compared to CUS alone and NDEA alone treated groups. 
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Table 6: Circulatory level of liver function enzyme SCOT, SGPT and ALP in 
stressed, NDEA and pre stress NDEA treated mice. 
Groups 
Control 
CUS Alone 
NDEA Alone 
Prestress-NDEA 
SCOT 
lU/Litre 
15.42±0.51 
23.10*±1.11 
57.81* ±2.62 
74.53'''±2.10 
SGPT 
lU/Litre 
24.13±1.22 
36.31'±1.50 
59.43* ±2.21 
89.32** ±1.72 
ALP 
mg/ml 
5.60±0.31 
7.93*±0.42 
14.5]*±0.4I 
25.52'''±0.86 
Each value represents the mean± SEM of 6 animals. 
* P< 0.05 when compared to control group. 
* P< 0.02 when compared to CUS alone and NDEA alone treated groups. 
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Table?: DNA damaging effect of CUS, NDEA and Prestress-NDEA on the 
peripheral blood lymphocytes, liver and lung cells of mice. 
Tail length (|xm) 
Groups Control CUS alone NDEA alone Prestresss-NDEA 
Lymphocyte 2.16±0.41 10.24*±1.31 30.8*±0.75 40.19*" 1.43 
Liver cell 2.37±0.33 12.90* ±0.75 44.12* ±0.88 54.7r*±1.01 
Lung cell 2.14±0.63 13.14*±1.01 47.14*±1.11 57.7*''±1.17 
Data represent means ± S.E.M. of 6 animals in each group. 
P <0.05 when compared to control group. 
*P<0.02 when compared to CUS alone and NDEA alone treated groups 
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Fig. 7. Single cell gel electrophoresis of mice liver cells showing Comets (lOOX) 
after stress/NDEA and pre stress NDEA treatment. (A) Control (B) CUS 
alone (C) NDEA alone and (D) pre-stress NDEA 
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Fig 8. Single cell gel electrophoresis of mice lung cells showing Comets (lOOX) 
after stress/NDEA and pre stress NDEA treatment. (A) control (B) CUS 
alone (C) NDEA alone and (D) pre-stress NDEA 
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Fig 9. Single cell gel electrophoresis of mice blood lymphocytes showing Comets 
(lOOX) after stress/NDEA and pre stress NDEA treatment. (A) control (B) 
CUS alone (C) NDEA alone and (D) pre-stress NDEA 
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(Discussion I 
Behavioural processes have long been suspected to influence many health processes 
including cancer progression and to a lesser extent, cancer onset, has been related to 
chronic stress, depression, lack of social support and other psychological factors 
(Reiche et al., 2004;Antoni et al., 2006;). Exposure to stress induces a cluster of 
physiological and behavioural changes in an effort to maintain the homeostasis of 
the organism. Stress has been shown to markedly influence incidence, growth and 
metastasis, and rejection of chemically induced or implanted tumours (Amkraut and 
Solomon., 1972;Zygmunt et al., 1985;). However, results are contradictory as both 
exacerbation and attenuation of tumour development has been reported by stress 
(Pradhan and Prabhati, 1974; Justice., 1985). 
Oxidative stress, a pervasive condition induced by stress has been implicated and 
recognized to be a prominent feature of various diseases like cancer and their 
progression. An imbalance in pro-oxidant/antioxidant status indicates production of 
reactive oxygen species (ROS), such as peroxides, hydroxyl and superoxide anion 
radicals, which induce cellular oxidative damage through DNA strand breaks and 
lipid peroxidation (Batcioglu et al., 2002). Indeed DNA damage induced by 
oxidative stress and/or deficient DNA-repair may have etiological or prognostic role 
in cancer (Mussarat et al., 1996). Previous studies in our lab have demonstrated the 
effect of restraint stress on the antioxidant status and DNA damage in rats. It was 
found that chronic restraint stress caused increased lipid peroxidation, compromised 
antioxidant status and enhanced DNA damage (Zaidi et al., 2005; Muqbil et al.. 
2006). Recent study in our lab has assessed the effect of chronic unpredictable stress 
on the antioxidant status in mice (Hasan et al., 2010). The present study shows that 
exposure of mice to chronic unpredictable stress resulted in a significant increase in 
the level of MDA along with a significant decrease in the antioxidant enzyme 
activities and the level of GSH. These results are supported by previous studies in 
which chronic unpredictable stress showed a disturbed oxidant- antioxidant balance 
(Zhang et al., 2009, Nayanatara et al., 2009). This may also be due to the fact that 
OH" radical is indeed generated during the course of stress from endogenous O2 and 
H2O2 through the metal catalysed Haber-Weiss reaction, and it plays a direct role in 
stress induced oxidative damage (Das et al., 1997). Increased lipid peroxidation 
accompanied with compromised host antioxidant status may result in accumulation 
of free radicals and as a consequence the levels of marker enzymes, GOT, GPT. 
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ALP in liver and SGOT, SGPT and ALP in circulation were increased significantly 
as compared to control. Oxidative stress has been reported to be closely associated 
with initiation and promotion stages of carcinogenesis (Jang and Pezzuto, 1998; 
Klaunig and Kamendulis, 2004). Many carcinogens have been shown to act through 
the generation of ROS (Blumberg, 1981; Cerruti, 1985). The generation of ROS and 
its subsequent accumulation induces oxidative stress at cellular level (Waris and 
Ahsan, 2006). The observed significant increase of MDA in NDEA-administered 
mice is in harmony with other studies who reported that there was a significant 
increase in MDA level after NDEA administration (Thirunavukkarasu and 
Sakthisekaran., 2001; Pradeep et al., 2007). However further significant increases in 
malondialdehyde were observed in pre -stress NDEA treated group. This enhanced 
MDA level could be the result of increased production of/or decreased destruction 
of ROS due to the increased depletion of the antioxidant system and hence decrease 
in anti-oxygenic potential. NDEA requires metabolic activation to become a 
carcinogen. NDEA has been shown to be metabolized to its active ethyl radical 
metabolite and accompanied with the generation of toxic ROS (Chakraborty et al.. 
2007). These ROS formed during NDEA metabolism can diffuse from the site of 
generation to other targets and produce deleterious effects by initiating lipid 
peroxidation directly or by acting as second messengers for the primary free radicals 
that initiate lipid peroxidation. Thus enhanced hepatic, lung and plasma lipid 
peroxidation in NDEA treated animals may be attributed to excessive generation of 
ROS exacerbated by decreased efficiency of host antioxidant defense mechanisms 
that include the antioxidant enzymes. GSH is the major cytosolic thiol compound 
which plays important cellular functions including destruction of hydrogen peroxide. 
lipid peroxides and free radicals. The present data showed that administration of 
NDEA caused a significant decrease in the level of GSH, which may be responsible 
for the increased lipid per oxidation. Exposure of CUS to NDEA administered mice 
further decreased the levels of GSH. This further decrease of GSH in pre-stress 
NDEA infused mice suggests that cells deficient in thiol groups undergo fast lipid 
per oxidation, as GSH is one of the guarding factors against oxidative stress. 
Antioxidants are the free radical scavengers and it is reasonable to speculate that 
abnormality of antioxidant enzymes must occur during carcinogenesis. When 
compared to their appropriate normal cell counterparts, tumor cells have abnormal 
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activities of antioxidant enzymes. Enhanced lipid per oxidation associated with 
depletion of antioxidants is a characteristic finding in a variety of malignancies 
(Anis et al., 2001). SOD and CAT are primary antioxidant enzymes involved in the 
inactivation of environmental carcinogen and direct elimination of toxic free radicals 
and electrophiles, which might result in amelioration of oxidative damage. It has 
been found that tumor cells are nearly low in MnSOD activity, usually low in 
CuZnSOD activity, and almost always low in catalase activity. GPx and GR 
activities are highly variable (Oberley and Buettner, 1979;Oberley and Oberley, 
1986; Sun, 1990). It was found that SOD, CAT and GR activities were, in general, 
low in the tumors as compared to corresponding normal tissues (Tisdale el al., 
1983). The activities of these free radical scavenging enzymes were found to be 
decreased in rats treated with NDEA (Yadav and Bhatnagar., 2007). In the present 
study NDEA administration caused decreased activities of SOD and CAT in liver 
and lung tissues of animals resulting in compromised host antioxidant status. 
Further significant decrease in the activities of SOD and CAT by CUS in NDEA-
treated mice could be due to over utilization of these enzymatic antioxidants to 
scavenge the products of lipid per oxidation and oxidative stress. A large number of 
studies have established an association between cancer incidence and various 
disorders of GSH-related enzyme functions, alterations of glutathione S-transferases 
(GSTs) being most frequently reported. GSTs are a family of enzymes that utilize 
glutathione in reactions contributing to the transformation of a wide range of 
compounds, including carcinogens, therapeutic drugs, and products of oxidative 
stress. Low activities of antioxidant enzymes and other free radical scavengers, with 
low GSH content may cause the accumulation of free radicals, which can result in 
damage to DNA, RNA, lipids and proteins, and perhaps finally lead to cancer. A 
significant decrease in the activity of GSH dependent enzymes, GST and GR was 
observed in NDEA treated mice. This may be due to the decreased expression of 
these antioxidants during tissue damage as previously described (Kweon et al., 
2003). The further decreased levels of GST and GR as observed in pre -stress 
NDEA mice might help in NDEA induced carcinogenesis by decreasing its 
clearance from the system. 
The extracellular fluids of animals, such as blood plasma, tissue fluid. CSF etc. 
contain little or no catalase activity and only low activities of SOD. There is also 
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very little reduced glutathione (GSH) in most extracellular fluids-about 20ulVl in the 
plasma of rats (Halliwel & Gutteridge, 1990). Therefore, the major anioxidants 
found in blood plasma are ascorbic acid, uric acid and glucose in addition to 
transferrin and albumin. NDEA treatment in the present study resulted in decreased 
levels of serum antioxidants glucose, uric acid, SOD, CAT, GST and GR. Uric acid 
can act as antioxidant both by binding iron and copper ions in forms that do not 
accelerate free radical reactions, and also by directly scavenging oxidizing species 
such as singlet 02, HOCl and peroxyl radicals (Davies et. al., 1986). It therefore 
inhibits lipid peroxidation. Glucose also acts as a scavenger of hydroxyl radicals 
with rate constant comparable to that of mannitol (Halliwel & Gutteridge, 1990). 
The levels of these antioxidants were found to be decreased with increase in lipid 
peroxidation in plasma of mice exposed either to CUS alone or NDEA alone. These 
levels were further decreased when NDEA was given to mice pre-exposed to stress. 
which shows that stress itself alters the antioxidant status, thus facilitating and 
enhancing the NDEA induced carcinogenesis. 
Liver enzymes such as LDH, GOT, GPT, ACP, and ALP are considered to be the 
biochemical markers for assessing liver function. Increased permeability of cells 
probably due to increased membrane lipid peroxidation may lead to necrosis usually 
characterized by rise in these marker enzymes (Athar, 2004). Due to increased cell 
permeability these enzymes are also released into circulation thus altering their 
normal levels in serum/plasma too. Thus increased levels of SGOT, SGPT and ALP 
were also observed following NDEA treatment. Five to ten fold elevations of these 
two enzymes are reported in patients with primary or metastatic carcinoma of liver 
(Ellis et al., 1978). In this study, we demonstrated that the administration of NDEA 
to mice lead to a marked elevation in the levels of GOT, GPT and ALP which is 
indicative of hepatocellular damage, as previously reported (Sadik et al.. 2008). 
Further elevations of these enzymes in pre-stress NDEA mice could potentially be 
attributed to the release of these enzymes from the cytoplasm into the blood 
circulation after rupture of the plasma membrane and by increased cellular damage. 
Reactive oxygen species (ROS) have been suggested as causative factors in 
mutagenesis, carcinogenesis and tumor promotion and have been implicated in the 
etiology and pathophysiology of many human diseases (Dhawan et al., 1999; Vaiko 
et al., 2006). They induce strand breaks and cause oxidative modification of DNA 
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bases (Cerutti, 1985). Damage to DNA integrity is considered as the basic trigger of 
various diseases including cancer. Damaged DNA also results in impaired ability of 
cells to repair or prevent disease (Hoeijimakers, 2001). Several studies have 
examined the effect of stress on DNA integrity as stress has been found to cause 
production of ROS resulting in oxidative stress and increased lipid peroxidation. 
During oxidative stress, MDA or other aldehydes are formed in biological system, 
which react with amino acids and DNA resulting in alterations in replication, 
transcription and leading to tumor formation (Perchellet and Perchellet, 1989). 
Exposure to conditional emotional stimuli results in DNA damage in rats by 
increasing the levels of 8-OH-dG significantly as compared to controls (Adachi et 
al., 1993). While DNA fragmentation was observed in gastric mucosa of rats 
exposed to both acute and chronic stress (Bagchi et al., 1999). Stress is also found to 
effect DNA repair system as rotational stress decreased the levels of 
methyltransferase, an important repair enzyme, in spleen of rats (Glaser et al., 
l985;Forlenza et al., 2000;). Psychological stress also impaired the repair of DNA 
damage induced by exposure to a carcinogen, in rats (Glaser et al., 1985). The 
discrepancies between these data remain unresolved and it remains unclear whether 
the consistent effects of stress on DNA integrity stem from ROS production, due to 
the inconsistent results observed on the generation of ROS in stress. 
In the present study chronic unpredictable stress was found to cause oxidative stress 
and damage to DNA of lymphocytes, liver and lung cells of mice which was 
significant from that of control values. Pre-stress NDEA treatment showed still 
higher frequencies of DNA damage in comparison with control, CUS alone or 
NDEA alone groups. DNA damage was measured in terms of increased DNA tail 
length as compared to controls. A plausible explanation for this may be that the 
chronic stress used here incured DNA damage within the cell either by altering the 
ability of cells to repair DNA, or by causing oxidative stress and inhibiting apoptosis 
as observed by others (Glaser et al., 1985; Kiecolt-Glaser et al., I985;Adachi et al., 
1993). Mechanisms that play roles in NDEA carcinogenicity include DNA adduct 
formation followed by gene mutation (Dyroff et al., 1986; Deal, 1989; Travis et al.. 
1991) and the administration of NDEA was reported to generate lipid peroxidation 
products in general (Hietanen et al.,1987) and enhance the formation of the 
activated oxygen species in the preneoplastic nodules (Scholz et al., 1990). The 
84 
(Discussion I 
increased formation of reactive oxygen substances both in circulation, liver and lung 
tissues by NDEA exposure either alone or after stress treatment further confirms an 
enhanced DNA damage by chronic stress. Thus enhanced lipid peroxidation 
accompanied by depletion of GSH, GSH dependent enzymes and free radical 
scavengers in liver, lung and plasma and DNA breakage may be the result of the 
generation of hydroxy! radicals and other ROS in situ (Valko et al., 2007). 
Moreover, oxygen radical damage to deoxyribose or DNA is considered to give rise 
to TBA reactive material (Quinlan & Gutteridge, 1987). Thus, oxidative stress 
arising due to ROS overproduction coupled with deficiency of host antioxidant 
defense mechanisms observed in the present study may be an important factor 
contributing to the increase in DNA damage in NDEA treated animals. Exposure to 
stress may therefore play an important role from the very early stages of 
carcinogenesis right at the basic cellular level by causing oxidative stress and/or 
increasing the damaging potential of a carcinogen. This is confirmed by the fact that 
enhanced DNA-damage was observed in mice treated with NDEA following 
exposure to stress as compared to those treated with NDEA alone. It may thus be 
suggested that chronic unpredictable stress though having direct effect on DNA may 
act indirectly by impairing the DNA repair ability of cell thereby priming the cell for 
subsequent damage by the carcinogen. Thus we conclude that not only NDEA 
infusion but chronic unpredictable stress also alters the antioxidant status oF mice 
and the condition further deteriorates if animals are exposed to stress prior to NDEA 
administration resulting in the formation of free radicals or ROS which may cause 
tissue injury and increase membrane lipid peroxidation. As a result, the levels of 
marker enzymes are increased and the increased membrane peroxidation may 
facilitate their release in the circulation. Thus an additive pro oxidant effect of stress 
and NDEA is observed. 
Our study suggests an association between the observed changes in biochemical 
parameters, notably oxidative stress, due to chronic stress on the toxicity of 
environmental chemicals. Exposure to NDEA causes induction of oxidative stress 
and DNA damage by generation and accumulation of large amount of free radicals. 
Chronic stress further e.xacerbates this condition thus putting an individual at an 
increased risk of developing cancer. This study may offer a sensitive and useful 
approach for assessment of effects of psychological stress on the carcinogenic risks 
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of environmental chemicals. Further studies may be aimed at combining parameters 
of psychological stress with those of redox state, DNA-repair activity and 
antioxidant defence so as to identify the relations between psychological stress and 
carcinogenesis. As cancer treatment evolves towards a more patient-specitlc 
approach, consideration of the influence of bio-behavioural factors provides a novel 
perspective for mechanistic studies and new therapeutic targets. Such interventions 
may include behavioural interventions alone or in combination with 
pharmacological approaches. 
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Comet Assay 
A statistically significant (p<0.05) increase in DNA damage was observed in 
lymphocytes, liver and lung cells of animals treated with NDEA, in terms of 
increased tail length, in comparison to controls (Table 8). Pre-stress NDEA group 
showed further significant (p<0.02) increase in tail length that was found to be 
highest as compared to all other groups. In animals treated with quercetin along with 
NDEA, tail length though significantly (p<0.05) increased as compared to control 
group, but was reduced significantly (p<0.05) in comparison to NDEA alone treated 
animals thus showing protective effect of quercetin (Qu) against NDEA induced 
DNA damage. However, in animals exposed to chronic unpredictable stress (CUS) 
followed by NDEA-quercetin treatment, the tail length was again significantly 
increased (p<0.05) as compared to NDEA-quercetin treated group. Like quercetin 
the treatment with melatonin (Mlt) and popophyllum hexandrum rhizome extract 
(Phre) decreased the NDEA induced DNA damage significantly but prior exposure 
to CUS inhibited the DNA damage preventive potential of melatonin and Phr-extract 
(Table 8). A comparison of tail lengths of the three types of cells studied revealed 
that liver and lung cells exhibited enhanced level of DNA damage either on NDEA 
alone or pre-stress NDEA treatment. DNA damage by NDE.A and protective effects 
of quercetin, melatonin and Phreboth in presence and absence of stress in lung cells 
are shown in Fig 10. 
Fluorescent Spectroscopy 
The fluorescent spectra of control and experimental group of animals are shown in 
figuresll-13 and the emission characteristics are given in table 9. At 400 nm 
excitation, the plasma of control animals showed a prominent maxima at 430 nm 
which decreased at longer wavelengths as shown in Fig. 11-13. In experimental 
groups, the plasma of NDEA treated animals, in addition to a peak at 430 nm, 
showed a secondary peak at 630 nm and Fl 530nm/F1630nm was significantly 
(p<0.05) reduced. The intensity of secondary peak was increased in pre-stress 
NDEA group and Fl 530nm/FI630nm decreased further as com.pared to control and 
NDEA alone group. In NDEA-quercetin treated group the secondary peak was 
significantly reduced and Fl 530nm/FI630nm was found to be nearly approaching 
the control values (Table 9). However, in animals exposed to CUS prior to NDEA-
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quercetin treatment the intensity of secondary pealc increased and Fl 
530nm/F1630nm decreased again and was significantly (p<0.05) different from 
NDEA alone treated group (Fig. 11). 
Melatonin and Phre treatment were found to have same effect on fluorescent spectra 
of plasma as quercetin and exposure to CUS prior to Melatonin and Phr-extract 
treatment resulted in a significantly different spectra from NDEA alone group (figs 
12, 13,Table9). " 
Oxidative status and the level of marker enzymes 
Quercetin, melatonin and Phr-extract were found to have protective effect against 
NDEA induced alterations of various antioxidant enzymes or biochemical markers 
in liver and lung tissues as well as in circulation. A significant decrease (p<0.05) in 
the activities of SOD, CAT, GST and GR was observed in NDEA or Pre stress-
NDEA treated animals as depicted in table 10,11 . Quercetin, Melatonin or Phre 
treatment along with NDEA however, resulted in a significant (p<0.05) increase in 
these antioxidant enzymes in liver and lung tissues, while pre-exposure to CUS was 
found to decrease the protective effect of quercetin, melatonin and Phre as observed 
by significant decrease (p<0.05) of these antioxidant enzymes as compared to 
control group. Circulatory levels of in vivo antioxidants showed pattern similar to 
that of hepatic and lung antioxidants as shown in tables 13. Levels of various 
biochemical markers of liver function were increased significantly (p<0.05) both in 
the liver and circulation in the NDEA and pre-stress NDEA treated animals, as 
compared to NDEA-quercetin or NDEA melatonin or NDEA-Phre group 
(Table 12,14). The increase in their levels was reduced significantly (p<0.05) when 
animals were supplemented either with quercetin, melatonin or Phre. However on 
pre-exposure to CUS their levels were increased again significantly (p<0.05) as 
compared to control and NDEA-quercetin or NDEA melatonin or NDEA 
podophyllum hexandrum rhizome group and comparable to that of NDEA alone 
group as shown in tables 12,14. Similar effect was observed on TBARS levels in 
liver, lung and circulation of control and treated animals as shown in figs 14-16 
accompanied with decrease in hepatic, lung and plasma GSH content (fig. 17-19). 
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Table 8: DNA damaging effect of NDEA alone and pre-stress NDEA and effect 
of quercetin or melatonin or Phre treatment on NDEA induced DNA 
damage measured in terms of tail length 
Groups 
Tail length (^m) 
Liver lung Lymphocytes 
Control 2.31±0.12 2.82±0.16 3.01 ±0.17 
NDEA alone 44.21* ±0.88 47.40*±1.11 31.40'±1.40 
Pre stress-NDEA 54.70** ±1.01 60.70**±1.17 49.70** ±1.16 
NDEA-Qu 10.44''±0.6 11.41 "±0.41 9.41*±0.59 
Prestress-NDEA Qu 32.32**±1.36 27.12**±1.6 25.93'*±1.47 
NDEA-Mlt 12.4l''±0.52 13.1l''±0.46 I2.62*±0.44 
Prestress-NDEA Mlt 35.9l'"'±2.3 33.52*''±1.3 27.5l'"'±1.56 
NDEA-Phre 13.21*±0.67 13.82*±0.82 14.41*±0.86 
Prestress-NDEA Phre 36.7r**±2.I 35.73**'±!.38 29.43*"±l.62 
Data represents means ± S.E.M. of 6 animals in each group. 
*p<0.05 when compared to control. 
p< 0.05 when compared to NDEA alone group. 
** 
m 
* * * 
p<0.05 when compared to NDEA-Qu group. 
p<0.05 when compared to NDEA -Mlt- group 
p <0.05,when compared to NDEA-Phre group. 
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Fig 10. Single cell gel electrophoresis of lung cells in NDEA and Prestress NDEA 
mice after treatment with quercetin, melatonin and Phre showing comets 
(lOOx). 
(A) Control (B) NDEA alone 
(C) Pre-stress NDEA (D) NDEA -Quercetin 
(E) Pre-stress NDEA-Quercetin (F) NDEA-Melatonin 
(G) Pre-stress NDEA Melatonin (H) NDEA -Phre 
(1) Pre-stress NDEA Phre 
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Fig 11. Emission spectra of plasma of NDEA and pre-stress NDEA alone or along 
with quercetin treated animals on excitation at 400nm. 
Data represents mean ± S.E.M. of 6 animals in each group. 
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•control 
•NDEA 
prestress-NDEA 
•NDEA-MK 
•Prestress-NOEA-Mt 
T T " 
430 460 490 520 550 580 610 640 670 700 
Wave length (nm) 
Fig 12. Emission spectra of plasma of NDEA and Pre stress NDEA alone or along 
with melatonin treated animals on excitation at 400nm. 
Data represents mean± S.E.M. of 6 animals in each group. 
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Fig 13. Emission spectra of plasma of NDEA and Pre stress NDEA alone or along 
with Phre treated animals on excitation at 400nm. 
Data represents mean± S.E.M. of 6 animals in each group. 
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Table 9: Emission characteristics of Plasma of control and experimental groups of 
mice during fluorescent spectral analysis excited at 400nm. 
Groups Fl(530/630) 
control 
NDEA alone 
Prestress-NDEA 
NDEA-Qu 
Prestress-NDEA Qu 
NDEA - Melt 
Prestress-NDEA Mlt 
NDEA-Phre 
Pre-stress-NDEA-Phre 
2.02±0.10 
0.72*±0.03 
0.53*''±0.02 
1.83*±0.05 
0.82**±0.04 
1.84**0.05 
0.92***0.04 
1.74''±0.06 
0.75***±0.03 
Data represents means ± S.E.M. of 6 animals in each group. 
* p<0,05, when compared to control. 
# p< 0.05 when compared to NDEA alone group. 
** p<0.05 when compared to NDEA-Qu group. 
## p<0.05 when compared to NDEA -Mlt group 
***p <0.05 when compared to NDEA -Phre group 
94 
<SifSidtsII 
XZZZi Control 
n n NDEA alone 
TSB Prestress-NDEA 
NDEA-Qu 
IS2S Prestress-NDEA-Ou 
caNDEA-MIt 
^ Prestness-NDEA-MH 
C33 NDEA-Phre 
Prestress-NDEA-Phre 
4 5 6 
Treatment groups 
Fig 14. Hepatic levels of MDA in animals treated with NDEA, pre-stress NDEA 
alone and along with either Quercetin or melatonin or Phre. 
Data represents mean± S.E.M. of 6 animals in each group 
* p<0.05 when compared to control. 
# p< 0.05 when compared to NDEA alone group. 
** p<0.05 when compared to NDEA-Qu. group. 
## p<0.05 when compared to NDEA -Mlt. group 
*** p<0.05 when compared to NDEA -Phre group 
95 
^(fsuGtsII 
7 1 
6 -
B S 
a. 
o 
e 
c < 
Q 
2 2 
4 -
3 -
*# 
^ Control 
mD NDEA atone 
^ 3 Prestress-NDEA 
mNDEA-Qu 
ess Prestress-NDEA-Qu 
cnNDEA-MIt 
• 1 Prestress-NDEA-MIt 
NDEA-Phre 
I Prestress-NDEA-Phre 
Treatment groups 
Fig 15. Lung tissue levels of MDA in animals treated with NDEA, pre-stress 
NDEA alone and along with either Quercetin or melatonin or Phre. 
Data represents mean± S.E.M. of 6 animals in each group 
* p<0.05 when compared to control. 
# p< 0.05 when compared to NDEA alone group. 
** p<0.05 when compared to NDEA-Qu. group. 
## p<0.05 when compared to NDEA -Mlt. group 
*** p<0.05 when compared to NDEA -Phre. group 
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Fig 16. Plasma levels of MDA in animals treated with NDEA, pre-stress NDEA 
alone and along with either Quercetin or melatonin or phre. 
Data represents mean± S.E.M. of 6 animals in each group 
* p<0.05 when compared to control. 
# p< 0.05 when compared to NDEA alone group. 
** p<0.05 when compared to NDEA-Qu. group. 
## p<0.05 when compared to NDEA -Mlt. group 
*** p<0.05 when compared to NDEA -Phre group. 
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E 3 Control 
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Fig 17. Hepatic GSH content in animals after treatement with NDEA, NDEA-
Quercetin, NDEA-melatonin, NDEA-phre alone and on pre-exposure to 
chronic unpredictable stress. 
Data represents mean± S.E.M. of 6 animals in each group 
* p<0.05 when compared to control. 
# p< 0.05 when compared to NDEA alone group. 
** p<0.05when compared to NDEA-Qu. group. 
## p<0.05 when compared to NDEA -Mlt. group 
*** p<0.05 when compared to NDEA -Phre group. 
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Fig 18. Lung tissue GSH content in animals after treatement with NDEA, NDEA-
Quercetin, NDEA-melatonin, NDEA-Phre alone and on pre-exposure to 
chronic unpredictable stress. 
Data represents mean± S.E.M. of 6 animals in each group 
* p<0.05 when compared to control. 
# p< 0.05 when compared to NDEA alone group. 
** p<0.05 when compared to NDEA-Qu. group. 
## p<0.05 when compared to NDEA -Mlt. group 
*** p<0.05 when compared to NDEA -Phre group. 
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Fig 19. Plasma GSH content in animals after treatement with NDEA, NDEA-
Quercetin, NDEA-melatonin, NDEA-phre alone and on pre-exposure to 
chronic unpredictable stress. 
Data represents mean± S.E.M. of 6 animals in each group 
* p<0.05 when compared to control. 
# p< 0.05 when compared to NDEA alone group. 
** p<0.05 when compared to NDEA-Qu. group. 
## p<0.05 when compared to NDEA -Mlt. group 
*** p<0.05 when compared to NDEA -Phre group. 
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Table 10: Levels of free radical metabolizing enzymes in liver after treatment with 
quercetin, melatonin and Phre in NDEA and pre-stress NDEA treated 
animals. 
SOD CAT GST GR 
Groups (units/mg (units/mg (units/mg (units/mg 
protein) protein) protein) protein) 
control 623.30±11.10 97.40±4.87 876.40±13.82 0.312±0.03 
NDEA alone 500.80*±8.20 57.40*±2.85 623.40*±ll.l 0.]98*±0.02 
Prestress-
NDEA 
434.20**7.4 39.60**1.58 498.70 "±14.9 0.091 "±0.01 
NDEA-Qu 598.41*±9.92 90.51*±3.60 863.20** 13.16 0.276**0.02 
530.60***7.90 65.71***2.90 640.30***11.60 0.212***0.01 
Pre-stress 
NDEA Qu 
NDEA-Mlt 587.90**5.3 87.70**4.35 860.30**12.11 0.261**0.02 
Pre-stress-
NDEA Mlt 
52I.I0'"'*6.1 63.60'"'*3.18 635.92'"'*7.71 0.207'"'±0.02 
NDEA-Phre. 559.63**7.61 79.31**3.96 856.41**6.71 0.251**0.02 
Pre-Stress 
515.60****6.51 60.34****3.06 631.71****8.20 0.201****0.02 
NDEA Phre. 
Data represents means * S.E.M. of 6 animals in each group. 
* p<0.05 when compared to control. 
# p< 0.05 when compared to NDEA alone group. 
** p<0.05 when compared to NDEA-Qu. group. 
## p<0.05 when compared to NDEA -Mlt. group 
*** p<0.05 when compared to NDEA -Plire group. 
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Tablell: Levels of free radical metabolizing enzymes in lung tissues after 
treatment with quercetin, melatonin and Phre in NDEA and pre-stress 
NDEA treated animals. 
Groups SOD (units/mg protein) 
CAT 
(units/mg 
protein) 
GST (units/mg GR (units/mg 
protein) protein) 
control 
NDEA 
alone 
Prestress-
NDEA 
NDEA-Qu 
Pre-stress 
NDEA Qu 
NDEA-
Mlt 
Pre-stress-
NDEA 
Mlt. 
NDEA-
Phre. 
Pre-stress 
NDEA 
Phre. 
756.6]±12.70 
563.30*±16.81 
261.88**±7.83 
710.72''±14.51 
579.51**±7.41 
688.47''± 10.64 
568.64'"'± 16.61 
670.52''± 10.51 
565.72***±6.90 
38.61±].14 
22.41*±1.12 
14.51**±0.91 
32.43''±1.62 
26.82**±1.32 
30.48*±1.51 
24.5''#±1.22 
28.5l''±0.85 
23.82***±1.15 
474.11 ±14.22 
335.60*±10.52 
198.53*''±3.76 
453.12''± 13.62 
345.63**±10.4I 
445.66"* 13.31 
340.3***14.52 
438.81**7.52 
337.31****6.41 
0.321*0.032 
0.150**0.015 
0.090***0.102 
0.298**0.031 
0.165***0.016 
0.273**0.027 
0.I60**.016* 
0.268**0.013 
0.155****0.015 
Data represents means * S.E.M. of 6 animals in each group. 
* p<0.05 when compared to control. 
# p< 0.05 when compared to NDEA alone group. 
** p<0.05 when compared to NDEA-Qu. group. 
## p<0.05 when compared to NDEA -Mlt. group 
*** p<0.05 when compared to NDEA -Phre group. 
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Table 12: Level of liver function enzyme GOT, GPT and ALP after Quercetin, 
melatonin and Phre treatment in NDEA and pre-stress NDEA treated 
animals. 
Groups 
control 
NDEA alone 
Prestress-NDEA 
NDEA-Qu 
Pre-stress NDEA Qu. 
NDEA-Mlt. 
Pre-stress-NDEA Mlt. 
NDEA-Phre. 
Pre-stress NDEA-Phre. 
GOT 
lU/litre 
40.8±2.3 
86.4*±2.5 
110.5**±5.1 
55./±2.2 
78.r*±2.5 
59.l''±3.2 
80.3** :^4.2 
62.5*±3.1 
80.9"*±4.6 
GPT 
lU/litre 
25.5±1.3 
65.3*±2.5 
130.9*''±6.5 
34.2''±1.7 
73.4'*±2.8 
36.3''±1.8 
72.4'"'±3.6 
37.8*±1.85 
70.r"±3.5 
ALP 
mg/ml 
7.8±0.39 
20.2*±1.2 
46.6*"* 1.84 
10.2''±0.5 
16.2**±0.64 
12.1 "±0.5 
18.3**i0.73 
12.9*±0.42 
19.3***±0.96 
Data represents means ± S.E.M. of 6 animals in each group. 
* p<0.05 when compared to control. 
# p< 0.05 when compared to NDEA alone group. 
** p<0.05 when compared to NDEA-Qu. group. 
## p<0.05 when compared to NDEA -Mlt. group 
* * * p<0.05 when compared to NDEA -Phre group 
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Table 14: Circulatory level of liver function enzyme SCOT, SGPT and ALP after 
treatment with quercetin, melatonin and Phre in NDEA and pre-stress-
NDEA-treated mice. 
Groups 
Control 
NDEA alone 
Prestress-NDEA 
NDEA-Qu 
Pre-stress NDEA Qu. 
NDEA-Mlt. 
Pre-stress-NDEA Mlt. 
NDEA-Phre. 
Pre-stress NDEA-Phre. 
SCOT 
lU/litre 
15.5±0.78 
59.4*±2.97 
96.2*''±4.81 
20.1 "±1.2 
64.r*±1.3 
22.l''±1.10 
63.5''*±3.2 
24.l''±1.21 
61.8"±3.] 
SGPT 
lU/litre 
26.5±1.32 
65.5*±3.3 
100.3***4.1 
30.1**1.2 
59.9"±2.9 
32.1**1.6 
60.3***3.4 
32.4**1.6 
61.4***3.1 
ALP 
mg/ml 
4.6*0.09 
14.2**0.7 
31.2***1.55 
6.8**0.34 
12.9***0.6 
7.6**0.38 
13.6***0.65 
8.1**0.43 
13.1****0.67 
Data represents means * S.E.M. of 6 animals in each group. 
* p<0.05 when compared to control. 
# p< 0.05 when compared to NDEA alone group. 
** p<0.05 when compared to NDEA-Qu. group. 
M p<0.05 when compared to NDEA -Mlt. group 
*** p<0.05 when compared to NDEA -Phre group 
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(Discussion II 
The results of the present study indicate that the compounds used; quercetin, 
melatonin and rhizome extract of podophyllum hexandrum were effective in 
protecting animals against NDEA induced oxidative stress and DNA damage ,while 
chronic unpredictable stress was shown to diminish their chemopreventive effect. 
This observation was supported by the results of fluorescent studies, which were 
comparable to those of comet assay and biochemical markers that are considered as 
hallmarks of oxidative stress. 
Reactive oxygen species (ROS) have been considered as major pivotal determinants 
in the processes of tumor development. ROS, of course, arise whenever the cell is 
involved in oxygen utilization in its conversion of water, and this production may be 
enhanced by drugs, xenobiotics and diseases (Ames et al., 1993). ROS are actively 
involved in the metabolic activation of procarcinogens and the processes of tumor 
initiation, promotion and progression. Several lines of evidence indicate that 
oncogene mutation leading to protooncogene activation and tumor suppressor gene 
inactivation may play a crucial role in tumor initiation, promotion and progression. 
Some tumor cells produce ROS although the source of these products and their 
contribution to the transformed and malignant phenotype is not completely known. 
Thus, antioxidants, such as superoxide dismutase, catalase, tea polyphenols, vitamin 
(Vit.) C, Vit. E, and others, may be protective against cancer and may inhibit cell 
proliferation, and the intracellular ROS scavenger may actually contribute to 
suppression of tumor development. Antioxidant defense systems to counter this 
cannot provide complete protection from the noxious effects of ROS, which includes 
oxidative damage to DNA. There is a crucial balance between free-radical 
generation and antioxidant defense as a force in disease prevention. An imbalance 
between protection against free radicals and their generation can be associated with 
the pathogenesis of a wide variety of diseases (Halliwel & Gutteridge, 1999). Since 
oxidative/ electrophilic stress is generally perceived as one of the major causes for 
the accumulation of mutations in the genome, antioxidants are believed to provide 
protection against cancer. A number of natural and synthetic antioxidants are known 
to retard chemical carcinogenesis in experimental animal models (Sardas, 2003). 
The present study was undertaken to evaluate the effectiveness of quercetin, 
melatonin and podophyllum hexandrum rhizome extract (Phre) on NDEA induced 
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carcinogenesis both in presence and absence of stress. NDEA is known to cause 
oxidative stress and DNA damage in mammalian cells through free radical 
formation and lipid peroxidation (Anis et al.,2001, Chakraborty et a!., 2007). 
Chronic unpredictable stress enhanced the DNA damaging potential of NDEA 
which is evident from increased DNA damage of pre-stress-NDEA group animals in 
comparison to all other groups as discussed earlier. This is due to the fact that 
chronic unpredictable stress causes oxidative stress and increased lipid peroxidation 
in these animals. 
The role of the pineal gland in tumor development has been under intensive study 
during the last few years. In cancer patients the morphological signs of pineal 
function decrease and disturbances in the circadian secretion pattern of the main 
hormone of the pineal gland, melatonin, were observed (Vijaylaxmi et al., 
2002).Melatonin (N-acetyl-5-methoxytrptamine) has been recognized as the chief 
pineal secretory product for several decades. Later it has emerged as a widely 
distributed compound which is locally synthesized in several organs and tissues to 
serve as an autacoid (Pandi et al.,2006; Reiter et al.,2007). In pharmacological 
amounts, melatonin effectively reduces oxidative stress through several mechanisms 
(Reiter et al.,2007; Tan et al., 2007). Melatonin scavenges hydrochlorous acid, 
detoxifies highly toxic hydroxyl radical and peroxyl radical in vitro and scavenges 
peroxynitrite. Melatonin has also been reported to increase the synthesis of 
glutathione (GSH) and of several antioxidant enzymes. As a result of oxidation, 
melatonin gives rise to a cascade of antioxidant compounds like cyclic 3-
hydroxymelatonin, Nl-acetyl-N2-formyl-5-methoxykynuramine and, with a highest 
potency, Nl-acetyl-5-methoxykynuramine.Therefore, melatonin is considered to be 
a broad spectrum antioxidant that is more powerful than GSH in neutralizing ROS 
and that can protect cell membranes more effectively than other antioxidants (Reiter 
et al.,2007). As melatonin and its metabolites are very effective to protect DNA (Tan 
et al., 1994;Allegra et al.,2003) and in view that DNA damage is a prerequisite to 
cancer initiation, we carried out this study to examine whether melatonin was 
effective in preventing liver, lung and circulating indexes of oxidative damage in the 
NDEA and pre-stress NDEA treated mice. 
Results of the present study show a significant decrease in the activities of SOD, 
CAT, GR and GST in carcinogen treated mice. This decrease in activities of these 
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enzymes was restored by melatonin, bringing tiie values close to that of controls. 
The mode of action of this antioxidant is probably to prevent free radical damage on 
enzymes by scavenging free radicals produced. Moreover, it is reported that in 
addition to its radical scavenger effect, melatonin contributes to antioxidant capacity 
by increasing expression of antioxidant enzymes (Kotler et al., 1998). Further, the 
decrease in the levels of circulatory antioxidants glucose and uric acid was also 
replenished by melatonin treatment probably by acting directly as free radical 
scavenger as in vitro studies have revealed that melatonin acts as a direct scavenger 
of OH2 H2O2 singlet oxygen (t02), and inhibitor of lipid peroxidation (Anisimov et 
al., 2006). The amount of MDA, which is a product of lipid peroxidation is a 
measure of oxidative stress status of a cell or tissue. It is clearly demonstrated that 
oxidative stress induced by NDEA treatment causes considerable lipid peroxidation 
in liver, lung and plasma of mice. Melatonin significantly inhibited lipid 
peroxidation by lowering MDA levels, as melatonin has been proved to be a very 
efficient, neutralizer of the peroxyl radicals generated during lipid peroxidation 
(Lesnikov and Pierpoali, 1994). The depleted GSH content of liver and lung by 
NDEA infusion was found significantly enhanced by melatonin treatment probably 
due to the fact that melatonin stimulates the rate-limiting enzyme in the synthesis, y-
glutamylcysteine synthase (Anisimov et al., 2006). Increased levels of biochemical 
markers of liver function, ALP, GOT and OPT were also normalized following 
melatonin treatment. There is evidence that melatonin stabilizes membranes thereby 
helping them resist oxidative damage (Anisimov et al., 2006), which may be 
responsible for decreased SCOT and SGPT levels as compared to NDEA treated 
animals where oxidative damage to membranes caused the release of these enzymes 
into circulation. Thus, melatonin can be considered as an effective chemopreventive 
agent against NDEA induced carcinogenesis. However, the chemopreventive effect 
of melatonin was significantly reduced in NDEA treated animals pre-exposed to 
chronic unpredictable stress. Activities of antioxidant enzymes in liver,lung and 
plasma were decreased with increased levels of MDA. Hepatic GSH content was 
decreased while marker enzymes were increased significantly as compared to 
control and values were comparable to those of NDEA alone treated animals. This 
may due to the reason that stress besides causing oxidative stress in animals 
enhances the NDEA-induced pro-oxidant effect as well as DNA damage. Though 
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melatonin has been found to protect animals against stress induced gastric ulcer 
(Bandyopadhyay et al., 2000), its antioxidant property may not be sufficient to 
counter the combined burden of chronic unpredictable stress and carcinogen induced 
oxidative stress resulting in decreased chemoprevention. 
NDEA treatment in the present study was shown to induce DNA damage in 
lymphocytes, liver and lung cells of mice, measured by alkaline comet assay in 
terms of increased DNA tail length. However, melatonin supplementation for the 
entire experimental period resulted in significant decrease in NDEA induced DNA 
damage in all the three types of cells studied as melatonin and its metabolites are 
very effective to protect DNA (Tan et al.,1993;Allegra et al,2003). Being both 
lipophilic and hydrophilic, it acts not only in every cell but also in sub cellular 
compartments besides its ability to neutralize free radicals directly, thereby reducing 
oxidative damage (Harman, 1994; Reiter, 1995). These properties allow melatonin 
to preserve macromolecules including DNA, protein and lipid from oxidative 
damage resulting from chemical carcinogen exposure. Collectively, the data indicate 
that melatonin may exert its chemopreventive role is the modulation of lipid 
peroxidation and antioxidants in both the target organ and the circulation. 
Another compound that has received increased attention in the recent years and used 
in the present study is quercetin. The study of quercetin as potential chemopreventer 
is assuming increasing importance considering its involvement in the suppression of 
many tumor-related processes including oxidative stress, apoptosis, proliferation, 
and metastasis (Akira et al.,2008). Quercetin has also received greater attention as 
pro-apoptotic flavonoid with a specific and almost exclusive activity on tumor cell 
lines rather than normal,non-transformed cells (Lugli et al.,2009).Experimental 
studies have shown that quercetin could inhibit carcinogenesis and tumour growth in 
skin, colon and oral cavity (Elangoven et al.,1994;Makita et al.,1996).AIthough 
different aspects of the molecular mechanisms involved in the preventive effects of 
Qu on cancer have been covered, its efficacy in vivo as chemopreventer or 
chemoterapeutical has to be further elucidated.In the present study quercetin was 
effective in protecting animals against NDEA induced oxidative stress and DN.^  
damage. This may be either due to the inhibition of phase in enzymes like CYP450 
involved in metabolic activation of procarcinogens to active carcinogens or 
induction of phase II enzymes e.g., GSTs which in coordination with GSH are 
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involved in the clearance of carcinogenic metabolites from the system, by quercetin. 
Therefore, quercetin in the present study was found to protect animals against 
NDEA induced DNA damage and oxidative stress. The DNA damage in 
lymphocytes, liver and lung cells was significantly reduced by quercetin 
supplementation. Similarly, the decreased activities of antioxidant enzymes SOD, 
CAT, GR and GST and GSH contents in liver, lung and circulatory antioxidants 
glucose and uric acid induced by NDEA were found to approach normal values 
following parallel quercetin treatment. NDEA induced increase of MDA levels was 
also reduced by quercetin treatment. The levels of marker enzymes in liver and 
plasma were increased significantly in pre-stress carcinogen treated animals, these 
levels were also brought to near normal values on quercetin supplementation, further 
confirming its protective effect on NDEA induced carcinogenesis as quercetin is 
considered a strong antioxidant and scavenger of free radicals (Husain et 
al.l987;Robak and Gryglewski 1988;) and inhibitor of lipid peroxidation (;Terao et 
al., 1994;Saija et al. 1995;).However, when animals were pre-exposed to chronic 
unpredictable stress followed by NDEA treatment, no protection by the drug was 
observed against NDEA induced DNA damage and oxidative stress. The extent of 
DNA damage and oxidative stress in these animals were similar to those of NDEA 
alone treated group. Recent studies indicate that both physical and psychological 
stress may also be included among the factors which modulate cytochrome P450s 
and other drug metabolizing enzymes (Konstandi et al., 1998). Stressed organisms 
are less capable of defending themselves against cancer cells, infectious agents and 
other disease processes (Riley, 1981). Stress was found to enhance the benzo [a] 
pyrene induced CYPs and related activities. In addition, stress was able to alter the 
inducibility of monooxygenase activities by strong inducers such as B [a] P 
(Konstandi et al., 2000). Though little is known about the biochemical mechanisms 
by which stress affects xenobiotic metabolism, this may be the possible mechanism 
by which stress diminishes the protective effect of quercetin in pre-stress- NDEA 
quercetin treated group. As a result increased DNA damage and oxidative stress is 
observed in this group as compared to control or NDEA- quercetin treated group. 
Recent researches have shown that the antioxidants of plant origin with free-radical 
scavenging properties could have great importance as therapeutic agents in several 
diseases caused due to oxidative stress (Ramchoun et al.,2009). Plant extracts and 
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phytoconstituents are found effective as radical scavengers and inhibitors of lipid 
peroxidation (Yildirim et al.,2001;Dash et al.,2007,).Many synthetic antioxidant 
compounds have shown toxic and/or mutagenic effects, which have stimulated the 
interest of many investigators to search natural antioxidant (Nagulendran et 
al.,2007). 
In the present study extract of dried rhizome of podophyllum hexandrum was 
effective in protecting animals against NDEA induced oxidative stress and DNA 
damage. This may be either due to the free radical scavenging property of Phre and 
inhibition of phase II enzymes like CYP450 involved in metabolic activation of 
procarcinogens to active carcinogens or induction of phase I! enzymes e.g., GSTs 
which in coordination with GSH are involved in the clearance of carcinogenic 
metabolites from the system. 
Podophyllum hexandrum has been shown to manifest radioprotective action as 
evaluated by various parameters viz. metal chelation, free radical scavenging (Prem 
and goel.,2000), antioxidant potential both at in vitro and in vivo levels (Camilo et 
al.,2000; Gupta et al.,2007;Pankaj et al., 2009) and stimulation of cell proliferation . 
Various constituents of Podophylllum hexandrum such as cytokines and polyphenols 
could be responsible for such actions ( Mittal et al.,2002 ). The Phre in the present 
study was found to protect animals against NDEA induced DNA damage and 
oxidative stress as earlier studies of podophyllum hexandrum on other systems have 
been shown in respect of antioxidant enzymes, DNA damage and recovery (Pankaj 
et al 2007).NDEA induced DNA damage in lymphocytes, liver and lung cells was 
significantly reduced by Phre administration .Similarly, the decreased activities of 
antio.xidant enzymes SOD, CAT, GR and GST and GSH contents in liver,lung and 
circulatory antioxidants glucose and uric acid induced by NDEA were found to 
approach normal values follov/ing Phre treatment. NDEA induced increase of MDA 
levels was also reduced by this treatment. The levels of marker enzymes in liver and 
serum were increased significantly in carcinogen treated animals; these levels were 
also brought to near normal values on Phre supplementation further confirming its 
protective effect on NDEA induced carcinogenesis by scavenging free radicals and 
reducing lipid peroxidation. However, when animals were pre-exposed to chronic 
unpredictable stress followed by NDEA-Phre treatment, no protection was observed 
against NDEA induced DNA damage and oxidative stress. The extent of DNA 
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damage and oxidative stress in these animals were similar to those of NDEA alone 
treated group. Recent studies indicate that stressed organisms are less capable of 
defending themselves against cancer cells, infectious agents and other disease 
processes (Riley, 1989) as both physical and psychological stress may also be 
included among the factors which modulate cytochrome P450s and other drug 
metabolizing enzymes (Konstandi et al., 1998). As a result increased DNA damage 
and oxidative stress is observed in this group as compared to control or NDEA-Phre 
treated group. 
It is well known that biochemical events during pathological conditions of the tissue 
differ from their normal counterparts. Since tissues contain native 
chromophores/fluorophors, alteration in the pathological status can be detected 
sensitively using fluorescent spectroscopy (Zonios, 1998). As it is well known that 
tumour angiogenesis takes place during the proliferation (Fox et al., 1996) it is 
thought that transport of these fluorophors may be possible and can be detected in 
circulation. The natural intrinsic fluorophors mainly NAD(P)H, porphyrins and 
flavins display their characteristic spectra at 470, 520 and 630 nm respectively 
which characterize the local environment (Alfano et al., 1987). The ratio of 
fluorescent intensity at 530 nm and at 630 nm (FI530nm/630nm) is definite for a 
given tissue and an alteration in the ratio of these fluorophores depicts a change in 
the local and native environment. The plasma of NDEA treated animals in addition 
to a peak at 430nm like control samples, showed a prominent peak at 630nm which 
may be due to the change in the local environment or due to the production of new 
fluorophores induced by the carcinogen. Pre-stress significantly increased the PI at 
630 nm and 520 nm and decreased the ratio of FI530nm/630nm in plasma when 
compared to NDEA treated group. The mechanism is not clear, however, the 
increased oxidative stress in pre-stress NDEA group may result in the increased 
production of fluorophores. The treatment of quercetin,melatonin and Phre reduced 
the peaks at 630nm and 540nm and changed FI530nm/630nm significantly as 
compared to NDEA alone group bringing values more or less close to that of control 
group. This may be either due to interaction directly with the metabolic activation 
process, perhaps by inhibiting the cytochrome P450 dependent monooxygenase 
enzyme system or indirectly through stimulation of glutathione and glutathione 
peroxidase enzyme, in case of melatonin (Anisimov et al., 2006), thereby reducing 
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oxidative damage of the carcinogen. However, quercetin, melatonin and Phre are 
found less effective on NDEA induced damage when animals are pre-exposed to 
chronic unpredictable stress. The possible explanation could be that these 
compounds may be involved indirectly, as chronic unpredictable stress is known to 
induce oxidative stress and enhances NDEA induced pro-oxidant status too. thereby 
interfering with their chemopreventive potentials . The results of fluorescence 
spectroscopy are therefore highly comparable with those of Comet assay. 
Thus, we conclude that quercetin which acts as an antioxidant, is highly effective 
against NDEA induced damage and so is melatonin and Phre through modulation of 
uptake and activation system of carcinogens. Chronic unpredictable stress, in 
addition to enhancing NDEA induced damage, reverses or inhibits the 
chemopreventive effect of quercetin, melatonin and Phre. The present study has 
clearly demonstrated that prior exposure to CUS not only enhanced the cancer 
causing potential of NDEA through increased oxidative stress but also modulated 
the antioxidant potential of various antioxidants either alone or in the presence of 
antioxidants. Therefore, stress management must be considered as a serious factor 
during cancer chemopreventive trials and further studies should be aimed at 
reducing exposure to stressful conditions during cancer chemoprevention. 
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Comet Assay 
A statistically significant (p<0.05) increase in DNA damage was observed in 
lymphocytes, liver and lung cells of animals treated with NDEA, in terms of 
increased tail length, in comparison to controls as shown in table 15. Pre-stress 
NDEA group showed further significant (p<0.02) increase in tail length that was 
found to be highest as compared to all other groups. In animals treated with cisplatin 
(Csp) along with NDEA, the tail length was significantly (p<0.05) increased as 
compared to control group, but was found reduced significantly (p<0.05) as 
compared to NDEA alone treated animals thus showing protective effect of cisplatin 
against NDEA induced DNA damage. However exposure to chronic unpredictable 
stress (CUS) prior to NDEA-cisplatin treatment significantly (p<0.05) increased 
DNA damage as depicted by increased tail length as compared to NDEA-cisplatin 
treated group. Administration of quercetin (Qu) to NDEA-cisplatin treated animals 
reduced the tail length significantly (p<0.0 5) as compared to NDEA-cisplatin alone 
treated animals. However expose to CUS followed by NDEA-cispIatin-quercetin 
treatment, the tail length was again significantly increased (p<0.05) as compared to 
NDEA-cisplatin-quercetin treated group. Like quercetin the treatment with 
melatonin (Mlt) and popophyllum hexandrum rhizome extract (Phre) significantly 
(p<0.05) decreased the DNA damage in NDEA-cisplatin group but prior exposure to 
CUS inhibited the DNA damage preventive potential of melatonin and Phre in 
NDEA-cisplatin treated animals (Table 15). DNA damage by NDEA and protective 
effects of cisplatin, quercetin, melatonin and phre both in presence and absence of 
stress in lung cells are shown in fig 20. 
Fluorescent Spectroscopy 
The fluorescent spectra of control and experimental group of animals are shown in 
figs 21-24 and the emission characteristics are given in table 16. At 400 nm 
excitation, the plasma of control animals showed a prominent maxima at 430 nm 
which decreased at longer wavelengths as shown in Figs 21-24. In experimental 
groups, plasma of NDEA treated animals, in addition to a peak at 430 nm, showed a 
secondary peak at 630 nm and Fl 530nm/FI630nm was significantly (p<0.05) 
reduced (Table 16). The intensity of secondary peak was increased in pre-stress 
NDEA group and Fl 530nm/630nm decreased further as compared to control and 
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NDEA alone group. In animals treated with cisplatin along with NDEA, the 
intensity of secondary peak was decreased (Fig.21) and Fl 530nm/630nm increased 
as compared to control and NDEA alone groups (Table 16). However, in animals 
exposed to chronic unpredictable stress (CUS) followed by NDEA-cisplatin 
treatment, the intensity of secondary peak was increased and FI 530/FI630 was 
decreased as compared to NDEA cisplatin group (Table 16). Administration of 
quercetin to NDEA-cisplatin treated animals significantly (p<0.05) decreased the 
intensity of secondary peak and increased the FI 530nm/F1630nm as compared to 
NDEA-cisplatin group. However, in animals exposed to CUS followed by NDEA-
cisplatin-quercetin treatment, the intensity of secondary peak was increased and FI 
530nm/F1630nm was decreased significantly (p<0.05) as compared to NDEA-
cisplatin-quercetin treated group. 
Cisplatin-Melatonin and cisplatin-Phre treatment was found to have same effect on 
fluorescent spectra of plasma in NDEA-cisplatin group as NDEA-cisplatin-quercetin 
(Figs 23,24) and exposure to CUS prior to Melatonin and Phre treatment resulted in 
a significantly (p<0.05) different spectra from NDEA-cisplatin-melatonin and 
NDEA-cisplatin-Phre treated (Table 16). 
Oxidative status and the level of marker enzymes 
Quercetin, melatonin and Phre administration to NDEA-cisplatin treated animals 
decreased the activities of SOD,CAT,GST and GR to a significant (p<0.05) level in 
liver and lung tissues (Table 17,18) Circulatory levels of in vivo antioxidants 
showed pattern similar to that of hepatic and lung antioxidants (Table 20). Levels of 
various biochemical markers of liver function and in circulation were increased 
significantly (p<0.05) in NDEA-cisplatin treated animals as compared to controls 
(Table 19, 21). The increase in their levels was reduced significantly when animals 
were supplemented either with quercetin, melatonin or Phre. However on pre-
exposure to CUS their levels were increased again significantly (p<0.05) as 
compared to control and NDEA-cisplatin-quercetin or NDEA-cisplatin- melatonin 
or NDEA-cisplatin- Phre group and comparable to that of NDEA-cisplatin alone 
group as shown in tables 19,21. Similar effect was observed on TBARS levels in 
liver, lung and circulation of control and treated animals as shown in figs 25-27 
accompanied with decrease in hepatic, lung and plasma GSH content (figs 28-30). 
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Table 15: DNA damaging effect of NDEA alone and pre-stress NDEA and effect 
of cisplatin, quercetin, melatonin or Phre treatment on NDEA induced 
DNA damage measured in terms of tail length 
Groups 
Tail length (^m) 
Liver Lung Lymphocytes 
Control 
NDEA alone 
Pre stress-NDEA 
NDEA-Csp 
Prestress-NDEA Csp 
NDEA-Csp- Qu 
Prestress-NDEA-Csp- Qu 
NDEA-Csp-Mlt 
Prestress-NDEA-Csp- Mlt 
NDEA-Csp-Phre 
Prestress-NDEA-Csp-Phre 
1.31±0.06 
40.21* ±2.01 
53.70*" ±2.68 
20.32''±1.01 
30.34''±1.51 
9.44''±0.47 
18.32'±0.91 
11.4l''±0.57 
18.47'*±0.92 
12.21''±0.61 
19.7r±0.98 
1.72 ±0.08 
44.40*±2.22 
57.70*''±2.88 
22.33'±1.11 
32.43''±1.62 
II.41 "±0.57 
20.12=±1.00 
12.9l''±0.64 
21.98''±1.09 
13.23''±0.66 
20.73'±1.03 
2.31 ±0.11 
35.40*±1.77 
51.70'" ±2.58 
19.44'±0.97 
34.4''±1.72 
12.4I*'±0.62 
19.93'±0.99 
13.42''±0.67 
20.51''±1.02 
9.41''±0.47 
21.43'±i.07 
Data represents means ± S.E.M. of 6 animals in each group. 
* p<0.05, when compared to control. 
# p< 0.05, when compared to NDEA alone group. 
*p<0.05, when compared to NDEA alone group. 
''p<0.05, when compared to NDEA -cisplatin group 
"^p <0.05, when compared to NDEA-cisplatin-quercetin group. 
''p<0.05 when compared to NDEA-cisplatin-melatonin group. 
'^ p<0.05 when compared to NDEA-cisplatin-Phre group. 
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Fig 20. Single cell gel electrophoresis of lung cells in NDEA and Prestress NDEA 
mice after treatment with cisplatin, quercetin, melatonin and Phre showing 
comets (I OOx). 
(A) Control 
(C) Pre-stress NDEA 
(E) Prestress-NDEA cisplatin 
(G) Prestress-NDEA-cisplatin-quercetin 
(!) Pre-stress NDEA-cisplatin- Melatonin (J) NDEA -cisplatin-Phre 
(K) Pre-stress NDEA-cisplatin- Phre 
(B) NDEA alone 
(D) NDEA -Cisplatin 
(F) NDEA-cisplatin-Quercetin 
(H) NDEA-cisplatin-Melatonin 
117 
(A) (B) (C) 
(D) (E) (F) 
(G) (H) (I) 
(J) (K) 
pia.^O 
^{fsulisIII 
120 1 
-NDEA 
prestress-NOEA 
- NDEA-Csp 
- prestress-NDEA-C*p 
430 460 490 520 550 580 610 640 670 700 
wave length(nm) 
Fig 21. Emission spectra of plasma of NDEA and pre-stress NDEA alone or along 
with cisplatin treated animals on excitation at 400nm. 
Data represents mean ± S.E.M. of 6 animals in each group. 
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Fig 22. Emission spectra of plasma of NDEA and Pre stress NDEA alone or along 
with cisplatin and quercetin treated animals on excitation at 400nm. 
Data represents mean± S.E.M. of 6 animals in each group. 
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^ — prestress-NDEA 1 
NDEA-Csp I 
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NDEA-Csp-MIt ' 
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wave length(nm) 
Fig 23. Emission spectra of plasma of NDEA and Pre stress NDEA alone or along 
with cisplatin and melatonin treated animals on excitation at 400rmi. 
Data represents mean± S.E.M. of 6 animals in each group. 
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120 
•control 
-NDEA 
-prestress-NDEA 
NDEA-Csp 
- prestress-NDEA-Csp 
-NDEA-Csp-Phre 
- pnesfress-NDEA-Csp-Phre 
430 460 490 520 550 580 610 640 670 700 
wave length (nm) 
Fig 24. Emission spectra of plasma of NDEA and Pre stress NDEA alone or along 
with cisplatin and Phre treated animals on excitation at 400nm. 
Data represents mean± S.E.M. of 6 animals in each group 
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Table 16: Emission characteristics of Plasma of control and experimental groups of 
mice during fluorescent spectral analysis excited at 400nm. 
Groups 
control 
NDEA alone 
Prestress-NDEA 
NDEA-Csp 
Prestress NDEA -Csp 
NDEA-Csp-Qu 
Prestress-NDEA-Csp- Qu 
NDEA -Csp-Mlt 
Prestress-NDEA-Csp-Mlt 
NDEA-Csp-Phre 
Pre-stressNDEA-Csp-Phre 
(Fl 530/630) 
2.02±0.12 
0.72*±0.04 
0.54*''±0.03 
1 .SO'iO.OS 
0.82''±0.04 
1.80''±0.05 
0.64'±0.32 
1.78''±0.40 
0.68''±0.03 
1.72''±0.15 
0.60'±0.02 
Data represents means ± S.E.M. of 6 animals in each group. 
* p<0.05 when compared to control. 
# p< 0.05, when compared to NDEA alone group. 
*p<0.05 when compared to NDEA alone group. 
p<0.05 when compared to NDEA -cisplatin group 
•^p <0.05 when compared to NDEA-cisplatin-quercetin group. 
p<0.05 when compared to NDEA-cisplatin-melatonin group. 
^p<0.05 when compared to NDEA-cisplatin-Phre 
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Fig 25. Hepatic levels of MDA in animals treated with NDEA, pre-stress NDEA 
alone and along with either cisplatin alone ,cispIatin-Quercetin or cisplatin-
melatonin or cisplatin-Phre. 
Data represents means ± S.E.M. of 6 animals in each group. 
* p<0.05 when compared to control. 
# p< 0.05 when compared to NDEA alone group. 
*p<0.05 when compared to NDEA alone group. 
''p<0.05 when compared to NDEA -cisplatin group 
^p <0.05 when compared to NDEA-cisplatin-quercetin group. 
p<0.05 when compared to NDEA-cisplatin-melatonin group. 
*p<0.05 when compared to NDEA-cisplatin-Phre 
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Fig 26. Lung tissue levels of MDA in animals treated with NDEA, pre-stress 
NDEA alone and along with either cisplatin ,cisplatin-Quercetin or 
cisplatin-melatonin or cisplatin-phre 
Data represents means ± S.E.M. of 6 animals in each group. 
* p<0.05 when compared to control. 
# p< 0.05 when compared to NDEA alone group. 
*p<0.05 when compared to NDEA alone group. 
''p<0.05 when compared to NDEA -cisplatin group 
^ <0.05 when compared to NDEA-cisplatin-quercetin group. 
p<0.05 when compared to NDEA-cisplatin-melatonin group. 
^p<0.05 when compared to NDEA-cisplatin-Phre 
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Fig 27. Plasma levels of MDA in animals treated with NDEA, pre-stress NDEA 
alone and along with either cisplatin, cisplatin-Quercetin or cisplatin-
melatonin or cisplatin-Phre 
Data represents means ± S.E.M. of 6 animals in each group.. 
* p<0.05 when compared to control. 
# p< 0.05 when compared to NDEA alone group. 
*p<0.05when compared to NDEA alone group. 
''p<0.05 when compared to NDEA -cisplatin group 
% <0.05 when compared to NDEA-cisplatin-quercetin group. 
p<0.05 when compared to NDEA-cisplatin-melatonin group. 
'^ p<0.05 when compared to NDEA-cisplatin-Phre 
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Fig 28. Hepatic levels of GSH in animals treated with NDEA, pre-stress NDEA 
alone and along with either cisplatin alone,cisplatin-Quercetin or 
cisplatin-melatonin or cisplatin-Phre 
Data represents means ± S.E.M. of 6 animals in each group. 
* p<0.05 when compared to control. 
# p< 0.05 when compared to NDEA alone group. 
*p<0.05 when compared to NDEA alone group. 
''p<0.05 when compared to NDEA -cisplatin group 
^ <0.05 when compared to NDEA-cisplatin-quercetin group. 
p<0.05 when compared to NDEA-cisplatin-melatonin group. 
*p<0.05 when compared to NDEA-cisplatin-Phre 
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Fig 29. Lung levels of GSH in animals treated with NDEA, pre-stress NDEA 
alone and along with either cisplatin ,cisplatin-Quercetin or cisplatin-
melatonin or cisplatin-Phre. 
Data represents means ± S.E.M. of 6 animals in each group. 
* p<0.05 when compared to control. 
# p< 0.05 when compared to NDEA alone group. 
*p<0.05 when compared to NDEA alone group. 
V^O.OS when compared to NDEA -cisplatin group 
S <0.05 when compared to NDEA-cisplatin-quercetin group. 
p<0.05 when compared to NDEA-cisplatin-melatonin group. 
*p<0.05 when compared to NDEA-cisplatin-Phre. 
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Fig 30. Plasma levels of GSH in animals treated with NDEA, pre-stress NDEA 
alone and along with either cisplatin ,cisplatin-Quercetin or cisplatin-
melatonin or cisplatin-Phre. 
Data represents means ± S.E.M. of 6 animals in each group. 
* p<0.05 when compared to control. 
# p< 0.05 when compared to NDEA alone group. 
^p<0.05 when compared to NDEA alone group. 
''p<0.05 when compared to NDEA -cisplatin group 
y <0.05 when compared to NDEA-cisplatin-quercetin group. 
p<0.05 when compared to NDEA-cisplatin-melatonin group. 
^p<0.05 when compared to NDEA-cisplatin-Phre 
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Table 19: Level of liver function enzyme GOT, GPT and ALP after 
Cisplatin,cisplatin-Quercetin, cisplatin-melatonin and cisplatin-Phre 
treatment in NDEA and pre-stress treated animals. 
Groups 
control 
NDEA alone 
Prestress-NDEA 
NDEA-Csp 
Prestress-NDEA Csp 
NDEA-Csp-Qu 
Pre-stress NDEA Csp-Qu. 
NDEA-Csp-Mlt. 
Pre-stress-NDEA-Csp-Mlt. 
NDEA-Csp-Phre. 
Pre-stress NDEA-Csp-Phe. 
GOT 
lU/litre 
42.81±2.14 
87.43*±4.37 
U5.5r*±5.77 
65.41 "±3.27 
85.52''±4.27 
50.7l''±2.53 
62.ir±3.10 
53.13''±2.65 
63.32''±3.16 
53.50''±2.67 
63.9r±3.19 
GPT 
lU/litre 
27.50±1.22 
70.35*±3.51 
135.90**±6.54 
56.66'±2.83 
67.84''±3.39 
40.22''±2.01 
54.44'^ ±2.72 
42.45^±2.12 
55.54''±2.77 
43.34''±2.I6 
55.34*±2.76 
ALP 
mg/ml 
6.81±0.34 
21.22*±1.06 
48.60*''±2.43 
I5.44'-'±0.77 
19.34''±0.96 
10.2''±0.51 
16.22'±0.81 
11.31''±0.56 
17.33''±0.86 
11.91^±0.59 
I9.3r±0.96 
Data represents means ± S.E.M. of 6 animals in each group. 
* p<0.05 when compared to control. 
# p< 0.05 when compared to NDEA alone group. 
p<0.05 when compared to NDEA alone group. 
p<0.05 when compared to NDEA -cisplatin group 
p <0.05 when compared to NDEA-cisplatin-quercetin group. 
p<0.05 when compared to NDEA-cisplatin-melatonin group. 
°p<0.05 when compared to NDEA-cisplatin-phre group. 
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Table 21: Circulatory level of liver function enzyme SCOT, SGPT and ALP after 
treatment with cisplatin, cisplatin-quercetin, cisplatin-melatonin and 
cisplatin-phre in NDEA and pre-stress NDEA treated mice. 
Groups 
control 
NDEA alone 
Prestress-NDEA 
NDEA-Csp 
Prestress-NDEA-Csp 
NDEA-Csp-Qu 
Pre-stress-NDEA-Csp Qu 
NDEA-Csp-Mlt 
Pre-stress-NDEA-Csp Mlt. 
NDEA-Csp-Phre. 
Pre-stress NDEA-Phre. 
SCOT 
lU/Iitre 
17.5±0.78 
69.4*±2.97 
96.2**±4.81 
34.47'±1.72 
65.65''±3.28 
23.67''±1.22 
67.11'±1.32 
24.24^±1.10 
68.50''±3.2 
25.66''±1.21 
69.80'±3.13 
SGPT 
lU/litre 
28.5±1.32 
65.5*±3.3 
105.3**±4.1 
35.66'±1.78 
67.76^±3.38 
26.56''±l.21 
37.9'±2.91 
27.98''±1.62 
36.34.3''±3.41 
28.48''±1.64 
36.22'±3.13 
ALP 
mg/ml 
5.6±0.09 
16.2*±0.7 
34.2**±i.55 
10.55''±0.52 
15.22''±0.76 
7.65^±0.34 
9.9'-±0.62 
8.41.6''±0.38 
10.65''±0.65 
7.54''±0.43 
9.13'±0.67 
Data represents means ± S.E.M. of 6 animals in each group. 
* p<0.05 when compared to control. 
# p< 0.05 when compared to NDEA alone group. 
p<0.05 when compared to NDEA alone group. 
p<0.05 when compared to NDEA -cisplatin group 
p <0.05 when compared to NDEA-cisplatin-quercetin group. 
p<0.05 when compared to NDEA-cisplatin-melatonin group. 
''p<0.05 when compared to NDEA-cisplatin-phre group. 
b, 
d 
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Chemotherapy is one of the mainstays of medical intervention for cancer. Although 
chemotherapy improves the survival rates of cancer patients, but the related toxicity 
is a major concern in the treatment of patients with cancer, particularly in those 
patients who are cured or achieve prolonged survival. Besides acute toxicity 
occurring immediately following the administration of cytostatic agents, e.g. nausea, 
alopecia, oral mucositis ( Raber et al.,2000) and bone marrow depression, long-term 
side-effects can reduce the quality of life of these patients. However, concern has 
been expressed (Seifried et al.,2003;D'Andrea .,2005,) that the protective action of 
supplemental antioxidants on chemotherapy induced oxidative damage might not be 
restricted to normal tissues, antioxidants can exert their effects on all tissues to some 
degree, thereby protecting tumor cells as well as healthy ones. Free radical mediated 
oxidative stress is one of the ways through which most of the chemotherapeutic 
drugs (such as cisplatin,doxorubicin, bleomycin, vincristin, cyclophosphamide and 
hydroxyurea) exert their cyotoxic effects (Hartley., 1988). 
Antioxidants are compounds that can counteract free radicals and prevent them from 
causing tissue and organ damage (Ratnam et al.,2006). Administration of 
supplemental antioxidants - either dietarj' or pharmaceutical- concurrently with 
cytotoxic regimens has been reported to cause modest decreases in treatment-related 
side effects (Sieja .,2000; Pace et al.,2003; Suhail et al., 2010).Although antioxidants 
may play a role in the primary prevention of cancer in part by reducing the oxidative 
modification of DNA (Khan et al.,2008,), the same action might be expected to be 
counter productive against chemotherapeutic agents that act solely via the 
production of reactive oxygen species and induction of apoptosis (Ratnam et 
al.,2006). Considerable in vitro and animal data have shown the protective effect of 
vitamins and other antioxidants against radiation and chemotherapy 
(Sonneveld.,1978;Greggi et al.,2000). It seems likely that they would therefore 
reduce treatment-related toxicities and there are promising, although not 
unequivocal, data that this indeed is the case (Paceet al.,2003; WeijI et 
al.,2004).Antioxidants may prove to be an important nutrient for enhancing 
antineoplastic activity' because of its role in preventing the peroxidation of lipids 
(Zaidi and Banu.,2004). In animal studies, combinations of high doses of vitamin E 
and chemotherapy have had beneficial effects, detrimental effects, and no effect 
(Conklin.,2000). Vitamin C is a water-soluble nutrient having antioxidant properties. 
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The decreased levels of the physiological antioxidant defense mechanism during 
chemotherapy may lead to increased oxidative stress and free radical-mediated 
organ damage. 
Many compounds have been identified as good protectors against the free radicals 
by triggering antioxidants gene expression (Sharma et al.,1994). Melatonin, a 
hormone of the pineal gland has been known to be a chemopreventive agent in in 
vitro studies and experimental animal models (Cos et al., 2005). In pharmacological 
amounts, melatonin effectively reduces oxidative stress through several mechanisms 
(Martinez et al., 2005). Considering the low toxicity of melatonin and its ability to 
reduce the side effects and increase the efficacy of drugs, its use as a combination 
therapy with anticancer agents seems important and worthy of pursuit. 
Quercetin is a strong antioxidant and scavenger of free radicals (Husain et 
al.l987;Robak and Gryglewski 1988;). In addition, inhibition of Na+, K+ATPase 
acitivity (Robinson et al. 1984), and inhibition of lipid peroxidation (Terao et al., 
1994;Saija et al., 1995) have been described. Several mechanisms of protection 
seem possible, since cisplatin toxicity is associated with generation of free oxygen 
radicals, stimulation of lipid peroxidation, and loss of mitochondrial membrane 
potential (Leibbrandt et al., 1995; Kuhlmann et al., 1997). 
Natural polyphenolics are reported to contain several biologically active 
flavonoides, polyphenols and podophyllotoxin glycoside, and the like that might 
contribute toward enhancing DNA repair(Gao et al.,2006).The therapeutic efficacy 
of podophyllum hexandrum is predominantly attributed to their properties of free 
radical scavenging, reduced lipid peroxidation (Gupta et al.,2007), transient metal-
chelation (Kumar and goel) and protection to endogenous defense enzymes (Gupta 
et al.,2007) and to cellular DNA. 
In the present study, we investigated the effects of supplementation with 
quercetin,melatonin and podophyllum hexandrum rhizome extract (Phre) on the 
therapeutic efficacy of commonly used anticancer drug (cisplatin) in NDEA treated 
mice both in presence and absence of chronic unpredticable stress. 
The results of the present study indicate that the antioxidant compounds like 
quercetin, melatonin and phre used were effective in improving the antioxidant 
status and DNA damage of NDEA-cisplatin administered mice. This observation 
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was supported by the results of fluorescent studies, which were comparable to those 
of comet assay and biochemical markers. 
Results of the present study show a significant decrease in the activities of SOD, 
CAT, GR and GST in NDEA-cisplatin treated mice. This decrease in activities of 
these enzymes was restored by quercetin, melatonin and Phre bringing the values 
close to that of controls. The mode of action of these antioxidant compounds is 
probably to prevent free radical damage on enzymes by scavenging free radicals 
produced. Moreover, the free radical scavenger effect of these antioxidant 
compounds may be contributed to antioxidant capacity by increasing expression of 
antioxidant enzymes. Further, the decrease in the levels of circulatory antioxidants 
glucose and uric acid was also replenished by quercetin, melatonin and phre 
treatment probably by acting directly as free radical scavenger as many in vitro and 
in-vivo studies have revealed that these antioxidants acts as a direct scavenger of 
free radicals and inhibitor of lipid peroxidation (Saija et al., 1995; Robak and 
Gryglewski 1988; Anisimov et al., 2006, Gupta et al.,2007; showkat et al.,(a),20IO; 
showkat et al., (b),2010).The amount of MDA, which is a product of lipid 
peroxidation is a measure of oxidative stress status of a cell or tissue. Quercetin, 
melatonin and podophyllum hexandrum extract significantly inhibited lipid 
peroxidation by lowering MDA levels, as these antioxidants has been proved to be a 
very efficient, neutralizer of the peroxyl radicals generated during lipid peroxidation 
(Lesnikov and Pierpoali, 1994; Saija et al., 1995; showkat et al.,(a),2010). The 
depleted GSH content of liver, lung and plasma in NDEA-cisplatin treated animals 
was significantly enhanced by quercetin,melatonin and phre treatment probably due 
to the fact that all these compounds may stimulate the rate-limiting enzyme in the 
synthesis, y-glutamylcysteine synthase (Anisimov et al., 2006). Increased levels of 
biochemical markers of liver function, ALP, GOT and GPT were also normalized 
following this antioxidant treatment. However, the chemopreventive effect of these 
antioxidants was significantly reduced in NDEA cisplatin treated animals pre-
exposed to chronic unpredictable stress. Activities of antioxidant enzymes in liver, 
lung and plasma were decreased with increased levels of MDA. Hepatic GSH 
content was decreased while marker enzymes were increased significantly as 
compared to control and values were comparable to those of NDEA-cisplatin alone 
treated animals. This may due to the reason that chronic unpredictable stress besides 
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causing oxidative stress in animals enhances the NDEA-cisplatin induced pro-
oxidant effect as well as DNA damage. Though quercetin, melatonin and Phre has 
been found to increase the therapeutic efficacy of cisplatin in TMDEA treated animals 
however chronic unpredictable stress reduced their antioxidant potential probably by 
the combined increased oxidative stress of the carcinogen and chronic unpredictable 
stress. 
The DNA damage in lymphocytes, liver and lung cells of Cisplatin-NDEA treated 
mice as measured by alkaline comet assay was increased significantly as compared 
to control. However, quercetin, melatonin and Phre supplementation for the entire 
experimental period resulted in significant decrease in Cisplatin-NDEA-induced 
DNA damage in all the three types of cells studied. Quercetin, melatonin and Phre 
has been shown to reduce the DNA damage, besides their ability to neutralize free 
radicals directly, thereby reducing oxidative damage (Harman, 1994; Reiter, 1995; 
Reiter et al.,2007; Akira et al.,2008; showkat et al.,(a),2010).These properties allow 
quercetin ,melatonin and Phre to preserve macromolecules including DNA, protein 
and lipid from oxidative damage resulting from cisplatin -carcinogen 
exposure.Within a conceptualized framework of stress and disease,bio-behavioral 
factors are understood to influence multiple aspects of tumor growth including 
apoptosis, angiogenesis, invasion,and immunological escape to the metastatic 
cascade (Antoni et al.,2006).Transferring laboratory mice from group housing to 
social isolation is reported to accelerates growth of induced tumors and attenuate the 
effects of chemotherapy (Grimm et al.,1996; Kerr ,1997).Some studies indicate that 
both physical and psychological stress may be the factors involved which modulate 
cytochrome P450s and other drug metabolizing enzymes (Konstandi et al., 1998). 
Stressed organisms are less capable of defending themselves against cancer cells, 
infectious agents and other disease processes (Riley, 1981). Restraint stress was 
found to enhance the benzo [a] pyrene induced CYPs and related activities. In 
addition, restraint stress was able to alter the inducibility of monooxygenase 
activities by strong inducers such as B [a] P (Konstandi et al., 2000).Though little is 
known about the biochemical mechanisms by Vv'hich stress affects xenobiotic 
metabolism,but CDS might have a diminished the protective effect of quercetin, 
melatonin and Phre in pre-stress- NDEA -cisplatin antioxidant treated groups 
through modulation of cytochrome p450 and drug metabolizing enzymes as 
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psychological stress is reported to do so (Konstandi et a!., 1998). As a result 
increased DNA damage and oxidative stress is observed in this group as compared 
to control or Cisplatin-NDEA- antioxidant treated groups. 
It is well known that biochemical events during pathological conditions of the tissue 
differ from their normal counterparts. Since tissues contain native 
chromophores/fluorophors, alteration in the pathological status can be detected 
sensitively using fluorescent spectroscopy (Zonios, 1998). As it is well known that 
tumor angiogenesis takes pJace during the proliferation (Fox et a/., 1996) it is 
thought that transport of these fluorophors may be possible and can be detected in 
blood erythrocytes. The natural intrinsic fluorophors mainly NAD(P)H, porphyrins 
and flavins display their characteristic spectra at 470, 520 and 630 nm respectively 
which characterize the local environment (Alfano et al., 1987). The ratio of 
fluorescent intensity at 530 nm and al 630 nm (FI530nm/630nm) is definite for a 
given tissue and an alteration in the ratio of these fluorophores depicts a change in 
the local and native environment. The plasma of Cisplatin-NDEA treated animals in 
addition to a peak at 430nm like control samples, showed a prominent peak at 
630nm which may be due to the change in the local environment or due to the 
production of new fluorophores induced by the carcinogen. Pre-stress significantly 
increased the Fl at 630 nm and PI 520 nm and decreased the ratio of 
FI530nm/FI630nm in plasma when compared to cisplatin NDEA treated group. The 
mechanism is not clear, however, the increased oxidative stress in pre-stress NDEA-
Cisplatin group may result in the increased production of fluorophores. The 
treatment of quercetin,melatonin or Phre reduced the peaks at 630nm and 540nm 
and changed FI530nm/FI630nm significantly as compared to NDEA-Cisplatin alone 
group bringing values more or less close to that of control group. This may be either 
due to interaction directly with the metabolic activation process, perhaps by 
inhibiting the cytochrome P450 dependent monooxygenase enzyme system or 
indirectly through stimulation of glutathione and glutathione peroxidase enzyme, in 
case of melatonin (Anisimov et al., 2006), thereby reducing oxidative damage of the 
carcinogen-cisplatin. However, quercetin, melatonin and Phre are found less 
effective on NDEA-cisplatin induced damage when animals are pre-exposed to 
stress. The possible explanation could be that these antioxidants may be involved 
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indirectly, as stress is known to induce oxidative stress and enhances carcinogen 
induced pro-oxidant status too (Muqbil & Banu, 2006). 
The results of fluorescence spectroscopy are therefore highly comparable with those 
of Comet assay. Thus, we conclude that quercetin, melatonin and Phre which act as 
antioxidants are highly effective against NDEA-cisplatin induced damage due to 
their antioxidant potential. Chronic unpredictable stress, in addition to enhancing 
NDEA-cisplatin induced damage, reverses or inhibits the chemopreventive effect of 
these antioxidants, may be due to enhanced levels of free radicals in stress (Muqbil 
and Banu,2006) 
Thus supplementation of quercetin, melatonin and Phre to the NDEA treated mice 
during cisplatin chemotherapy significantly enhanced the in vivo status of major 
antioxidant enzymes (SOD, CAT, GST and GR), reduced glutathione, while 
decreasing the levels of lipid peroxidation and DNA damage. Thus, it can be 
concluded that antioxidant compounds may be given as prophylactic/therapeutic 
supplements for reducing the treatment related side effects and enhancing the 
therapeutic efficacy of antineoplastic agents. This approach may be helpful in 
enhancing the quality of life of the cancer patients by limiting the oxidative stress 
associated with chemotherapy and by preserving the endogenous antioxidant 
defense systems. As the name of the disease cancer itself is sufficient enough to 
cause psychological trauma and can generate stress in patients. Thus stress 
management must be considered as a serious factor during cancer chemopreventive 
trials and further studies should be aimed at reducing exposure to stressful 
conditions during chemotherapy. 
139 

Summaiy 
The mechanism by which certain carcinogens and radiation cause carcinogenesis is 
believed to be mediated by free radicals. It is increasingly proposed that reactive 
oxygen species (ROS) play a key role in human cancer development, especially as 
evidence is growing that antioxidants may prevent or delay the onset of some types 
of cancer. ROS have been shown to possess many characteristics of carcinogens. 
Mutagenesis by ROS could contribute to the initiation of cancer, in addition to being 
important in the promotion and progression phases. A substantial body of evidence 
has been produced that links the production of reactive oxygen radicals, and 
subsequently oxidative stress and damage, to pathogenesis of chronic diseases 
including cancer. Oxidative stress has been defined as an imbalance between 
oxidants and antioxidants in favour of the former, resulting in an overall increase in 
cellular levels of reactive oxygen species. Free radicals have been shown to be 
capable of damaging many cellular components such as DNA; proteins and lipids. 
Proteins can be damaged by oxygen radicals leading to a loss of both free radical 
scavenging enzyme activity and structural integrity, leading to compromised host 
antioxidant defense mechanisms and cell membrane structure, respectively. This 
eventually may culminate in neoplastic transformation. 
Environmental factors are recognized to play a major role in the etiology of various 
cancers that account for over 80% of human malignancies. Nitrosamines are formed 
by chemical reactions between nitrites and secondary amines or proteins. 
Nitrosamines exert their toxic and mutagenic effects by increased DNA damage and 
generation of reactive oxygen species. N-nitrosodiethylamine (NDEA) is a dialkyl 
nitrosoamine, belongs to the group of N-nitrosamines causing a wide range of 
tumors in all animal species and used as a carcinogenic agent to induce cancer in 
animal models. Exposure of man to N-nitrosamines occurs through consumption of 
products such as salt preserved food, tobacco, cosmetics, pharmaceutical and 
agricultural chemicals. In the present study it was found that NDEA treatment 
induced oxidative stress by significantly decreasing the activities of SOD, CAT, GR 
and GST in liver,lung and circulation along with a decrease in the level of glucose 
and uric acid in circulation. Hepatic,lung and plasma GSH content was found 
depleted with increased levels of MDA (lipid peroxidation). Levels of marker 
enzymes ALP, GOT and GPT in liver as well as ALP, SGOT and SGPT levels in 
circulation were also increased significantly. Further the role of stress on NDEA 
140 
Sumrnary 
induced oxidative stress was assessed. Increasing evidence suggests that 
psychological stress contributes to increased susceptibility to a number of diseases, 
including cancer. Psychological stress, via release of chemical mediators, can induce 
long-term changes in the organism resulting in an altered responsiveness of the 
organism to external carcinogens. Exposure to stress situations can stimulate 
abnormal production of reactive oxygen species that are involved in oxidative stress, 
which is capable of causing damage to various cellular constituents, such as DNA, 
proteins and lipids, leading to carcinogenesis .Although the evidence that stressful 
life events are related to the development of cancer is controversial, a number of 
human studies have correlated stressful life events with increased cancer risk and 
decreased survival probability. However, much attention has been paid to the 
possible influence of stress on prognosis in patients who already have cancer while 
very limited information is available on any possible direct role of stress on the 
development of neoplasia. The present investigation sought to evaluate the impact of 
chronic unpredictable stress on N-nitrosodiethylamine (NDEA) induced 
carcinogenesis. 
in order to model chronic stressful experiences, chronic unpredictable stress (CUS) 
paradigm (with varied type and timing of stressors) has been widely used to study 
the impact of stress on disease process in experimental animals. Exposure to CUS 
resulted in a significant decrease in the activities of superoxide dismutase (SOD), 
catalase (CAT), glutathione reductase (GR), gluatathione-S-transferase (GST) and 
glutathione (GSH) in liver and lung tissues as well as glucose, uric acid, SOD, CAT, 
GR and GST in circulation in comparison to untreated controls. This was 
accompanied with significantly increased levels of malondialdehyde (MDA) and 
marker enzymes ALP, GOT and GPT in liver, lung and circulation. Similar results 
were obtained by administration of NDEA. Moreover, when NDEA treated animals 
were pre-exposed to CUS there was marked increase in oxidative stress. This was 
reflected by a further decrease in the activities of antioxidant enzymes and other 
antioxidants as compared to NDEA alone or CUS alone treated animals. Levels of 
markei enzj'mes in liver and circulation were increased significantly with increased 
levels of MDA indicating an enhanced lipid peroxidation. 
NDEA has been shown to be metabolized by cytochrome P-450 llEl (CYP 2E]) to 
its active ethyl radical metabolite, which could interact with DNA causing mutation 
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and carcinogenesis The toxic metabolites and ROS formed during its metabolism, in 
addition to causing oxidative stress, also result in oxidative DMA damage. In the 
present study, NDEA was found to induce DNA damage in lymphocytes, liver and 
lung cells of animals, in terms of increased DNA tail length, measured by alkaline 
comet assay. CUS enhanced the NDEA induced DNA damage in lymphocytes, liver 
and lung cells. CUS in addition to causing oxidative stress by itself enhanced the 
pro-oxidant effect of NDEA. Formation of oxidative stress-related molecules, 
increased h'pid peroxidation with decreased activities of free radical scavenging 
enzymes may serve as the mediator to modulate tissue and cellular events 
responsible forT J^DEA induced carcinogenesis. 
Since free radicals are involved in initiation and promotion stages of carcinogenesis, 
one may expect that free radical scavengers should function as inhibitors in the 
neoplastic processes. Antioxidants have been shown to ii^ hibit both initiation and 
promotion in carcinogenesis and counteract cell immortalization and transformation. 
A number of natural and synthetic antioxidants are known to retard chemical 
carcinogenesis in experimental animal models through chemoprevention. 
Chemoprevention is the use of one or several agents to prevent the occurrence of 
cancer. In this study two compounds -quercetin and melatonin and a medicinal plant 
extract of Podophyllum hexandrum rhizome were used to evaluate the effectiveness 
on NDEA induced carcinogenesis and the modulatory effect of chronic 
unpredticable stress on it. Quercetin,meIatonin and podophyllum hexandrum 
rhizome extract (Phre) exerted their antioxidant role against NDEA induced 
carcinogenesis. This was assessed in terms of DNA damage, fluorescent studies and 
biochemical parameters. DNA damage, measured as increased DNA tail length, 
induced by NDEA was prevented largely when animals were supplemented 
with quercetin, melatonin or Phre. The biochemical events during pathological 
conditions are known to differ from their normal counter parts, which can be 
detected sensitively using fluorescent spectroscopy. NDEA induced carcinogenesis 
was detected from altered ratio of fluorescent intensity (Fl 530nm/630nm) which is 
otherwise definite for a given normal tissue. This ratio was however, comparable to 
control values after treatment with quercetin, melatonin or Phre. The results of 
biochemical parameters showing decreased oxidative stress were also in line with 
those of comet assay and fluorescent studies, thus confirming the chemopreventive 
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properties of quercetin, melatonin and Phre against NDEA induced carcinogenesis. 
However, when animals were pre- exposed to chronic unpredictable stress the 
chemoprevention by these compounds was abolished and results were comparable to 
that of NDEA alone treatment. 
Chemotherapy is one of the mainstays of medical intervention for cancer. Although 
chemotherapy improves the survival rates of cancer patients, but the related toxicity 
is a major concern in the treatment of patients with tumours, particularly in those 
patients who are cured or achieve prolonged survival. Cispiatin is currently one of 
the most important cytostatic agents in the treatment of a wide range of tumours. 
Free radical mediated oxidative stress is one of the ways through which most of the 
chemotherapeutic drugs exert their cyotoxic effects. Antioxidants are compounds 
that can counteract free radicals and prevent them from causing tissue and organ 
damage. Administration of supplemental antioxidants - either dietary or 
pharmaceutical- concurrently with cytotoxic regimens has been reported to cause 
modest decreases in treatment-related side effects. In the present study, we 
investigated the effects of supplementation with quercetin, melatonin and Phre on 
the therapeutic efficacy of commonly used anticancer drug (cispiatin) in NDEA 
treated mice both in presence and absence of chronic unpredictable stress. 
Quercetin,melatonin and Phre improved the chemotherapeutic efficacy of cispiatin 
against NDEA induced carcinogenesis. This was assessed in terms of DNA damage, 
fluorescent studies and biochemical parameters. DNA damage, measured as 
increased DNA tail length, in NDEA-cisplatin treated mice was prevented 
largely when animals were supplemented with quercetin, melatonin or Phre. The 
altered ratio of fluorescent intensity (Fl 530nm/FI630nm) in NDEA -cispiatin 
treated animals which is otherwise definite for a given normal tissue was however 
comparable to control values after treatment with quercetin, melatonin or Phre. The 
results of biochemical parameters showing decreased oxidative stress were also in 
line with those of comet assay and fluorescent studies, thus confirming the 
chemoprotective properties of quercetin, melatonin and Phre against chemotherapy 
induced toxicities in NDEA administered animals. However, when animals were 
pre- exposed to chronic unpredictable stress the chemoprevention by these 
compounds was abolished and results were comparable to that of NDEA-cisplatin 
alone treatment. 
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Thus exposure to environmental chemicals like NDEA causes accumulation of large 
amount of free radicals by inducing oxidative stress and DNA damage. Chronic 
stress further exacerbates this condition thus putting an individual at an increased 
risk of developing cancer. 
For chemopreventive studies, quercetin, melatonin and a medicinal plant extract of 
Podophyllum hexandrum rhizome were found effective against NDEA induced 
carcinogenesis. However pre-exposure to chronic unpredictable stress was found to 
decrease their chemopreventive efficacy, thus playing an important role during 
cancer development as well as cancer chemoprevention. 
In chemotherapeutic studies the efficacy of cisplatin was significantly enhanced and 
the related toxicity was reduced by supplementation with quercetin, melatonin and 
Phre during NDEA carcinogenesis. Thus, it can be concluded that antioxidant 
compounds may be given as prophylactic/therapeutic supplements for reducing the 
treatment related side effects and enhancing the therapeutic efficacy of 
antineoplastic agents. This approach may be helpful in enhancing the quality of life 
of the cancer patients by limiting the oxidative stress associated with chemotherapy 
and by preserving the endogenous antioxidant defense systems. 
The present study has clearly demonstrate that prior exposure to CUS not only 
enhanced the cancer causing potential of NDEA through increased oxidative stress 
but also modulated the antioxidant potential of various antioxidants and 
chemotherapeutic efficacy of cisplatin either alone or in the presence of 
antioxidants. 
The experimental model currently employed might provide an insight at the most 
basic level of cell mutation, for investigating the effect of both physical and 
psychological stress on the etiology of NDEA induced carcinogenesis. This study 
may aid in the understanding of cancer initiation and can serve as a useful tool for 
further studies aimed at the development of interventions for disease prevention by 
identifying the relation between psychological factors and carcinogenesis. 
Modulation of stress induced oxidative stress should therefore be taken into 
consideration during cancer chemoprevention and chemotherapy as consideration of 
the influence of bio-behavioural factois provides a novel perspective for mechanistic 
studies and new therapeutic targets. Such interventions may include behavioural 
interventions alone or in combination with pharmacological approaches. 
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Concfusions 
> Chronic unpredictable stress increases oxidative stress by altering the oxidant 
antioxidant balance. 
> Exposure to multiple doses of a carcinogenic agent like NDEA causes 
accumulation of large amount of free radicals thereby altering the over all in vivo 
antioxidant status and causing DNA damage. 
> Chronic unpredictable stress exacerbates the carcinogenic potential of NDEA 
through increased oxidative stress and DNA damage thus, putting an individual 
at an increased risk of developing cancer. 
> Exposure to chronic unpredictable stress (CUS) prior to the carcinogen treatment 
may work as a promoter of carcinogenesis. 
> Quercetin (Qu), melatonin (Mlt) and podophyllum hexandrum rhizome extract 
(Phre) proved to be effective chemopreventive agents against NDEA induced 
carcinogenesis. 
> Cisplatin also exhibited a protective effect against NDEA induced 
carcinogenesis and its chemotherapeutic efficacy was markedly improved by co-
administration of Qu,Mlt and Phre 
> Prior exposure to CUS not only enhanced the cancer causing potential of NDEA 
through increased oxidative stress but also modulated the antioxidant potential of 
antioxidants and chemotherapeutic efficacy of cisplatin either alone or in the 
presence of stress, thus playing an important role during cancer development as 
well as cancer chemoprevention. 
> Stress management must be considered as a serious factor during cancer 
chemopreventive trials and further studies should be aimed at reducing exposure 
to stressful conditions during chemoprevention /chemotherapy. 
145 

<Bi66o^apfiy 
Adachi, S., Kawamura, K., and Takemoto, K. (1993) Oxidative damage of nuclear 
DNA in liver of rats exposed to psychological stress. Cancer Res. 53, 4153-4155. 
Adam, W., Guenther, G.N., Saha-Moeller, C.R. (1998). DNA Cleavage Induced by 
Alkoxyl Radicals Generated in the Photolysis of N-Alkoxypyridinethiones. Free 
Rad. Biol. Med. 24, 234-238. 
Adamson, R.H., Thorgeirsson, U.P., Sugimura, T. (1996). Extrapolation of 
heterocyclic amine carcinogenesis data from rodents and nonhuman primates to 
humans. Arch.Toxicol. 18, 303-318. 
Ahsan, H., Ali, A., Ali, R. (2003). Oxygen free radicals and systemic autoimmunity. 
Clin Exp Immunol. 31, 398-404. 
Aikens, J., Dix, T. A. (1991). Perhydroxyl radical (HOO*) Initiated lipid-
peroxidation—The role of fatty-acid hydroperoxides. J. Biol. Chem. 266, 15091-
15098. 
Akira, M., Hitoshi, A., Junji, T. (2008). Multitargeted cancer prevention by 
quercetin. Cancer Letters 269, 315-25. 
Alfano, R.R., Tang, G.C., Pradhan, A., Lam, W., Choy, D.S.J., Opher, E. (1987). 
Fluorescence spectra from cancerous and normal human breast and lung tissues. 
IEEE QE 23, 1086-118. 
AUegra, M., Reiter, R.J, Tan, D.X., (2003). The chemistry of melatonins interaction 
with reactive species. J Pineal Res, 34:1-10. 
Alliangana, D.M. (1996). Effects of beta-carotene, flavonoid, quercetin and 
quinacrine on cell proliferation and lipid peroxidation breakdown products in BHK-
21 cells. East Afr. Med. J. 73, 752-57. 
Al-Qirim, T.M., Shahwan, M., Zaidi, K.R., Banu, N.(2002).Effect of khat, it 
constituents and 
Ames, B. N. (1989) Free Radical Res. Commun. 7, 121-128. 
Ames, B.N. (1983). Dietary carcinogens and anticarcinogens. Oxygen radicals and 
degenerative diseases. Science. 221, 1256-6664. 
Ames, B.N., Gold, L.S. (1990). Too many rodent carcinogens: mitogenesis increases 
mutagenesis. Science. 249, 970-71. 
Ames, B.N., Shigenaga, M.K, Gold, L.S. (1993). DNA lesions, inducible DNA 
repair, and cell division: three key factors in mutagenesis and carcinogenesis. 
Environ. Health Perspect. 101, 35-44. 
Ames, B.N., Shigenaga, M.K., Hagen, T.M. (1993). Oxidants, antioxidants and 
degenerative diseases of aging. Proc. Natl. Acad. Sci. U.S.A. 90, 7915-7922. 
Amkraut, A., Solomon, G.F. (1972). Stress and murine sarcoma virus (Moloney)-
induced tumors. Cancer Res. 32, 1428-1433. 
Amstad, P.A., Liu, H., Ichimiya, M., Berezesly, I.K., Trump, B.F. (1997), 
Carcinogenesis. 18, 479-484. 
146 
(BiBGoffrapfiy 
Andersen. B.L., Farrar. W.B., Golden-Kreutz. D., Kutz, L.A., MacCallum, R., 
Courtney, M.E. (1998). Stress and immune responses after surgical treatment for 
regional breast cancer. J Natl Cancer Inst 90, 30-6. 
Anis K.V., Rajesh Kumar N.V., Kuttan, R. (2001). Inhibition of chemical 
carcinogenesis by biberine in rats and mice. J. Pharm. Pharmacol. 53, 763-768. 
Anisimov, V.N. (2001). Melatonin and colon carcinogenesis, in: C. Bartsch, H. 
Bartsch, D.E. Blask, D.P.Cardinali,W.J.M. Hrushesky, D.Mecke (Eds.),The Pineal 
Gland and Cancer. Neuroimmunoendocrine Mechanisms in Malignancy, Springer, 
Berlin, pp. 240-258. 
Anisimov, V.N., Popovich, I.G., Zabezhinski, M.A. (1997). Melatonin and colon 
carcinogenesis: In. Inhibitory effects of melatonin on development of intestinal 
tumors induced by 1, 2-dimethylhydrazine in rats. Carcinogenesis 18, 1549-1553. 
Anisimov, V.N., Popovich, I.G., Zabezhinski, M.A., Anisimov, S.V., Vesnushkin, 
G.M., Vinogradova, I.A., (2006). Melatonin as antioxidant, geroprotector and 
anticarcinogen. Biochim Biophys Acta. 1757, 573-89. 
Antolin, I., Rodriguez, C, Sainz, R.M., Mayo, J.C, Uria, H., Kotler, M.L., 
Rodriguez-Colunga, M.J., Tolivia, D., Menendez-Pelaez, A. (1996). Neurohormone 
melatonin prevents cell damage: effect on gene expression for antioxidant enzymes, 
FASEB J. 10, 882-890. 
Antoni, M.H., Lutgendorf, S.K., Cole, S.W., Dhabhar, F.S., Sephton, S.E., 
McDonald, P.G. (2006). The influence of bio-behavioural factors on tumour 
biology: Pathways and mechanisms. Nat Rev Cancer. 6, 240-248. 
Aoshima, H., Satoh, T., Sakai, J., Yamada, M., Enokido, Y. (1997). Generation of 
free radicals during lipid hydroperoxide triggered apoptosis in PC12h cells. 
Biochem. Biophys. Acta. 1345, 35-42. 
Arendt, J. (1995). Melatonin and the mammalian pineal gland. Chapman & Hall, 
London. 
Arif, J.M., Smith, W.A., Gupta, R.C. (1999). DNA adduct formation and persistence 
in rat tissues following exposure to the mammary carcinogen dibenzo[a,l]pyrene. 20, 
1147-1150. 
Armitage, J.D. (1992). Tumor proliferative rate and response to chemotherapv. Ann. 
Intern. Med. 116, 771-772. 
Aruoma, O.I., Halliwell, B., Dizdaroglu, M. (1989). Iron ion-dependent 
modification of bases in DNA by the superoxide radical-generating system 
hypoxanthine/xanthine oxidase. J. Biol. Chem. 264, 13024-13028. 
Auersperg, N, Edelson, M.I., Mok, S.C, Johnson, S.W., Hamilton, T.C. (1998). The 
biology of ovarian cancer. Semin Oncol. 25,281-304. 
Aust, S.D.. Syingen, B.A. (1982). In: Free Radicals in Biology (Pyror, W.A., ed,). 
Academic Press, New York,, pp. 1 -28. 
147 
(BiBBograpfiy 
Aydin, S.,Yargicoglu, P., Derin, N., Aliciguzel, Y., Abidin, I., Agar, A. (2005). The 
effect of chronic restraint stress and sulfite on visual evoked potentials (VEPs): 
relation to lipid peroxidation. Food Chem. Toxicol. 43, 1093-1101. 
Bagchi, D., Carryl, O.R., Tran, M.X., Bagchi M., Garg, A., Milnes, M.M., Williams, 
C.B., Balmoori, J., Bagchi, D.J., Mitra, S.J. (1999). Acute and chronic stress-
induced oxidative gastrointestinal mucosal injury in rats and protection by bismuth 
subsalicylate. Mol. Cell. Biochem. 196,109-116. 
Bandyopadhyay, D., Biswas, K., Bandyopadhyay, U., Reiter, R.J., Banerjee, R.K. 
(2000). Melatonin protects against stress-induced gastric lesions by scavenging the 
hydroxy] radical. J. Pineal. Res. 29, 143-151. 
Banister, J.V., Bannister, W.H., Rotilo, G. (1987). Aspects of the structure, function, 
and applications of superoxide dismutase. CRC Crit. Rev. Biochem. 22, 111-180. 
Bansal, A.K, Trivedi, R., Soni, G.L., Bhatnagar, D. (2000). Hepatic and renal 
oxidative stress in acute toxicity of N-nitrosodiethylamine in rats. Indian J. Exp. 
Biol. 38, 916-920. 
Banu, N., Vaidya, M.P., Udupa, K.N. (1988) Alterations in circulating 
neurotransmitters and their enzymes with severity of breast cancer. Ind. J. Med. Res. 
87:791-797. 
Barber, D.A., Harris, S.R. (1994). Oxygen free radicals and antioxidants: a review. 
Am Pharm. 34,26-35. 
Barlow-Walden, L.R., Reiter, R.J., Abe, M. Pablos, M., Menendez-Pelaez, A., Chen, 
L.D., Poeggeler, B. (1995). Melatonin stimulates brain glutathione peroxidase 
activity, Eurochem. Int. 26,497-502. 
Barrett, J.C, Anderson, M. (1993). Molecular mechanisms of carcinogenesis in 
humans and rodents. MolCarcinog. 7, 1-13. 
Bartsch, C, Bartsch, H. (2006). Pineal gland and cancer-an epigenetic approach to 
the control of malignancy: evaluation of the role of melatonin, in: S.R. Pandi-
Perumal, D.P. Cardinali (Eds.), Melatonin: biological basis of its function in health 
and disease, Eurekah.com, Austin, TX, pp. 71-87. 
Bartsch, C, Bartsch, H., Blask, D.E., Cardinali, D.P., Hrushesky, W.J.M., Mecke D. 
(2001). The Pineal Gland and Cancer. Neuroimmunoendocrine Mechanisms in 
Malignancy, Springer, Berlin. 
Bartsch, H., Spiegelhalder, B. (1996). Environmental exposure to N-nitroso 
compounds (NNOC) and precursors: an overview. Eur J Cancer Prev 5, 11-17. 
Bassukas, I.D., Maurer-Schultz, B. (1993). Lethal toxicity of cyclophosphamide 
depends on the tumor stage. Studies on the syngenic adenocarcinoma E0771 in 
C56bl/6j mice. Anticancer Res. 13, 827-834. 
Batcioglu, K., Karagozler, A.A., Gene, M., Celik,S., (2002). Compari son of the 
chemopreventive potentials of melatonin and vitamin E plus selenium on 7,12-
dimethylbenz(a)anthraceneinduced inhibition of mouse liver antioxidant enzymes. 
Eur.Cancer. Prev. 11:57-61. 
148 
(BiSRt^rapky 
Beckman, J.S., Beckman, T.W., Chen, J., Marshall, P.A., Freeman, B.E. (1990). 
Apparent hydroxyl radical production by peroxynitrite: implications for endothelial 
injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87, 1620-24. 
Beecher, G.R., Warden, B.A., Merken, H. (1999). Analysis of tea polyphenols.Proc 
Soc. Exp. Biol. Med. 220,267-70. 
Benchfield, S.R., Woods, S.C, Elich, M.S. (1978). Effects of cold stress on tumor 
growth. Physiol. Behav., 21,537-540. 
Berenblum, I. (1974). Carcinogenesis as a biological problem, vol. 34. North 
Holland, Amsterdam, pp. 376. 
Beuge, J.A., Aust, S.D. (1978). Microsomal lipid peroxidation. Methods Enzymol. 
52,302-310. 
Bhattacharya, A.K., Pradhan, S.N. (1979). Effects of stress on DMBA-induced 
tumor growth, plasma corticosterone, and brain biogenic amines in rats. Res. 
Commun. Chem. pathol. Pharmacol. 23,107-116. 
Bickers, D.R., Athar, M. (2006). Oxidative stress in the pathogenesis of skin disease. 
J. Invest. Dermatol. 126, 111. 
Blask, D.E. (1993). Melatonin in oncology, in: H.S. Yu., R.J. Reiter (Eds.), 
Melatonin biosynthesis, physiological effects, and clinical applications, CRC Press, 
Boca Raton, pp. 447-475. 
Blumberg, P.P. (1980). In vitro studies on the mode of action of the phorbol esters, 
potent tumor promoters: part 1. Crit. Rev. Toxicol. 8, 153-197. 
Boddy, A.v.. Idle, J.R. (1993). The role of pharmacogenetics in chemotherapy: 
modulation of tumor response and host toxicity. Cancer surveys. 17, 79-104. 
Boffetta, P., Jourenkova, N., Gustavsson, P. (1997). Cancer risk from occupational 
and environmental exposure to polycyclic aromatic hydrocarbons. Cane. Caus. 
Control, 8, 444-472. 
Booth, J., Boyland, E., Sims, P. (1961). An enzyme from rat liver catalysing 
conjugations with glutathione. Biochem. J. 79, 516-524. 
Bosl, G.J., Motzer, R.J, (1997). Medical progress: Testicular germ-cell cancer. N 
Engl J Med 337, 242-253. 
Boyd, S.C, Sasame, H.A., Boyd, M.R. (1981). Effect of cold restraint stress on 
gastric and hepatic glutathione: a potential determinant of response to chemical 
carcinogens. Physiol. Behav. 27, 377-379. 
Bozzi, A., Mavalli, I., Finazzi, A.A., Strom, R., Wolf, A.M., Modovi,B., Rotilio, T. 
(1976). Enzyme defense against reactive oxygen derivatives. 11.Erythrocyte and 
tumor cells. Mol. Cell. Biochem. 10,11-16. 
Brady, H.R., Kone, B.C., Stromski, M.E., Zeidel, M.L., Giebisch, G., Gullans, S.R. 
(1990). Mitochondrial injuiy: an eariy event in cisplatin toxicity to renal proximal 
tubules. Am J Physiol. 258, 1181-7. 
149 
(BiSBograpfiy 
Brash, D.E., Rudolph, J.A., Simon, J.A., Lin, A., McKenna, G.J., Baden, H.P., 
Halperin, A.J., Ponten, J. (1991). A role for sunlight in skin cancer: UV-induced p53 
mutations in squamous cell carcinoma. Proc Natl Acad Sci USA, 88, 10124-8. 
Breimer, L.H. (1990).Molecular mechanisms of oxygen radical carcinogenesis and 
mutagenesis: the role of DNA base damage. Mol Carcinogenesis. 3, 188-197. 
Brendler, S.Y., Tompa, A., Hutter, K.F., Preussmann, R., Pooi-Zobel, B.L. (1992). 
In vivo and in vitro genotoxicity of several N-nitrosamines in extrahepatic tissues of 
the rat. Carcinogenesis 13,2435-41. 
Brennan, R.J., Schiestl, R.H. (1998). Chloroform and carbon tetrachloride induce 
intrachromosomal recombination and oxidative free radicals in Saccharomyces 
cerevisiae Mut. Res. 397, 271-278. 
Brennan, R.J., Schiestl, R.H. (1998). Chloroform and carbon tetrachloride induce 
intrachromosomal recombination and oxidative free radicals in Saccharomyces 
cerevisiae Mut. Res. 397, 271-278. 
Brunnemann, K.D., Hoffmann, D. (1978). Chemical studies on tobacco smoke LIX. 
Analysis of volatile nitrosamines in tobacco smoke and polluted indoor 
environments. In: Environmental Aspects of N-Nitroso Compounds Scientific 
Publication No. 19, pp. 343-356, Walker, E. A., Griciute, L., Castegnaro, M., Lyle, 
R. E. and Davis, W. (eds.) lARC, Lyon. 
Buechter, D.D. (1988). Free radicals and oxygen toxicity. Pharm. Res. 5, 253-260. 
Bultz, B.D., Carlson, L.E. (2005). Emotional distress: the sixth vital sign in cancer 
care. J Clin Oncol 23, 6440-1. 
Burdon, R.H., Alliangana, D., Gill, V. (1995). Superoxide and hydrogen peroxide in 
relation to mammalian cell proliferation. Free Radic. Biol. Med. 18, 775-94. 
Burish, T.G., Carey, M.P., Krozely, M.G., Greco, F.A. (1987). Conditioned side 
effects induced by cancer chemotherapy: prevention through behavioural treatment. 
J. Consult. Clin. Psychol. 55, 42-48. 
Byers, T., Perry, G. (1992). Dietary carotenes, vitamin C, and vitamin E as 
protective antioxidants in human cancers. Annu Rev Nutr. 12, 139-159. 
Cadenas, E. (1997). Basic mechanisms of antioxidant activity. Biofactors. 6, 391-
397. 
Cadenas, E., Sies, H. (1998). The lag phase. Free. Radic. Res., 28, 601-609. 
Camandola, S., Aragno, M., Cutrin, J.C, Tamagno, E., Danni, O., Chiarpotto, E., 
Parola, M., Leonarduzzi, G., Biasi, F., Poli, G. (1999). Liver AP-1 activation due to 
carbon tetrachloride is potentiated by 1,2-dibromoethane but is inhibited by alpha-
tocopherol or gadolinium chloride. Free Rad. Biol. Med. 26, 1108-1116. 
Camilo, C, Moraes, R.M., Dayan, F.E., Ferreira, D. (2000). Podophyllotoxin; 
Phytochemistry 54, 115-20. 
Carlberg, L, Mannervik, B., (1975). Purification and characterization of the 
flavoenzyme glutathione reductase from rat liver. J. Biol. Chem. 250, 5475-5480. 
150 
(BiSBogmpfiy 
Cassileth, B.R., Lusk, E.J., Miller, D.S., Brown, L.L., Miller, C. (1985). 
Psychosocial correlates of survival in advanced malignant disease. N. Engl. J. Med. 
312,1551-1555. 
Cerutti, P. A. (1985). Proxidant states and tumor promotion. Science 227, 375-381. 
Cerutti, P. (1994). Oxi-radicals and cancer. Lancet,. 344, 862-863. 
Chakraborty, T.A., Chatterjee, A., Rana, D., Dhachinamoorthi, P.A., Kumar, M. 
(2007). Carcinogen-induced early molecular events and its implication in the 
initiation of chemical hepatocarcinogenesis in rats: chemopreventive role of 
vanadium on this process, Biochim. Biophys. Acta 1772, 48-59. 
Chaudhary, A.K., Nokubo, M., Mamett, L.J., Blair, l.A. (1994). Analysis of the 
malondia!dehyde-2'-deoxyguanosine adduct in rat liver DNA by gas 
chromatography/electron capture negative chemical ionization mass spectrometry. 
Biol Mass Spectrom. 23,457-464. 
Cheng, K.C., Cahill, D.S., Kasai, H., Nishimura, S., Loeb, L.A. (1992). 8-
Hydroxyguanosine, an abundant form of oxidative DNA damage, causes G:T and 
A:C substitutions. J. Biol. Chem. 267, 166-72. 
Chien, S.Y., Wu, Y.C., Chung, J.G., Yang, J.S., Lu, H.F., Tsou, M.F., Wood, W.G., 
Kuo, S.J., Chen, D.R. (2009). Quercetin-induced apoptosis acts through 
mitochondrial- and caspase-3-dependent pathways in human breast cancer MDA-
MB-231 cells. Hum. Exp. Toxicol. 28, 493-503. 
Claiborne, A. (1985). Catalase activity in: R.A. Green Wald (Ed) CRC Handbook of 
Methods for Oxygen Radical Research. CRC Press, Boca Raton, FL, pp. 283-284. 
Cobb, M.W. (1990). Human Papilloma virus infection. J. Am. Acad.Dermatol. 22. 
547. 
Cohen, S.M. (1991). Analysis of modifying factors in chemical carcinogenesis. Prog 
Exp Tumor Res. 33, 21-40. 
Conklin Kenneth A.Chemotherapy-Associated Oxidative Stress:lmpact on 
Chemotherapeutic Effectiveness. Integrative Cancer Therapies 3(4); 2004 pp. 294-
300. 
Conklin, K.A., (2000). Dietary antioxidants during cancer therapy: impact on 
chemotherapeutic effectiveness and development of side effects. Nutr Cancer, 37, 1-
18. 
Conney AH. (1982). Induction of microsomal enzymes by foreign chemicals and 
carcinogenesis by polycyclic aromatic hydrocarbons: G.H.A. Clowes memorial 
lecture. Cancer Res. 4,4875-4917. 
Connolly, B.S., Bamett, C, Vogt, K.N., Li, T., Stone, J., Boyd, N.F. (2002). A 
meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer. 
Nutr Cancer. 44, 127-138. 
Cooper, E.L. (1984). Stress, immunity and aging. Marcel Dekker, Inc., New York. 
151 
<Bi6Gograplry 
Corbett, T.H., Griswold, D.P., Roberts, B.J., Pekham, J.C, Schabel, F.M. (1978). 
Biology and therapeutic response of a mouse mammary adenocarcinoma (16/c) and 
its potential as a model for surgical adjuvant chemotherapy. Cancer. Treat. Rep. 62, 
1471-1488. 
Cos, S., Martinez-campa, C , Mediavilla, M.D., Sanchez-Barcelo, E.J. (2005). 
Melatonin modulates aromatase activity in MCF-7 human breast cancer cells. J. 
Pineal Res. 38,217-222. 
Cos, S., Sanchez-Barcelo, E.J. (2000). Melatonin and mammary pathological 
growth. Front. Neuroendocrinol. 21,133-170. 
Cos, S., Sanchez-Barcelo, E.J. (2001). In vitro effects of melatonin on tumor cells, 
in: C. Bartsch, H. Bartsch, D.E. Blask, D.P. Cardinali, W.J.M. Hrushesky, D. Mecke 
(Eds.), The Pineal Gland and Cancer. Neuroimmunoendocrine Mechanisms in 
Malignancy, Springer, Berlin, pp. 221-239. 
Cragg, G.M., Kingston, D.G.I., Newman, D.J. (Eds.), 2005. Anticancer Agents from 
Natural Products. Brunner-Routledge Psychology Press,Taylor & Francis Group, 
Boca Raton, FL. 
Croyle, R.T. (1998). Depression as a risk factor for cancer: renewing a debate on the 
psychobiology of disease. J. Natl, cancer Inst. 90, 1856-1857. 
Csermely, P. (1998). Stress of life: from molecules to man. The New York Academy 
of Sciences, New York. 
D' Andrea GM. (2005) Use of antioxidants during chemotherapy and radiotherapy 
should be avoided. CA Cancer J Clin, 55, 319-321. 
D'Souza, R.J., Phillips, E.M., Jones, P.W., Strange, R.C., Aber, G.M. (1993). 
Interactions of hydrogen peroxide with interleukin-6 and platelet-derived growth 
factor in determining mesengial cell growth: effect of repeated oxidant stress. Clin. 
Sci. 86, 747-51. 
Das, U.N. (2002). A radical approach to cancer. Med. Sci. Monit. 78, 429-441. 
Das, D., Bandyopadhyay, D., Bhattacharjee, M., Banerjee, R.K. (1997). Hydroxy! 
radical is the major causative factor in stress-induced gastric ulceration. Free Radic 
Biol Med. 23,8-18. 
Dash, D.K., Yeligar, V.C, Nayak, S.S., Ghosh, T., Rajalingam, D., Sengupta, P., 
Maiti, B.C., Maity, T.K. (2007). Evaluation of hepatoprotective and antioxidant 
activity of Ichnocarpus frutescens (Linn.) R.Br, on paracetamol-induced 
hepatotoxicity in rats. Tropical Journal of Pharmaceutical Research, 6, 755-765. 
Davies, KJ., Goldberg, A.L.. (1987). Oxygen radicals stimulate intracellular 
proteolysis and lipid peroxidation by independent mechanisms in erythrocytes. J 
Biol Chem. 262, 8220-6. 
Davis, R.H., Parker, V/.L., Sampson, R.T., Murdoch, D.P. (1991). Isolation of a 
stimulatory system in an aloe extract. J. Am. Pediatr. Med. Assoc. 81,473-478. 
De Grey, A. D. N. J. (2002). H02': The forgotten radical. DNA Cell Biol., 21, 251-
257. 
152 
^iSSogmpky 
De Groot, H., Noll, T.(1989). Halomethane hepatotoxicity: induction of lipid 
peroxidation and inactivation of cytochrome P-450 in rat liver microsomes under 
low oxygen partial pressures. Toxicol. Appl. Pharmacol. 97, 530-537. 
Deal, F.H., Richardson, F.C., Swenberg, J.A., (1989). Dose response of hepatocyte 
replication in rats following continous exposure to diethylnitosamine. Cancer Res. 
49, 6985-6988. 
Dechambre, R., Gosse, C. (1973). Individual versus group caging of mice with 
grafted tumors. Cancer Res. 33, 140-144. 
Demple, B., Harrison, L., (1994). Repair of oxidative damage to DNA. Annu. Rev. 
Biochem. 63, 915-48. 
Denissenko, M.F., Venkatachalam, S., Ma, Y.H., Wani, A.A. (1996) Site-specific 
induction and repair of benzo[a]pyrene diol epoxide DNA damage in human H-ras 
protooncogene as revealed by restriction cleavage inhibition. Mutat. Res. 363, 27-
42. 
Dewhirst, M.W., Lora-Michiels, M., Viglianti, B.L., Dewey, W.C., Repacholi, M. 
(2003). Carcinogenic effects of hyperthermia. Irit J Hyperthermia. 19, 236-251. 
Dhawan, D., Balasubramanian, S., Amonkar, A.J., Singh, N. (1999). 
Chemopreventive effect of 4'-demethyl epipodophyllotoxin on DMBA/TPA-
induced mouse skin carcinogenesis. Carcinogenesis 20, 997-1003. 
Dimitroglou, E., Zafiropoulou, M., Messini-Nikolaki, N., Doudounakis, 
S.,Tsilimigaki, S., Piperakis, S.M., (2003). DNA damage in a human population 
affected by chronic psychogenic stress. International Journal of Hygiene and 
Environmental Health. 206, 39-44. 
Diplock, A.T., (1994). Antioxidants and disease prevention. Mol Aspects Med. 
15: 293-376. 
Dizdaroglu, M. (1992). Oxidative damage to DNA in mammalian chromatin. Mutat. 
Res. 275, 331^2. 
Dizdaroglu, M. 1993. Chemistry of free radical damage to DNA and nucleoproteins. 
In B. Halliwell and O.I. Aruoma (eds) DNA and Free Radicals, Chichester: Ellis 
Horwood, pp. 19-39. 
Doll, R. J. (1998). Effects of small doses of ionising radiation. J. Radiol. Protect. 18, 
163-174. 
Dypbukt, J.M., Ankarcrona, M., Burkitt, M., Sjoholm, A., Strom K, Orrenius, S., 
Nicotera P. (1994). Different prooxidant levels stimulate growth, trigger apoptosis, 
or produce necrosis of insulin secreting RINm5F cells. The role of intracellular 
polyamines. J. Biol. Chem. 269, 30553-30560. 
Dyroff, M.C., Richardson, F.C., Poppy, J.A., Bedell, M.A., Wenberg, J.A. (1986). 
Correlation of 04-ethyldeoxythymidine accumulation, hepatic initiation and 
hepatocellular carcinoma induction in rats continuously administered 
diethylnitrosamine. Carcinogenesis 7,241-246. 
Einhorn, L., Don-ohue, J.P., (1977). Cis-diamino dichloroplatinum. vinblastine and 
bleomycin combination chemotherapy in disseminated testicular cancer. Ann. 
Intern. Med. 87, 293-298. 
153 
(BiBGograplJy 
Elangoven, V., Balasubramanian, S., Sekar, N., Govindaswamy, S. (1994). Studies 
on the chemopreventive potential of some naturally occurring bioflavonoids in 7,12-
dimethylbenz(a)anthracene induced carcinogenesis in mouse skin. J.Clin. Biochem. 
Nutr. 17, 153-160. 
Ellis, G., Goldberg, D.M., Spooner, R.J., (1978). Serum enzyme tests in diseases of 
the liver and biliary tree. Am. J. Clin. Pathol. 70, 248-258. 
Epe, B (1993): in DNA and Free Radicals (Halliwell, B. and Aruoma, O. 
1., eds.), Ellis Horwood, Chichester, pp. 41-65. 
Erhola, M., Kellokumpu-Lehtinen, P., Metsa-Ketela, T., Alanko, K., Nieminen, 
M.M. (1996). Effects of anthracyclin-based chemotherapy on total plasma 
antioxidant capacity in small cell lung cancer patients. Free Radio Biol Med. 21. 
383-390. 
Esterbauer, H. (1985). Lipid peroxidation products: formation, chemical properties 
and biological activities. In: Pli, G., Cheeseman, K.H., Dianzani, M.U., Slater, T.F. 
(eds.), Free Radicals in Liver Injury. IRL Press, Oxford, pp. 29-47. 
Estrele, J., Ortega, A., Obrador, E. (2006). Glutathione in cancer biology and 
therapy. Crit. Rev. Clin. Lab. Sci. 43,2. 
Faber, M., Coudray, C, Hida, H., Mousseau, M., Favier, A. (1995). Lipid 
peroxidation products, and vitamin and trace element status in patients with cancer 
before and after chemotherapy including adriamycin: a preliminary study. Biol 
Trace Elem Res. 47, 117-123. 
Feig, D.I., Reid, T.M., Loeb, L.A. (1994). Reactive oxygen species in tumorigenesis. 
Cancer Res. 54, 1890-1894. 
Fischman, H.K., Pero, R.W., Kelly, D.D. (1996). Psychogenic stress induces 
chromosomal and DNA damage. International Journal of Neuroscience. 84, 219-
227. 
Flint, M.S., Baum, A., Chambers, W.H., Jenkins, F.J. (2007). Induction of DNA 
damage, alteration of DNA repair and transcriptional activation by stress hormones. 
Psychoneuroendocrinology 32,470-479. 
Floyd, R.A., Watson, J.J., Wong, P.K., Altmiller, D.H., Rickard, R.C. (1986). 
Hydroxyl free radical adduct of deoxyguanosine: sensitive detection and 
mechanisms of formation. Free Radic Res Commun. 1,163-172. 
Floyd, R.A. (1990). 8-Hydroxy-2'-deoxyguanosine in carcinogenesis. 
Carcinogenesis. 11, 1447-1450. 
Forlenza, M.J., Latimer, J.J., and Baum, A. (2000). The effect of stress on DNA 
repair capacity. Psychol. Health 15, 881-891. 
Formica, J.V., Regelson, W. (1995). Review of the biology of Quercctin and 
related bioflavonoids. Food Chem Toxicol. 33, 1061-80. 
Fox, B.H. (1981). Psychosocial factors and the immune system in human cancer, in: 
R. Ader (ed), Psychoneuroimmunology, Academic press, New York. pp. 103-157. 
154 
(Bi6Bo£rapfiy 
Fox, B.H. (1995). The role of psychological factors in cancer incidence and 
prognosis. Oncology (Hunt). 9, 245-253. 
Fox, S.B., Gatter, K.C., Harris, A.L. (1996). Tumor angiogenesis. J Pathol. 179. 
232-237. 
Fraga, C.G., Shigenaga, M.K., Park, J.W., Degan, P., Ames, B.N. (1990). Oxidative 
damage to DNA during aging: 8-hydroxy-20-deoxyguanosine in rat organ DNA and 
urine. Proc. Natl. Acad. Sci. USA. 87,4533-37. 
Frezza, E.E., Gerunda, G.E., Farinati, F., DeMaria, N., Galligioni, A., Plebani, F., 
Giacomin, A. (1994). CCU-induced liver-cirrhosis and hepatocellular-carcinoma in 
rats-relationship to plasma zinc, copper and estradiol levels. Hepato-Gastroenterol. 
41, 367-369. 
Fridovich, I. (1974). Superoxide dismutase. In: Meister, A., ed. Advances in 
enzymology. Vol. 41 New York Wiley & Sons, Inc. pp, 35-97. 
Fridovich, 1. (1975). Superoxide dismutase. Ann. Rev. Biochem. 44, 147-159. 
Fry, R.J.M., Ley, R.D. (1984). The mechanism of radiation carcinogenesis. Radiat. 
Phys. Chem., 24, 329-336. 
Gao, K., Hennning, S.M., Niu, Y., Youssefian, A.A., Seeram, N.P., Xu, A. (2006). 
The citrus flavonoid naringenin stimulates DNA repair in prostate cancer cells. J 
Nutr Biochem 17:89-95. 
Gelboin, HV. (1980). Benzo[a]pyrene metabolism, activation, and carcinogenesis: 
role and regulation of mixed-function oxidases and related enzymes. Physiol. Rev. 
60, 1107-1166. 
Gidron, Y., Russ, K., Tissarchondou, H., Warner, J. (2006). The relation between 
psychological factors and DNAdamage: A critical review. Biol Psychol 72, 291-
304. 
Giraldi, T., Perissin, L., Zorzet, S., Rapozzi, V. (1992). Metastasis and 
neuroendocrine system in stressed mice. Ann. NY. Acad. Sci. 650, 297-301. 
Giraldi, T., Perissin, L., Zorzet, S., Rapozzi, V. (1994). Stress and the effectiveness 
of antitumor chemotherapy in mice. First International Congress on Stress. 
Bethesda, MD. 
Glaser, R., Thorn, B, E., Tarr, K, L., Kiecolt-Glaser, J, K., and D'Embrosio, S, M. 
(1985). Effects of stress on methyltransferase synthesis: an important DNA repair 
enzyme. Health Psychol. 4,401-412. 
Golding, B.T., Patel, N., Watson, W.P. (1989). Dimer and trimer of 
malondialdehyde. J. Chem. Soc. Perkin. 1, 668-669. 
Goldman, P.R., Vogel, W.H. (1984). Striatal dopamine-stimulated adenylate cyclase 
activity reflects susceptibility of rats to 7,12-dimethylbenz(a) anthracene-induced 
mammary tumor development. Carcinogenesis (Lond.). 6, 971-973. 
155 
(BiBGograpfiy 
Gomes-Cameiro, M.R., Ribeiro-Pinto, L.F., Paumgartten, F.J. (1997). 
Environmental risk factors for gastric cancer: the toxicologist's standpoint. Cad 
Saude Piiblica 13, 27-38. 
Gopalakrishna, R., Gundimeda, U., Anderson, W.B., Colbum, N.H., Slaga, T.J. 
(1999). Tumor promoter benzoyl peroxide induces sulfhydryl oxidation in protein 
kinase C: its reversibility is related to the cellular resistance to peroxide-induced 
cytotoxicity. Arch. Biochem. Biophys. 363,246-258. 
Gowdey, G., Lee R.K., Carpenter, W.M. (1995). Treatment of HIV- related hairy 
leukoplakia with Podophyllum resin 25% solution. Oral Surg.Oral Med. Oral Pathol. 
Oral Radiol. Endocrinol. 79, 64-7. 
Greenwald, P., Kelloff, G.J. (1996). The role of chemoprevention in cancer control. 
In: Stewart, B.W., McGregor, D., Kleihues, P, editors. Principles of 
Chemoprevention. lARC Scientific Publication No. 139. Lyon: lARC 13-22. 
Greer, S., Morris, T., Pettingale, K.W. (1979). Psychological response to breast 
cancer: effect on outcome. Lancet. 2,785-787. 
Greggi Antunes, L.M., Darin, J.D. Bianchi, M.D., (2000). Protective effects of 
vitamin C against cisplatin induced nephrotoxicity and lipid peroxidation in adult 
rats: a dose-dependent study. Pharmacol Res, 41, 405-411. 
Grimm, M.S., Emerman, J.T., Weinberg, J. (1996). Effects of social housing 
condition and behavior on growth of the Shionogi mouse mammary carcinoma. 
Physiol Behav 59, 633-642. 
Grisham, J.W., Kaufmann, W.K., Kaufman, D.G. (1984). The cell cycle and 
chemical carcinogenesis. Surv SynthPatho Res. 1,49-66. 
Grossarth-Maticek, R., Eysenck, H.J. (1989). Length of survival and lymphocyte 
percentage in women with mammary cancer as a function of psychotherapy. 
Psychol. Rep. 65, 315-321. 
Gupta, K., Panda, D. (2002). Perturbation of microtubule polymerization by 
quercetin through tubulin binding: a novel mechanism of its antiproliferative 
activity. Biochemistry, 41, 13029-13038. 
Gupta, M.L., Tyagi, S., Flora, S.J., Agrawala, P.K., Choudhary, P., Puri. S.C. 
(2007). Protective efficacy of semi purified fraction of high altitude Podophyllum 
hexandrum rhizomes in lethally irradiated Swiss albino mice. Cell Mol Biol 53:29-
41. 
Gutierrez, J.B., Salsamendi, A.L. (2001). Foundations from Toxicological Sciences. 
Diaz de Santos, Madrid, 155-177. 
Gutteridge, J.M.C. (1977). The protective action of superoxide dismutase on metal-
ion catalysed peroxidation of phospholipids. Biochem. Biophys. Res. Commun. 77. 
379-386. 
Guyton, K.Z., Kensler, T.W. (1993). Oxidation mechanisms in carcinogenesis. Br. 
Med. Bui. 49, 523-544. 
156 
(BiSBo^apliy 
Habig, W.H., Pabst, M.J., Jakoby, W.B., (1974). Glutathione s-transferases: The 
first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249, 7130-7139. 
Halliwell, B. (1993). The chemistry of free radicals. Toxicol Ind Health. 9, 1 -21. 
Halliwell, B. (1996).Mechanisms involved in the generation of free radicals.Pathol 
Biol. 44,6-13. 
Halliwell, B. (1999). Oxygen and nitrogen are pro-carcinogens. Damage to DNA by 
reactive oxygen, chlorine and nitrogen species: measurement, mechanism and the 
effects of nutrition. Mutat. Res. 443, 37-52. 
Halliwell, B., Gutteridge, J.M.C (1992). Biologically relevant metal ion dependent 
hydroxyl radical generation. An update. FEBS Lett. 307, 108-112. 
Halliwell, B., Gutteridge, J.M.C. (1984). Oxygen toxicity, oxygen radicals, 
transition metals and disease. Biochem. J. 219, 1-14. 
Halliwell, B., Gutteridge, J.M.C. (1990). Role of free radicals and catalytic metal 
ions in human disease: an overview. Methods Enzymol. 186, 1-85. 
Halliwell, B., Gutteridge, J.M.C. (1999). Free Radicals in Biology and Medicine. 
Oxford UP: New York. pp. 131-147. 
Hanausek, M., Walaszek, Z., Slaga, T.J. (2003). Detoxifying cancer causing agents 
to prevent cancer. Integr. Cancer Ther. 2, 139-144. 
Hanke, J. (1980). Influence of drugs and poisons on the synthesis and activity 
microsomal enzymes participating in their metabolism. Folia Med. Crac. 22, 263. 
Harada, L.T., Tamada, K., Abe, K., Nomoto, K. (1997). Repeated restraint stress 
impairs the antitumor T cell response through its suppressive effect on ThI-type 
CD4+ T cells. Anticancer Res. 17,4259-4268. 
Harman, D.H. (1994). Free radical theory of aging: increasing the functional life 
span. Ann. N.Y. Acad. Sci. 717, 257-266. 
Harris, C.C, Hollstein, M. (1993). Clinical implications of the p53 tumorsuppressor 
gene. N Engl J Med. 329, 1318-27. 
Hartley, J.A., Reszka. K., Lown, J.W., (1988). Photosensitization by antitumor 
agents, Antrapyrazole-photosensitized formation of single strand- breaks in DNA. 
Free Radio Biol Med 4, 337-343. 
Hartwell, J.L., (1982). Plants Used Against Cancer. Quarterman, Lawrence, MA. 
Hasan, S., Bilal, N., Naqvi, S., Ashraf, G.M., Suhail, N., Sharma, S., Banu, N. 
(2010). Multivitamin-Mineral and Vitamins (E + C) Supplementation Modulate 
Chronic Unpredictable Stress-Induced Oxidative Damage in Brain and Heart of 
Mice. Biol Trace Element Res, (ahead of print). 
Hatch, G.E., Santrock, J., Slade, R., Hayes, J.M. (1988). Detection of CCI4-induced 
oxidation of hepatic tissue in vivo by oxygen-18 tracing.J.M. Toxicol. Appl. 
Pharmacol. 93, 81-88. 
157 
(Bi66ograpfiy 
Hauptmann, N., Cadenas, E. (1997). In Oxidative Stress and the Molecular Biology 
of Antioxidant Defenses; Scandalios, J.G., Ed.; Cold Spring Harbor Laboratory 
Press: Plainview, N.Y. pp. 1-17. 
Hayes, D.M, Cvitkovic E, Golbey, R.B., Scheiner, E., Helson, L., Krakoff, i.H. 
(1977). High dose cis-platinum diammine dichloride: amelioration of renal toxicity 
by mannitol diuresis. Cancer. 39,1372-81. 
Hecht, S.S. (1997). Approaches to cancer prevention based on an understanding of 
N-nitrosamine carcinogenesis. Proc. Soc. Exp. Biol. Med. 216,181-191. 
Hecht, S.S., Hoffman, D. (1988). Tobacco-specific nitrosamines,an important group 
of carcinogens in tobacco and tobacco smoke. Carcinogenesis, 9, 875-884. 
Heijnen, C.G., Haenen, G.R., van Acker, F.A., van der Vijgh, W.J., Bast, A. (2001). 
Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups. Toxicol In 
Vitro. 15, 3-6. 
Hennings, H., Shores, R., Wenk, M.L., Spangler, E.F., Tarone, R., Yupa, S.H. 
(1983). Malignant conversion of mouse skin tumors is increased by tumor initiators 
and unaffected by tumor promoters. Nature. 304, 67-69. 
Hietanen, E., Ahotupa, M., Bereziat,J. C, Bussacchini, V., Camus, A.M., Bartsch, 
H.,Wild, H. (1987). Lipid peroxidation and chemically-induced cancer in rats fed 
lipid rich diet. In: K. Lapis and S. Eckhardt (eds.). Carcinogenesis and Tumour 
Progression 4, 9-16. 
Higinbotham, K.G., Rice, J.M., Diwan, B.A., Kasprzak, K.S., Reed, CD., Perantoni, 
A.O. (1992). GGT to GTT transversions in codon 12 of the K-ras oncogene in rat 
renal sarcomas induced with nickel subsulfide or nickel subsulfide/iron are 
consistent with oxidative damage to DNA. Cancer Res. 52, 4747-4751. 
Hinuma, K., Matsuda, J., Tanida, N., Hori, S., Tamura, K., Ohno, T., Kano, M., 
Shimoyama, T. (1990). N-nitrosami nes in the stomach with special reference to in 
vitro formation, and kinetics after intragastric or intravenous administration in rats. 
Gastroenterol Jpn. 25,417-24. 
Hiroshi. Y., Honu-inui. Y., Chul-ho. Y., Guengerich. P.P., Shimada. T. (1992). 
C>'tochrome P-450 2E1 and 2A6 enzymes as major catalysts for metabolic 
activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human 
liver nitrosamines. Carcinogenesis 13,1789-94. 
Hix, S., Augusto, O. (1999) DNA methylation by tert-buty\ hydroperoxide-iron (II): 
A role for the transition metal ion in the production of DNA base adducts. Chem. 
Biol. Inter. 118, 141-149. 
Hoeijimakers, J.H. (2001) Genome maintenance mechanisms for preventing cancer. 
Nature. 411,3666-374. 
Hoffmann, D., Adams, J.D., Piade, J.J., Hecht, S.S. (1980). Chemical studies on 
tobacco smoke LXVIII. .Analysis of volatile and tobacco-specific nitrosamines in 
tobacco products. JARC Sci. PubJ. 31, 507-5 14. 
158 
(Bi6Bo£rapfiy 
Hollman, P.C, Katan, M.B. (1999). Dietary flavonoids: intake, health effects and 
bioavailability. Food Chem Toxicol. 37, 937-42. 
Hollstein, M., Sidransky, D., Vogelstein, B., Harris, C.C. (1991). p53 mutations in 
human cancers. Science. 253, 49-53. 
Hopkin, F.G., Elliott, K.A.C. (1931). The relation of glutathione to ceil respiration 
with special reference to hepatic tissue. Proc. Roy. Soc. 109, 58-88. 
Hotchkiss. J.H. (1989) Preformed N-nitroso compounds in foods and beverages. 
Cancer SurvS, 295-32]. 
Huang, Q., Stoner, G., Resan, J., Nickols, J., Mirvish, S.S. (1992). Metabolism of N-
nitrosomethyl-n-amylamine by microsomes from human and rat esophagus. Cancer 
Res. 52, 3547-51. 
Huang, R.P., Peng, A., Hossain, M.Z., Fan, Y., Jagdale, A., Boynton, A.L. (1999). 
Tumor promotion by hydrogen peroxide in rat liver epithelial cells. Carcinogenesis. 
20, 485-92. 
Husain, S.R., Cillard, J., Cillard, P. (1987). Hydroxyl radical scavenging activity of 
avonoids. Phytochemistry. 26, 2489-2491. 
Hussain, S.P., Haris, C.C. (1998). Molecular epidemiology of human cancer: 
contribution of mutation spectra studies of tumor suppressor genes. Cancer Res. 58, 
4023-37. 
larussi, D., Auricchio, U., Agretto, A., (1994). Protective effect of coenzyme QIO on 
anthracyclines cardiotoxicityxontrol study in children with acute lymphoblastic 
leukemia and non-Hodgkin lymphoma.Mol Aspects Med.15, 207-212. 
Imbert, T.F., (J998). Discovery of podophyllotoxins. Biochimie 80, 207-22. 
Iribarren, J„ Prolo, P., Neagos, N., Chiappelli, F. (2005). Post-traumic stress 
disorder:evidence-based research for the third millennium. Evid Based Complement 
Altemat Med 2, 503-12. 
Irie, M., Asami, S., Ikeda, M., Kasai, H. (2003). Depressive state relates to female 
oxidative DNA damage via neutrophil activation. Biochemistry, Biophysics 
Research Communications. 311, 1014-1018. 
Irie, M., Asami, S., Nagata, S., Ikeda, M., Miyata, M., Kasai, H. (2001). 
Psychosocial factors as a potential trigger of oxidative DNA damage in human 
leukocytes. Japanese Journal of Cancer Research. 92, 367-376. 
Irie, M., Asami, S., Nagata, S., Miyata, M., Kasai, H. (2000). Classical conditioning 
of oxidative DNA damage in rats. Neuroscience Letters. 288, 13-16. 
Irie, M., Asami, S., Nagata, S., Miyata, M., Kasai, H. (2002). Psychological 
mediation of a type of oxidative DNA damage, 8-hydroxydeoxyguanosine,in 
peripheral blood leukocytes of non-smoking and non-drinking workers. 
Psychotherapy Psychosomatics. 71, 90-96. 
Irie, M., Miyata, M., Kasai, H. (2005). Depression and possible cancer risk due to 
oxidative DNA damage. Journal of Psychiatric Research. 39, 553-560. 
159 
(BiBRograpky 
Ito, N., Hirose, M. (1989). Antioxidants-carcinogenic and chemopreventive 
properties. Adv. Cancer Res. 53,247-300. 
Janero, D.R. (1990). Malondialdehyde and thiobarbituric acid-reactivity as 
diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic. 
Biol. Med. 9, 515-540. 
Jang, M., Cai, L., Udeani, CO., Slowing, K.V., Thomas, C.F., Beecher, C.W., Pong, 
H.H., Famsworth, N.R., Kinghom, A.D., Mehta, R.G., Moon, R.C., Pezzuto, J.M. 
(1997). Cancer chemopreventive activity of resveratrol, a natural product derived 
from grapes. Science. 275,218-220. 
Jaworowski, Z. (1999). Radiation risks and ethics. Physics Today, 52, 24-29. 
Jemal, A., Siegel, R., Xu, J., Ward, E. (2010).Cancer statistics. CA Cancer J Clin. 
60, 277-300. 
Ji, C, Rouzer, C.A., Mamett, L.J., Pietenpol, J.A. (1998). induction of cell cycle 
arrest by the endogenous product of lipid peroxidation, malondialdehyde. 
Carcinogenesis. 19, 1275-1283. 
Johnson, E.O., Kamilaris, T.C., Chrousos, G.P., Gold, P.W. (1992). Mechanism of 
stress: a dynamic overview of hormonal and behavioural homeostasis. Neurosci. 
Biobehav. Rev. 16, 115-130. 
Jollow, D.J., Mitchel, J.R., Zampaglione, N., Gillete, J.R., (1974). Bromobenzene 
induced liver necrosis:protective role of glutathione and evidence for 3, 4 
bromobenzene oxide as the hepatotoxic intermediate. Pharmacology 11,151-169. 
Jung, Y.H., Heo, J., Lee, Y.J., Kwon, T.K., Kim, Y.H. (2010). Quercetin enhances 
TRAlL-induced apoptosis in prostate cancer cells via increased protein stability of 
death receptor 5. Life Sci. 86, 351-357 
Justice, A., (1985) Review of the effects of stress on cancer in laboratory animals: 
importance of time of stress application and type of tumour. Psychol. Bull. 98, 108-
138. 
Kakizoe, T. (2003). Chemoprevention of cancer-focussing on clinical trials. Jpn. J. 
Clin. Oncol. 33,421-442. 
Kang, D.H. (2002). Oxidative stress, DNA damage, and breast cancer. AACN 
Clincal Issues. 13, 540-549. 
Kapitulnik, J., Wislocki, P.G., Levin, W., Vagi, H., Jerina, D.M., Conney, A.H. 
(1978). Tumorigenicity studies with diol-epoxides of benzo(o)pyrene which indicate 
that (±)-/r««j'-7B,8a-dihydroxy-9a,10Q-epoxy-7,8,9,l 0-tetrahydrobenzo(a)pyrene is 
an ultimate carcinogen in newborn mice. Cancer Res. 38, 354-358. 
Karbownik, M., Garcia, J.J., Lewinski, A., Reiter, R.J. (2001). Carcinogen induced, 
free radical-mediated reduction in microsomal membrane fluidity: reversal by 
indole-3-propionic acid, J. Bioenerg. Biomembr. 33, 73-78. 
Karthikeyan K, Masilamani V, Govindasamy S. (1999). Spectrofluorimetric 
detection of DMBA-induced mouse skin carcinoma. Pathol Oncol Res. 5, 46-8. 
160 
(BiBGo^rapfiy 
Kaschnitz, P.M., Hatefi, Y. (1975). Lipid oxidation in biological membranes: 
Electron transfer proteins as initiators of lipid autoxidation. Arch. Biochem. 
Biophys. 171, 292-304. 
Katz, R.J., Roth, K.A., Carroll, B.J. (1981). Acute and chronic effects on open field 
activity in the rat: implications for a model of depression. Neurosci Biobehav Rev. 
5,247-251. 
Kawachi, I., Sparrow, D., Spiro, A., Vokona, S.P., Weiss, S.T. (1996). A 
prospective study of anger and coronary heart disease. The Normative Aging Study 
Circulation 94, 2090-5. 
Kelloff, G.J., Boone, C.W., Steele, V.E., Crowell, J.A., Lubet, R.A., Greenwald, P. 
(1996). Mechanistic considerations in the evaluation of chemopreventive data. In: 
Stewart, B.W., McGregor, D., Kleihues, P, ed. Principles of Chemoprevention. 
lARC Scientific Publication No. 139. Lyon: lARC, 203-19. 
Kelly, G.S. (1999). Nutritional and botanical interventions to assist with the 
adaptation to stress. Altem Med Rev 4, 249-65. 
Kerr, L.R., Grimm, M.S., Silva, W.A., Weinberg, J., Emerman, J.T., (1997) Effects 
of social housing condition on the response of the Shionogi mouse mammary 
carcinoma (SC115) to chemotherapy. Cancer Res 57, 1124-1128. 
Khan, N., Afaq, F., Mukhatr, H., (2008). Cancer chemoprevention through dietary 
antioxidants: progress and promise. Antioxid Redox Signal, 10, 475-5 i 0. 
Kharbanda, S., Ren, R., Pandey, P., Shafman, T.D., Feller, S.M., Weichselbaum, 
R.R., Kufe, D.W. (1995). Activation of the c-Abl tyrosine kinase in the stress 
response to DNA-damaging agents. Nature 376, 785-8. 
Kiecolt-Glaser, J.K., Stephens, R.E., Lipetz,P.D., Speicher,C.E., Glaser, R. (1985). 
Distress and DNA repair in human lymphocytes. J. Behav. Med. 8, 311-320. 
Kim, J.Y., Kim, E.H., Park, S.S., Lim, J.H., Kwon, T.K., Choi, K.S. (2008). 
Quercetin sensitizes human hepatoma cells to TRAlL-induced apoptosis via Spl-
mediated DR5 up-regulation and proteasome-mediated c-FLlPS down-regulation. J. 
Cell. Biochem. 105, 1386-1398. 
Klaunig, J.E., Kamendulis, L.M. (2004). The role of oxidative stress in 
carcinogenesis. Ann. Rev. Pharmacol. Toxicol. 44, 239-67. 
Klaunig, J.E., Xu, Y., Bachowski, S., Jiang, J. (1997). Free-radical oxygen-induced 
changes in chemical carcinogenesis: In Free Radical Toxicology, ed. KBWallace, 
London: Taylor & Francis, pp. 375-400. 
Klein, J.A., Ackerman, S.L. (2003). Oxidative stress, cell cycle, and 
neurodegeneration. J Clin Invest. I l l , 785-793. 
Knight, J.A. (1995). Diseases related to oxygen-derived free radicals. Ann. Clin. 
Lab. Sci. 25, 111-21. 
Kolaja, K.L., Klaunig, J.E. (1996). Selective Dieldrin Promotion of Hepatic Focal 
Lesions in Mice. Carcinogenesis. 17, 1243-50. 
161 
<Bi66o^apfiy 
Konstandi, M., Johnson, E., Lang, M.A., Camus-Radon, A.M., Marselos, M. (2000). 
Stress modulates the enzymatic inducibility by Benzo[a]Pyrene in the rat liver. 
Pharmacol. Res. 42, 206-211. 
Konstandi, M., Marselos M., Camus-Radon A.M., Johnson E., Lang M.A. (1998). 
The role of stress in the regulation of drug metabolising enzymes in mice. Eur. J. 
Drug Metab. Pharmacol. 23,483-490. 
Koppenol, W.H., Moreno J.J., Pryor, W.A., Ischirpopulos, H., Beckman, J.S. (1992). 
Peroxynitrite: a cloaked oxidant from superoxide and nitric oxide. Chem. Res. 
Toxicol. 5, 834-42. 
Korzets, A., Chagnac, A., Weinstein, T., Ori, Y., Malach, T., Gafter, U. J. (1999). 
H2O2 induces DMA repair in mononuclear cells: Evidence for association with 
cytosolic Ca^ "^  fluxes. Labor. Clin. Med., 133, 362-369. 
Kotler, M.L., Rodriquez, C, Sainz, R.M., Antolin, I., Menendez-Pelaez, A. (1998). 
Melatonin increases gene expression for antioxidant enzymes in rat brain cortex. J 
Pineal Res. 24, 83-9. 
Kovacic, P. (1959). An integrated concept of carcinogenic-anticarcinogenic action. 
Ohio. J. Sci. 59, 318-320. 
Kovacic, P., Pozos, R. S., Somanathan, R., Shangari, N., O'Brien, P. J. (2005). 
Mechanism of mitochondrial uncouplers, inhibitors, and toxins: Focus on electron 
transfer, free radicals, and structure-activity relationships. Curr. Med. Chem., 12, 
2601-2623. 
Kovacs, P., Juranek, 1., Stankovicova, T., Svec, P. (1996). Lipid peroxidation during 
acute stress. Pharmazie. 51, 51-53. 
Kreutzer, D.A., Essigmann, J.M. (1998). Oxidized, deaminated cytosines are a 
source of C:T transitions in vivo. Proc. Natl. Acad. Sci. USA 95, 3578-82. 
Kuhlmann, M.K., Burkhardt, G., Koehler, H. (1997). Insights into po-tential cellular 
mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol Dial 
Transplant 12, 2478-2480. 
Kumar, I.P, Goel, H.C. (2000). Iron chelation and related properties of Podophyllum 
hexandrum, a possible role in radio-protection. Indian J Exp Biol 38, 1003-6. 
Kuo, P.C., Liu, H.F., Chao, J.I. (2004). Survivin and p53 modulate quercetin-
induced cell growth inhibition and apoptosis in human lung carcinoma cells. J. Biol. 
CAew., 279, 55875-55885. 
Kweon, S., Park, K.A., Choi, H., 2003. Chemopreventive effect of garlic powder 
diet in diethylnitrosamine-induced rat hepatocarcinogenesis. Life Sci. 73, 2515-
2526. 
La-barba, R.C. (1970). Experimental and environmental factors in cancer: a review 
of research with animals. Psychosom. Med. 32, 259-276. 
Labuc, G.E., Archer M.C. (1982). Esophageal and hepatic micro somal metabolism 
of N-nitromethylbenzylamine and N-nitrosodimethylamine in the rat. Cancer Res. 
42,3181. 
162 
(BiSGo^rapliy 
Laconi, E., Tomasi, C, Curreli, F., Diana, S., Laconi, S., Serra, G., Collu, M., Pani, 
P. (2000). Early exposure to restraint stress enhances chemical carcinogenesis in rat 
liver. Cancer Lett. 161,215-220. 
Lake B.G., Harris, R.A., Collins, M.A., Cotrell, R.C., Phillips, l.C, Gangoli, S.D. 
(1982). Studies on the metabolism of dimethylnitrosamine in vitro by rats liver 
preparations. Inihibition by substrates and inhibitors of monoamine oxidase. 
Xenobiotica 12, 567-79. 
Lamson, D.W., Brignall, M.S. (1999). Antioxidants in cancer therapy; their actions 
and interactions with oncologic therapies. AlternMed Rev. 4, 304-329. 
Lee, K.H., Xiao, Z. (2005). Podophyllotoxins and analogs. In: Cragg,G.M., 
Kingston, D.G.L, Newman, D.J. (Eds.), Anticancer Agents from Natural Products. 
Brunner-Routledge Psychology Press, Taylor & Francis Group, Boca Raton, FL, pp. 
71-88 . 
Lee, T.J., Kim, O.H., Kim, Y.H., Lim, J.H., Kim, S., Park, J.W., Kwon, T.K. (2006). 
Quercetin arrests G2/M phase and induces caspase-dependent cell death in U937 
cells. Cancer Lett. 240, 234-242. 
Lee, Y.J., Shacter, E. (1999). Oxidative stress inhibits apoptosis in human 
lymphoma cells. J Biol Chem. 274, 19792-19798. 
Legha, S.S., Wang, Y.M., Mackay, B. (1982). Clinical and pharmacologic 
investigation of the effects of alpha-tocopherol on adriamycin cardiotoxicity. Ann N 
Y Acad Sci. 393,411-418. 
Leibbrandt, M.E.I., Grushenka, H.I.W., Metz, A.L., Oziba, A.A., Haskins, J.R. 
(1995) Critical subcellular targets of cisplatin and related platinum analogs in rat 
proximal tubule cells. Kidney Int. 48, 761-770. 
Leonard, S. S., Harris, G. K., & Shi, X. (2004). Metal-induced oxidative stress and 
signal transduction. Free Radic. Biol. Med. 37, 1921-1942. 
Lesnikov, V.A., Pierpaoli, W. (1994). Pineal cross-transplantation (old-to-young and 
vice versa) as evidence for an endogenous "ageing clock". Ann. N.Y. Acad. Sci. 
719,416-473. 
Levine, S., Ursin, H. (1991). What is stress? In: M.R. Brown, G.F. Koob, C. Rivier 
(eds). Stress Neurobiology and Neuroendocrinology, pp, 3-21. Marcel Dekker, Inc., 
New York. 
Lichtman, R.R., Taylor, S.E., Wood, J.V. (1987). Social support and marital 
adjustment after breast cancer. J. Psychosoc. Oncol. 5,47-74. 
Lillberg, K. (2003). Stressful life events and risk of breast cancer in 10,808 
women:A cohort study. Am J Epidemiol. 157,415^23. 
Lin, K., Shen, Z.Y., Lu, S.H., Wu, Y.N. (2002). Intake of volatile N-nitrosamines 
and their ability to exogenously synthesize in the diet of inhabitants from high-risk 
area of esophageal cancer in southern China. Biomed. Environ. Sci. 15, 277-282. 
Liochev, S. I., Fridovich, I. (1994). The role of O2 in the production of HO: In vitro 
and in vivo. Free Radic. Biol. Med., 16,29-33. 
163 
(BiBGoffrapliy 
Liu, H., Wang, Z. (2005). Effects of social isolation stress on immune response and 
survival time of mouse with liver cancer. World J Gastroenterol 11, 5902-4. 
Liu, J., Mori, A. (1999). Stress, aging and brain oxidative damage. Neurochem. Res. 
24, 1479-1497. 
Liu, J., Wang, X., Mori, A. (1994). Immobilization stress induced antioxidant 
defence changes in rat plasma: effect of treatment with reduced glutathione, 
International Journal of Biochemistry. 26, 511-517. 
Liu, J., Wang, X., Shigenega, M.K., Yeo, H.C., Mori, A., Ames, B.N. (1996). 
Immobilization stress causes oxidative damage to lipid, protein and DNA in the 
brain of rats, FASEB Journal. 10, 1532-1538. 
Liu, J.K., Wang, X.Y., Shigenaga, M.K., Yeo, H.C., Mori, A. (1996). 
Immobilization stress causes oxidative damage to lipid, protein, and DNA in the 
brain of rats. FASEB J 10,1532-8. 
Locke, S.E. (1982). Stress, adaptation and immunity: studies in humans. Gen. Hosp. 
Psychiatry. 4, 49-58. 
Loeppky, R.N. (1999). The mechanism of bioactivation ofN-nitrosodiethanolamine. 
Drug Meta. Rev. 31, 175-193. 
Loft, S., Poulsen, H.E. (1996) Cancer risk and oxidative DNA damage in man. J. 
Mol. Med. 74,297-312. 
Loft, S., Poulsen, H.E., Vistisen, K., Knudsen, L.E. (1999). Increased urinary 
excretion of 8oxo-2'-deoxyguanosine, a biomarker of oxidative DNA damage, in 
urban bus drivers. Mut. Res. 441, 11-19. 
Loo, T. L., Hall, S.W., Salem, P., Benjamin, R.S, Lu., K. (1978). Clinical 
pharmacological and toxicological studies of Cis-diamminedichloroplatinum (II) by 
continuous intravenous infusion. Biochimie 60, 957-960. 
Low H (] 974/ Nitroso compounds. Arch. Environ. Health 29, 256. 
Lowry, O.H., Rosebrough, N.J., Parr, A.L., Randall, R.J. (1951). Protein 
measurement with the folin phenol reagent. J. Biol. Chem. 193, 265-275. 
Lu, X.Y., Kim, C.S., Frazer, A., Zhang W., (2006). Leptin: a potential novel 
antidepressant. Proc. Natl. Acad. Sci. USA .103, 1593-1598. 
Luch, A. (2005). Nature and nurture - lessons from chemical carcinogenesis. Nat 
Rev Cancer. 5, 113-125. 
Ludek, B., Jiri, D., Miroslav, N. (1998). QSAR for acute toxicity of saturated and 
unsaturated halogenated aliphatic compounds. Chemosphere, 36, 1345-1365. 
Lugli, E., Ferraresi, R., Roat, E., Troiano, L., Pinti, M., Nasi, M., (2009). Quercetin 
inhibits lymphocyte activation and proliferation without inducing apoptosis in 
peripheral mononuclear cells. Leuk Res 33,140-50. 
Lugli, E., Troiano, L., Ferraresi, R., Roat, E., Prada, N., Nasi, M., Pinti, M., Cooper, 
E.L., Cossarizza, A. (2005). Chariacterization of cells with different mitochondrial 
membrane potential during apoptosis. Cytometry A, 68, 28-35. 
164 
(BiSBograpfiy 
Lunec, J., Holloway, K.A., Cooke, M.S., Faux, S., Griffiths, H.R., Evans M.D. 
(2002) Urinary 8-oxo-2'-deoxyguanosine: redox regulation of DNA repair in vivo. 
Free Radio. Biol. Med. 33, 875-85. 
Lutz, W. (1984). Microsomal cytochrome P-4501iver cells and industrial and 
environmental xenobiotics. Post.Hig. Med. Dosw. 38, 451 -80. 
Lutz, W.K. (2002). Differences in individual susceptibility to toxic effects of 
chemicals determine the dose-response relationship and consequences of setting 
exposure standards.Toxicol Lett. 126, 155-158. 
Ma, H., Nguyen, C, Lee, K.S., Kahn, M. (2005). Differential roles for the 
coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression. 
Oncogene. 24, 36\9-3631. 
Maclean, G.D., Longenecker, B.M. (1994). New possibilities for cancer therapy 
with advances in cancer immunology. Can. J. Onco. 4, 249-254. 
Makita, H., Tanaka, T., Fijitsuka, H., Tatematsu, N., Satoh, K.A., Mori, H. (1996). 
Chemoprevention of 4-nitroquinoline-l-oxide induced rat oral carcinogenesis by the 
dietary flavonoids chalone, 2-hydroxychalone and quercetin. Cancer Res. 56, 4904-
4909. 
Mann, P.J.G. (1932). The reduction of glutathione by a liver system. Biochem. J. 26, 
785-790. 
Manson, M.M., Benford, D.J. (1999). Factors influencing the carcinogenicity of 
food chemicals. Toxicology, 134, 93-108. 
Marcus, C.J., Habig, W.H., Jakoby, W.B. (1978). Glutathione transferase from 
human erythrocytes. Non-identity with the enzymes from liver Arch. Biochem. 
Biophys. 188,287-93. 
Marklund, S., Marklund, G. (1974). Involvement of superoxide anion radical in the 
autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. 
Biochem. 47,469-474. 
Marklund, S.L. (1984). Extracellular superoxide dismutase in human tissues and 
human cell lines. J. Clin. Invest. 74, 1398-1403. 
Marklund, S.L., Holme, E., Hellner, L. (1982). Superoxide dismutase in 
extracellular fluids. Clin. Chim. Acta. 126,41-51. 
Marks, R. (1999). Photoprotection and prevention of melanoma. Eur. J. Dermatol.. 
9,406-12. 
Mamett, L. J. (1999). Lipid peroxidation—DNA damage by malondialdehyde. Mut. 
Res-Fund. Mol. Mech Mutagen. 424, 83-95. 
Mamett, L. J. (2000). Oxyradicals and DNA damage. Carcinogenesis, 21, 361-370. 
Martinez, G.R., Almeida, E.A., Klitzke, C.F., Onuki, J., Prado, F.M., Medeiros, 
M.H., Mascio, D.P. (2005). Measurement of melatonin and its metabolites: 
importance for the evaluation of their biological roles. Endocrinology. 27, 111-118. 
165 
<3i6Bograpky 
Masella, R., Di Benedetto, R., Vari, R., Filesi, C, Giovannini, C. (2005). Novel 
mechanisms of natural antioxidant compounds in biological systems: Involvement 
of glutathione and glutathionerelated enzymes. J. Nutr. Biochem. 16, 577-586. 
Masuda, H., Tanaka, T., Takahama, U. (1994). Cisplatin generates superoxide anion 
by interaction with DNA in a cell-free system. Biochem Biophys Res Commun. 203, 
1175-80. 
Matsukawa, Y., Nishino, H., Okuyama, Y., Matsui, T., Matsumoto, T., Matsumura, 
S., Shimizu, Y., Sowa, Y., Sakai, T. (1997). Effects of quercetin and/or restraint 
stress on formation of aberrant crypt foci induced by azoxymethane in rat colons. 
Oncology, 54, 118-121. 
Matsumoto, K., Yobimoto, K., Huong, N.T.T., Abdel-Fattah, M., Van Hien, T., 
Watanbe, H. (1999). Psychological stress induced enhancement of brain lipid 
peroxidation via nitric oxide systems and its modulation by anxiolytic and 
anxiogenic drugs in mice. Brain. Res. 839, 74-84. 
McCord, J.M., Fridovich, 1. (1969). Superoxide dismutase. An enzymatic function 
for eryhtrocuprein (hemocuprein). J. biol. Chem. 244,6049-6055. 
McCord, J.M., Keele, B.B., Fridovich, I. (1971). An enzyme based theory of 
obligate anaerobiosis: the physiological function of superoxide dismutase. Proc. 
Natl. Acad. Sci.U.S.A. 68, 1024-1027. 
Mehta, R. (1995). The potential for the use of cell proliferation and oncogene 
expression as intermediate markers during liver carcinogenesis. Cancer Lett. 93, 85-
102. 
Meister, A., Anderson, M.E. (1983). Glutathione. Annu. Rev. Biochem. 52, 711-60. 
Melanie, F., Kenneth, M,. Frank, J., Thomas, C, Mai, Sun., Andrew, B. (2010). 
Psychological Stress Accelerates the Onset of Tumour Formation and Alters the 
Type and Location of Tumours in a DMBA Mouse Carcinogenesis Model. Stress 
and Health, John Wiley & Sons, Ltd. 
Metodiewa, D., Jaiswal, A.K., Cenas, N., Dickancaite, E., Segura-Aguilar, J. (1999). 
Quercetin may act as a cytotoxic prooxidant after its metabolic activation to 
semiquinone and quinoidal product. Free Radic Biol Med. 26, 107-16. 
Michejda, C.J., Kroeger-Koepke, M.B., Koepke, S.R. (1982). Nitrogen formation 
during in vivo and in vitro metabolism of N-nitrosamines. In: Nitrosamines and 
Human Cancer Banbury Report 12, Magee, P. N. (ed.) Cold Spring Harbor 
Laboratory, Cold Spring, pp. 69-81. 
Miller, D.M., Buettner, G.R., Aust, S.D. (1990). Transition metals as catalysts of 
"auto oxidation" reaction. Free Radic. Biol. Med. 8, 95-108. 
Mills, E.E. (1988). The modifying effect of betacarotene on radiation and 
chemotherapy induced oral mucositis. Br J Cancer 57, 416^17. 
Minamoto, T., Mai, M., Ronai, Z. (2000). K-rasmutation;early detection inmolecular 
diagnosis and ri.sk assessment of colorectal, pancreas, and lung cancers-a review. 
CancerDetect Prev. 24, 1-12. 
166 
(BiSBo^raplry 
Mittal, A., Pathania, V., Agarwala, P.K., Prasad, J., Singh, S., Goel, H.C. (2002). 
Influence of Podophyllum hexandrum on endogenous antioxidant defense system in 
mice: possible role in radioprotection. J Ethnopharmacol 76, 253-262. 
Moller, P., Wallin, H. (1998). Adduct formation, mutagenesis and nucleotide 
excision repair of DNA damage produced by reactive oxygen species and lipid 
peroxidation product. Mutat Res. 410,271-90. 
Moriya, M. (1993). Single-stranded shuttle phagemid for mutagenesis studies 
inmammalian cells: 8-oxoguanine in DNA induces targeted G:C /T:A transversions 
in simian kidney cells. Proc. Natl. Acad. Sci. USA 90, 1122-1126. 
Mukai, F.H., Goldstein, B.D. (1976). Mutagenicity of malondialdehyde, a 
decomposition product of peroxidized polyunsaturated fatty acids. Science 191, 868-
886. 
Muqbil, 1., Asfar, S.A., Naheed, B. (2006). Prior exposure to restraint stress 
enhances7,12- dimethylbenz(a)anthracene (DMBA) induced DNA damage in rats. 
FEBS Letters 580, 3995-3999. 
Muqbil, I., Naheed, B., (2006). Enhancement of pro oxidant effect of 
Dimethylbenz(a)anthracene (DMBA) in rats by pre exposure to restraint stress. 
Cancer Letters. 240, 213-220. 
Musarrat, J., Wani, A. A. (1994) Carcinogenesis 15, 2037-2043. 
Musatov, S.A., Anisimov, V.N., Andre, V. (1998). Modulatory effects of melatonin 
on genotoxic response of reference mutagens in the Ames test and the comet assay, 
Mutat. Res. 417, 75-84. 
Mussarat, J., Arezine-Wilson., Wani, A.A., (1996). Prognostic and aetiological 
relevance of 8-hydroxy guanosine in human breast carcinogenesis. Eur. J. Cancer 
32,1209-1214. 
Muzio, G., Marengo, B., Salvo, R. (1999). Liver cancer is induced by a 
subnecrogenic dose of NDEA when associated with fasting/refeeding: role of 
glutathione-transferase and lipid peroxidation. Free Radic.Biol. Med. 26 ,1314-
1320. 
Nagao, M., Ochiai, M., Ushijama, T., Watanebe, M., Sugimura, T., Nakagama, H. 
(1998). Mut. Res. 402, 85. 
Nagulendran, K., Velavan, S., Mahesh, R., Begum, V.H., (2007) In vitro 
antioxidant activity and total polyphenolic content of Cyperus rotundus rhizomes, E-
Joumal of Chemistry 4,440-449. 
Nair, V., Turner, G.A., OfFerman, R.J. (1984). Novel adducts from the modification 
of nucleic acid bases by malondialdehyde. J. Am. Chem. Soc. 106, 3370-3371. 
Nayanatara, A.K., Nagaraja, H.S., Ramaswamy, C, Bhagyalaxmi, K., Ramesh, 
B.M., Damodara Gowda, K. M., Venkappa, S. M. (2009). Effect of 
chronic unpredictable stressors on some selected lipid parameters and Bio 
chemical parameters in wistal Rats. Journal of Chinese clinical medicine 4, 92-97. 
167 
(BiBGograpfiy 
Nelson, R.L. (1992).Dietary iron and colorectal cancer risk. Free Radic Biol Med. 
12,161-168. 
Newman, D.J., Cragg, G.M., Snader, K.M., (2003). Natural products as sources of 
new drugs over the period 1981-2002. Journal of Natural Products, 66, 1022-1037. 
Nikonorow, M., Urbanek-Karlowska, B. (1987) Nitrosamines. in Toxicology foods; 
PZWL: Warsaw, pp 270-281. 
Nohl, H., Kozlov, A.V., Gille, L., Staniek, K. (2003). Cell respiration and formation 
of reactive oxygen species: facts and artifacts. Biochem. Soc Trans. 31,1308-1311. 
Oberley, L. W., Oberley, T. D. (1986). Free radicals, cancer and ageing. In: Johnson, 
J. E., J.r; Walford, R., Harman, D., Miquel. J., eds. Free radicals, ageing and 
degenerative diseases. New York: Alan R Liss, Inc. 325-371. 
Oberley, L.W., Buettner, G.R. (1979). Role of superoxide dismutase in cancer: a 
review. Cancer Res. 39, 1141-1149. 
O'Brien, P.J. (1969). Intramolecular mechanisms for the decomposition of a lipid 
peroxide. I. Decomposition of lipid peroxide by metal ions, heme compounds, and 
nucleophiles. Can J Biochem 47,485-492. 
Ohshima, H., Tatemichi, M., Sawa, T. (2003). Chemical basis of inflammation-
induced carcinogenesis. Arch Biochem Biophys. 417, 3-11. 
Ohshima, H., Tazawa, H., Sylla, B.S., Sawa, T. (2005).Prevention of human cancer 
by modulation of chronic inflammatory processes. Mutat Res. 591, 110-122. 
Oishi, K., Machida, K. (2002). Different effects of immobilization stress on the 
mRNA expression of antioxidant enzymes in rat peripheral organs. Scand. J. Clin. 
Lab. Invest. 62, 115-21. 
Olinski, R., Jaruga, P., Zastawny, T.H. (1998). Oxidative DNA base modifications 
as factors in carcinogenesis. Acta. Biochim. Pol. 45, 561-72. 
Olivenza, R., Morro, M.A., Lizasoain, I., Lorenzo, P., Fernandez, A.P., Bosca, L., 
Leza, J.C. (2000). Chronic stress induces the expression of inducible nitric oxide 
synthase in rat brain cortex. Journal of Neurochemistry. 74, 745-791. 
Osterdahl, B.C. (1990). The migration of tobacco-specific nitro samines into the 
saliva of chewers of nicotine-containing chewing gum. Food Chem. Toxicol, 28, 
619-22. 
Pablos, M.I., Reiter, R.J., Ortiz, G.G., Guerrero, J.M., Agapito, M.T., Chuang, J.I., 
Sewerynek, E. (1998). Rhythms of glutathione peroxidase and glutathione reductase 
in brain of chick and their inhibition by light, Neurochem. Int. 32, 69-75. 
Pace, A., Savarese, A., Picardo, M. (2003). Neuroprotective effect of vitamin E 
supplementation in patients treated with cisplatin chemotherapy. J Clin Oncol. 21, 
927-931. 
Pandi-Perumal, S.R., Srinivasan, V., Maestroni, G.J.M. (2006). Melatonin: natures 
most versatile biological signal? FEBS J 273, 2813-2838. 
168 
(BiSGogri^lry 
Pankaj, C , Sandeep, K.S., Rakesh, K.S. (2009). REC-2006-A Fractionated Extract 
of Podophyllum hexandrum Protects Cellular DNA from Radiation-induced Damage 
by Reducing the Initial Damage and Enhancing Its Repair in vivo. Evid Based 
Complement Alternat Med. [Epub ahead of print]. 
Parke, D.V. (1990). loannides C. Role of cytochrome P-450 in mouse liver tumor 
production. Prog Clin Biol Res. 331,215-230. 
Pastor, N., Weinstein, H., Jamison, E., & Brenowitz, M. (2000). A detailed 
interpretation of "OH radical footprints in a TBP DNA complex reveals the role of 
dynamics in the mechanism of sequence specific binding. J. Mol. Biol. 304, 55-68. 
Pastor, N., Weinstein, H., Jamison, E., Brenowitz, M. (2000). A detailed 
interpretation of 'OH radical footprints in a TBP DNA complex reveals the role of 
dynamics in the mechanism of sequencespecific binding. J. Mol. Biol. 304, 55-68. 
Pastore, A., Federici, G., Bertini, E., Piemonte, F. (2003). Analysis of glutathione: 
Implication in redox and detoxification. Clin. Chim. Acta. 333, 19-39. 
Perchellet, J.P., and Perchellet, M. (1989) Antioxidant and multistage carcinogenesis 
in mouse skin. Free Rad. Biol. Med. 7,377-408. 
Percy, M.E. (1984). Catalase: an old enzyme with a new role? A review. Can. J. 
Biochem. Cell Biol. 62,1006-1014. 
Perissin, L., Zorzet, S., Piccini, P., Rapozzi, V. Giraldi, T. (1991). Effects of 
rotational stress on the effectiveness of cyclophosphamide and razoxane in mice 
bearing Lewis lung carcinoma. Clin. Exp. Metas. 9, 541-549. 
Pevet, P., Bothorel, B., Slotten, H., Saboureau, M. (2002). The chronobiotic 
properties of melatonin, Cell Tissue Res. 309, 183-191. 
Pieri, C, Marra, M., Moroni, F., Decchioni, R., Marcheselli, F. (1994). Melatonin: a 
peroxyl radical scavenger more effective than vitamin E, Life Sci. 55, 271-276. 
Pierrefiche, G., Laborit, H. (1995). Oxygen free radicals, melatonin, and aging, Exp. 
Gerontol. 30, 213-227. 
Pitot, H.C. (2001). Animal models of neoplastic development. Dev Biol. 106, 53-
57. 
Pitot, H.C, Dragan, Y.P. (1991). Facts and theories concerning the mechanisms of 
carcinogenesis. FASEB J. 5, 2280-2286. 
Pitot, H.C, Goldsworthy, T., Moran, S. (1981). The natural history of 
carcinogenesis: implications of experimental carcinogenesis in the genesis of human 
cancer. J. Supramol Struct. Cell. Biochem. 17,133-146. 
Plumb, M.A., Smith, G.CM., Cunniffe, S.M.T., Jackson, S.P., O'Neill, P. (1999). 
DNA-PK activation by ionizing radiation-induced DNA single-strand breaks. Int. J. 
Radiat. Biol. 75,553-61. 
Pool-Zobel, B.L., Guigas, C, Klein, R., Neudecker, C, Renner, H.W., Schmezer, P. 
(1993). Assessment of genotoxic effect by lindane. Food. Chem. Toxicol. 31:271-
283. 
169 
(BiSCiograplry 
Poulsen, H.E., Prieme, H., Loft, S. (1998). Role of oxidative DNA damage in cancer 
initiation and promotion. Eur. J. Cancer. Prev. 7, 9-16. 
Pradeep, K., Mohan, C.V., Gobianand, K., Karthikeyan, S. (2007). Silymarin 
modulates the oxidant-antioxidant imbalance during diethylnitrosamine induced 
oxidative stress in rats. Eur. J. Pharmacol. 560, 110-116. 
Pradhan, S.N., Prabhati, R., 1974. Effects of stress on growth of transplanted and 7, 
12-dimethlybenz(a)anthracene-induced tumors and their modification by 
psychotropic drugs. J. Natl Inst. 53, 1241-1245. 
Prem, K.I., Goel, H.C., (2000). Iron chelation and related properties of 
P.hexandrum, a possible role in radioprotection. Ind J Expt Biol 39, 1002-1006. 
Prochaska, H.J., Santamaria, A. B., Talalay, P. (1992). Rapid detection of inducers 
of enzymes that protect against carcinogens. Proc. Natl. Acad. Sci. USA. 89, 2394-
2398. 
Przezdziecki, Z. (1980). Biological transformation of toxic substances; PWN: 
Warsaw, PP 53-64, 140-146. 
Qi, W., Reiter, R.J., Tan, D.X., Manchester, L.C., Siu, A.W., Garcia, J.J. (2001). 
Increased level of oxidatively damaged DNA induced by chromium (111) and H2O2: 
protection by melatonin and related molecules, J. Pineal Res. 29, 54-61. 
Quinlan, G.J., Gutteridge, J.M.C. (1987). Oxygen radical damage to DNA by 
rifamycin SV and copper ions. Biochem. Pharmacol. 36, 3629-33. 
Raber-Durlacher, J.E., WeijI, N.I., Abu, S.M, De Koning, B., Zvvinderman, A.H., 
Osanto, S. (2000). Oral mucositis in patients treated with chemotherapy for solid 
tumours: a retrospective analysis of 150 cases. Support Care Cancer 8, 366-371. 
Radi, R. (1998). Peroxynitrite reactions and diffusion in biology. Chem. Res. 
Toxicol. 11, 720-21. 
Ramakrishnan, G., Raghavendran. H.R., Vinodhkumar, R., Devaki, T. (2006). 
Suppression of N-nitrosodiethylamine induced hepatocarcinogenesis by silymarin in 
rats. Chem. Biol. Interact. 161, 104-114. 
Ramchoun, M., Harnafi, H., Alem, C , Benlys, M., Elrhaffari, L., Amrani, S. (2009). 
Study on antioxidant and hypolipidemic effects of polyphenol rich extract from 
Thymus vulgaris and Lavendula multifida. Pharmacognosy Research, 1 , 106-112. 
Ramchoun, M., Harnafi, H., Alem, C , Benlys, M., Elrhaffari, L., Amrani, S. (2009). 
Study on antioxidant and hypolipidemic effects of polyphenol rich extract from 
Thymus vulgaris and Lavendula multifida. Pharmacognosy Research 1,106-112. 
Rashid, R., Langfinger, D., Wagner, R., Schuchmann, H.P., Von Sonntag, C. (1999). 
Int. J.Radiat. Biol. 75, 101. 
Ratnam, D.V., Ankola, D.D., Bhardwaj, V. Sahana, D.K., Kumar, M.N., (2006). 
Role of antioxidants in prophylaxis and therapy: a pharmaceutical perspective. J 
Control Release, 20, ! 89-207. 
170 
<3WBograpfiy 
Ravi, R., Somani, S.M., Rybak, L.P. (1995). Mechanisms of cisplatin ototoxicity: 
antioxidant system. Pharmacol. Toxicol. 76, 386-394. 
Ray, P., Pradhan, S.N. (1979). Growth of transplanted and induced tumors in rats 
under a schedule of punished behavior. J. Catl. Cancer Inst. 52, 575-577. 
Reddy, A.L., Fialkow, P.J. (1983). Papillomas induced by initiation-promotion 
differ from those induced by carcinogen alone. Nature. 304, 69-71. 
Reedijk, J. (1999). Why does Cisplatin reach Guanine-n7 with competing s-donor 
ligands available in the cell? Chem Rev. 99,2499-510. 
Reiche, E.M., Nunes, S.O., Morimoto, H.K. (2004). Stress, depression, the immune 
system, and cancer. Lancet Oncol. 5,617-625. 
Reid, T.M., Loeb, L.A., (1993). Effect of DNA-repair enzymes on mutagenesis by 
oxygen free radicals. Mutat. Res. 289, 181-6. 
Reiter, R.J., Tan, D.X., Terron, M.P., Flores, L.J., Czarnocki, Z. (2007). Melatonin 
and its metabolites: new findings regarding their production and their radical 
scavenging actions. Acta Biochim Pol 54, 1-9. 
Reiter, R.J. (1995). The pineal gland and melatonin relation to aging: a summary of 
the theories and of the data. Exp. Gerontol. 30, 199-212. 
Reiter, R.J., Tan, D.X., Manchester, L.C., Qi, W. (2001). Biochemical reactivity of 
melatonin with reactive oxygen and nitrogen species: a review of the evidence. Ceil 
Biochem. Biophys. 34,237-256. 
Retel, J., Hoebee, B., Braun, J.E., Lutgerink, J.T., van den Akker, E., Wanamarta, 
A.H., Joenje, H., Lafleur, M.V. (1993). Mutational specificity of oxidative DNA 
damage. Mutat Res. 299, 165-82. 
Rice-Evans, C, Burdon, R. (1993). Free radical-lipid interactions and their 
pathological consequences. Prog. Lipid Res. 32, 71-110. 
Riggins, J.N., Mamett, L.J. (2001). Mutagencity of the malondialdehyde 
oligomerization products 2-(3'oxo-r-propenyl)-malondialdehyde and 2,4-
dihydroxymethylene-3(2,2-dimethoxyethyl)-glutaraldehyde in Salmonella. Mutat. 
Res. 497, 153-157. 
Riley, V. (1981). Psychoneuroendocrine influences on immunocompetence and 
neoplasia. Science, 212, 1100-1109. 
Riou, C, Tonoli, H., Bemier-Valentin, F., Rabilloud, R., Fonlupt, P., Rousset, B. 
(1999). Susceptibility of differentiated thyrocytes in primar>' culture to undergo 
apoptosis after exposure to hydrogen peroxide: relation with the level of expression 
of apoptosis regulatory proteins, Bcl-2 and Bax. Endocrinology, 140, 1990-1997. 
Robak, J., Gryglewski, R.J., (1988). Flavonoids are scavengers of su-peroxide 
anions. Biochem Pharmacol 37, 837-841. 
Robinson, J.D., Robinson, L.J., Martin, N.J.(1984). Effects of oligo-mycin and 
quercetin on the hydrolytic activities of the (Na+ +K+)-dependent ATPase. Biochim 
Biophys Acta 772,295-306. 
171 
(BiSBograplry 
Roghani M, Da Silva C, Guvelli D, Castagna M. (1987). Benzene and toluene 
activate protein ... Biochem Biophys Res Commun. 142, 738-44. 
Rosenberg, B., Vancamp, L., Krigas, T. (1965). Inhibition of cell division in 
Escherichia coli by electrolysis products from a platinum electrode. Nature. 205, 
698-9. 
Routledge, M.N., Wink, D.A., Keefer, L.K., Dipple, A. (1994). DNA sequence 
changes induced by two nitric oxide donor drugs in the supF assay. Chem. Res. 
Toxicol, 7,628-632. 
Ryu, D.Y., Pratt, V.S.W., Davis, CD., Schut, H.A.J., Snyderwine, E.G. (1999). 
Cancer Res. 59,2587. 
Saad, S.Y., Najjar, T.A., Alashari, M. (2004). Role of nonselective adenosine 
receptor blockade and phosphodiesterase inhibition in cisplatin-induced 
nephrogonadal toxicity in rats.Clin. Exp. Pharmacol Physiol. 31, 862-867. 
Sadik, A.H.N., EL-Maraghy, S.A., Ismail, M.F. (2008). Diethylnitrosamine-induced 
hepatocarcinogenesis in rats: possible chemoprevention by blueberries. African 
Journal of Biochemistry Research. 2, 081-087. 
Saenger, W. (1984). Physical properties of nucleotides: charge densities, pK values, 
spectra and tautomerism. In: Principles of Nucleic Acid Structure, Ch. 5. p. 106, 
Cantor, C. R. (ed.) Springer-Verlag, New York. 
Sahin, E., Gumuslu, S. (2004). Alterations in brain antioxidant status, protein 
oxidation and lipid peroxidation in response to different stress models. Behav. Brain. 
Res. 155; 241-8. 
Sahin, E., Gumuslu, S., Ozturk, O., Abidin. 1., Yargicoglu, P., Agar, A. (2004). 
Marked changes in erythrocyte antioxidants and lipid peroxidation levels of rats 
exposed to acute, repeated and chronic restraint stress. Pharmazie. 59, 961-4. 
Sahnoun, Z., Jamoussi, K., Zeghal, K.M. (1997). Free radicals and antioxidants: 
human physiology, pathology and therapeutic aspects. Therapie. 52, 251 -270. 
Saija, A., Scalese, M., Lanza, M., Marzullo, D., Bonina, F., Castelli, F. (1995). 
Flavonoids as antioxidant agents: importance of their interaction with 
biomembranes. Free Radic. Biol. Med. 19, 481-486 
Sanchez-Barcelo, E.J., Cos, S., Fernandez, R., Mediavilla, M.D. (2003). Melatonin 
and mammary cancer: a short review, Endocr. Relat. Cancer 10, 153-159. 
Sandstrom, P.A., Mannie, M.D., Buttke, T.M. (1994). Inhibition of activation-
induced death in T cell hybridomas by thiol antioxidants: oxidative stress as a 
mediator of apoptosis. J. Leukoc. Biol. 55, 221-2. 
Sangeetha, P., Das, U.N., Koratkar, R., Suryaprabha, P. (1990). Increase in free 
radical generation and lipid peroxidation following chemotherapy in patients with 
cancer. Free Radic Biol Med. 8, 15-19. 
Santanna, I.D., de Sousa, E.B., de Moraes, A.V., Loures, D.L., Mesquita, E.T., da 
Nobrega, A.C. (2003). Cardiac function during mental stress: cholinergic 
modulation with pyridostigmine in healthy subjects. Clin Sci (Lond) 105, 161-5. 
172 
<Bi6(io£rapfry 
Sarasin, A. (1999). The molecular pathways of ultraviolet-induced carcinogenesis. 
Mut. Res. 428,5-10. 
Sardas, S. (2003). The role of antioxidants in cancer prevention and treatment. 
Indoor Built Env. 12,401-404. 
Sasaki, Y.F., Fujikawa, K., Ishida, K., Kawamura, N., Nishikawa, Y.. Ohta, S., 
Satoh, M., Madarame, H., Ueno, S., Susa, N. Jr., Matsusaka, N., Tsuda, S. (1999). 
The alkaline single cell gel electrophoresis assay with mouse multiple organs: 
results with 30 aromatic amines evaluated by the lARC and U.S. NTP. Mut. Res. 
440,1-18. 
Scandalios, J.G. (2002). The rise of ROS. TIBS. 27,483-486. 
Schafer, F.Q., Buettner, G.R. (2001). Redox environment of the cell as viewed 
through the redox state of the glutathione disulfide/glutathione couple. Free Rad. 
Biol. Med. 30, 1191-212. 
Schoket, B. (1999). DNA damage in humans exposed to environmental and dietary 
polycyclic aromatic hydrocarbons. Mut. Res. 424, 143-153. 
Scholz,W., Schutze, K., Kunz,W., Schwarz,M. (1990). Phenobarbitai enhances the 
formation of reactive oxygen in neoplastic rat liver nodules. Cancer Res. 50, 7015-
7022. 
Schreck. R., Albermann. K.I.J., Bauerle. P.A. (1992). Nuclear factor kB: an 
oxidative stressresponsive transcription factor of eukaryotic cells (a review). Free 
Radic Res Commun, 17, 221-237. 
Schut, H.A. Snyderwine, E.G. (1999). DNA adducts of heterocyclic amine food 
mutagens: implications for mutagenesis and carcinogenesis. Carcinogenesis. 20. 
353-368. 
Seifried, H.E., McDonald, S.S., Anderson, D.E., Greenwald, P., Milner, J.A., The 
antioxidant conundrum in cancer. Cancer Res, 63, 4295-4298. 
Seifter, E., Rettura, G., Padawer, J., Stratford, F., Weinzweig, J., Demetriou, A.A., 
Levenson, S.M. J. (1984). Natl. Cane. Inst., 73, 1167. 
Sen, N.P., Seaman,s., McPherson, M. (1980). Further studies on the occurrence of 
volatile and non-volatile nitrosamines in foods. lARC Sci. Publ. 31, 457-463. 
Seto, H., Akiyama, K., Okuda, T., Hashimoto, T., Takesue, T., ikemura, T. (1981). 
Structure of a new modified nucleoside formed by guanosine-malonaldehyde 
reaction. Chem. Lett. 707-708. 
Shacter, E., Williams, J.A., Hinson, R.M., Senturker, S., Lee Y-J. (2000). Oxidative 
stress interferes with cancer chemotherapy: inhibition of lymphoma cell apoptosis 
and phagocytosis. Blood. 96,307-313. 
Shan, B.E., Wang, M.X., Li, R.Q. (2009). Quercetin inhibit human SW480 colon 
cancer growth in association with inhibition of cyclin Dl and survivin expression 
through Wnt/beta-catenin signaling pathway. Cancer Invest. 27, 604-612. 
173 
(BiBGograpfiy 
Shapiro, R., Ellis, S., Hingerty, B.E., Broyde, S. (1998). Effect of Ring Size on 
Conformations of Aromatic Amine-DNA Adducts: The Aniline-C8 Guanine Adduct 
Resides in the B-DNA Major Groove, Chem. Res. Toxicol. 11, 335-341. 
Sharma, S., Stutzman, J.D., Kelloff, G.J., Steele, V.E., (1994). Screening of 
potential chemopreventive agents using biochemical markers of carcinogenesis. 
Cancer Res 54: 5848-585. 
Shibutani, S., Takeshita, M., Grollman, A.P. (1991). Insertion of specific bases 
during DNA synthesis past the oxidation-damaged base 8-oxo-dG. Nature 349, 431-
34. 
Shimada, T., Hayes, C.L., Yamazaki, H., Amin, S., Hecht, S.S., Guengerich, F.P., 
Sutter, T.R. (1996). Activation of chemically diverse procarcinogens by human 
cytochrome P450 IBl. Cancer Res. 56,2979-2984. 
Shimada, T., Kuriyama, Y.F. (2004). Metabolic activation of poiycyclic aromatic 
hydrocarbons to carcinogens by cytochromes P 450 1 Al and 1B1. Cancer Sci. 95, i -
6. 
Showkat, A.G., Ehtishamul, H., Akbar, M., Mohmmad, A.Z. (2010). Amelioration 
of carbon tetrachloride induced oxidative stress in kidney and lung tissues by 
ethanolic rhizome extract of Podophyllum hexandrum in Wistar rats. Journal of 
Medicinal Plants Research 4, 1673-1677. 
Showkat, A.G., Mohmmad, A.Z., Akbar, M., Ehtishamul, H. (2010). In vitro and in 
vivo evaluation of free radical scavenging potential of ethanolic extract of 
Podophyllum hexandrum. African Journal of Biochemistry Research. 4, 196-203. 
Shubik, P. (1950). The growth potentialities of induced skin tumors in mice. The 
effects of different methods of chemical carcinogenesis. Cancer Res. 10, 713-717. 
Sieber, W.J., Rodin. J., Larson. L., Ortega, S., Cammings, N., Levy, S. (1992). 
Modulation of human natural killer cell activity by exposure to uncontrollable stress. 
Brain Behav Immun 6,141-56. 
Sieja, K., (2000). Protective role of selenium against the toxicity of multi-drug 
chemotherapy in patients with ovarian cancer. Pharmazie, 55, 958-959. 
Sies H. (1991). Oxidative stress: introduction. In: Oxidative StressiOxidants and 
Antioxidants (Sies H, ed). San Diego, CA:Academic Press, pp 15-22. 
Sies, H. (1985). Oxidative stress: introductory remarks. In Oxidative Stress, ed. H 
Sies. Academic Inc. 
Simandan, T., Sun, J., Dix, T.A. (1998). Oxidation of DNA bases, 
deoxyribonucleosides and homopolymers by peroxyl radicals. Biochem. J. 335, 233. 
Singer, B., Grunberger, D. (1983. Alkylation of nucleic acids in duo. In: Molecular 
Biology of Mutagens and Carcinogens, pp.68-78, Singer, B. and Grunberger, D. 
(eds.) Plenum Press, New York. 
Singh, N.P., McCoy, M.T., Tice, R.R., Schneider, E.L. (1988). A simple technique 
for quantitation of low levels of DNA damage in individual cells. Exp. Cell. Res. 
175, 184-191. 
174 
(BiBBograpf^ 
Singh, T.N., Turro, C. (2004). Photoinitiated DNA Binding by cis 
[Ru(bpy)2(NH3)2] 2+. Inorg. Chem., 43, 7260-7262. 
Siclar, L.S., Anisman, H. (1979). Stress and coping factors influence tumor growth. 
Science. 205, 513-51. 
Sklar, L.S., Anisman, H. (1980). Social stress influences tumor growth. Psychosom. 
Med. 42, 347-365. 
Sklar, L.S., Anisman, H. (1981). Stress and cancer. Psychol. Bull. 89, 369-406 
Skog, K.I., Johansson, M.A., Jagerstad, M.I. (1998). Carcinogenic heterocyclic 
amines in model systems and cooked foods: a review on formation, occurrence and 
intake. Food Chem. Toxicol. 36, 879-896. 
Slaga, T.J. (1984). Mechanism involved in two stage carcinogenesis in mouse skin. 
In: Slaga TJ, ed. Mechanism of tumor promotion. Vol. 2: Tumor Promotion and 
Skin Carcinogenesis. Boca Raton, FL, pp. 1-16. 
Slater Slater, A.F., Stefan, C, Nobel, I., van den Dobbelsteen, D.J., Orrenius, S. 
(1995). 
Signalling mechanisms and oxidative stress in apoptosis. Toxicol. Lett. 82-83,149-
53. 
Sonneveld, P. (1978). Effect of alpha-tocopherol on the cardiotoxicity of adriamycin 
in the rat. Cancer Treat Rep. 62, 1033-1036. 
Sonneveld, P., (1978). Effect of alpha-tocopherol on the cardiotoxicity of 
adriamycin in the rat. Cancer Treat Rep, 62, 1033-103. 
Sood, A.K, Armaiz-Pena, G.N., Haider, J., Nick, A.M., Stone, R.L., Hu, W.. Carroll, 
A.R. (2010). Adrenergic modulation of focal adhesion kinase protects human 
ovarian cancer cells from anoikis. J Clin Invest. 120,1515-1523. 
Sosnovski, A.S., Kozlov, A.V. (1992). Increased lipid peroxidation in the rat 
hypothalamus after short-term emotional stress. Bull. Eksp. Boil. Med. 113, 486-
488. 
Sosnovski, A.S., Tsvetkova, M.A., Uzunova, P.I., Glbova, T.D., Peneva, V.I., 
Sokolova, T., Ribarov, S.R., Nikolov, N.A. (1992). Lipid peroxidation in emotional 
stress in rats: correlation with parameters of open field behavior. Bull. Eksp. Boil. 
Med. 113, 19-21. 
Spence, A.M., Berger, M.S., Livingston, R.B., Ali-Osman, F., Griffin, B. (1992). 
Phase II evaluation of high-dose intravenous cisplatin for treatment of adult 
malignant gliomas recurrent after chloroethylnitrosourea failure. J Neurooncol. 12. 
187-91. 
Spink, D.C., Spink, B.C., Cao, J.Q., De Pasquale, J.A., Pentecost, B.T., Fasco, M.J.. 
Li, Y., Sutter, T.R. (1998). Differential expression of CYPIAl and CYPiBl in 
human breast epithelial cells and breast tumor cells. Carcinogenesis. 19, 291-298. 
Spom, M.B. (1976) Approaches to prevention of epithelial cancer during the 
preneoplastic period. Cancer Res. 36, 2689-702. 
175 
(BiSBograpky 
Stahelin H.F., Wartburg A.V. (1991). The chemical and biological route form 
Podophyllatoxin glucoside to etoposide. Cancer Res. 9, 3645-52. 
Steplewski, Z., Vogel, W.H., Ehya, H., poropatich, C, Smith, J.M. (1985). Effects 
of restraint stress on inoculated tumor growth and immune response in rats. Cancer 
Res. 45,5128-5133. 
Steplewski, Z., Vogel, W.H., Ehya, H., poropatich, C, Smith, J.M. (1985). Effects 
of restraint stress on inoculated tumor growth and immune response in rats. Cancer 
Res. 45,5128-5133. 
Stevens, R.G., Nerishi, K.(1992) Iron and oxidative damage in human cancer. In; 
Biological Consequences of Oxidative Stress:Implications for Cardiovascular 
Disease and Carcinogenesis (Spatz L, Bloom AD, eds). New York: Oxford 
University Press, 138-161. 
Stojilkovic, v., Todorovic, A., Kasapovic, J., Pejic, S., Pajovic, S.B. (2005). 
Antioxidant enzyme activity in rat hippocampus after chronic and acute stress 
exposure. Ann. NY Acad. Sci. 1048,373-6. 
Stone, K., Ksebati, M., Mamett, L.J. (1990a). Investigation of the adducts formed by 
reaction of malondialdehyde with adenosine. Chem. Res. Toxicol. 3, 33-38. 
Stone, K., Uzieblo, A., Mamett, L.J. (1990b). Studies of the reaction of 
malondialdehyde with cytosine nucleosides. Chem. Res. Toxicol. 3, 467-472. 
Sugiyama, S., Hayakawa, M., Kato, T., Hanaki, Y., Shimizu, K., Ozawa, T. (1989) 
Adverse effects of anti-tumor drug, cisplatin, on rat kidney mitochondria: 
disturbances in glutathione peroxidase activity. Biochem Biophys Res Commun. 
Mar31;159, 1121-7. 
Suhail. N., Bilal. N., Khan H. Y., Hasan, S., Sharma, S. Khan, F.. Mansoor, T.. 
Banu, N. (2010) Effect of vitamins A and C on antioxidant status of breast-cancer 
patients undergoing chemotherapy. Journal of Clinical Pharmacy and Therapeutics 
(in press). 
Sun, Y. (1990). Free radicals antioxidant enzymes and carcinogenesis. Free Radic. 
Biol. Med. 8, 583-599. 
Szatrowski, T.P., Nathan, C.F. (1991). Production of large amounts of hydrogen 
peroxide by human tumor cells. Cancer Res. 51, 794-8. 
Tan, D., Reiter, R.J., Chen, L.D., (1994). Both physiological and pharmacological 
levels of melatonin reduce DNA adduct formation induced by the carcinogen 
safrole. Carcinogenesis 15,215-218. 
Tan, D.X., Chen, L.D., Poeggeler, B., Manchester, L.C., Reiter, R.J. (1993). 
Melatonin: a potent, endogenous hydroxy! radical scavenger, Endocr. J. 1, 57-60. 
Tan, D.X., Manchester, L.C., Terron, M.P., Flores, L.J., Reiter, R.J., (2007). One 
molecule, many derivatives: a never-ending interaction of melatonin with reactive 
oxygen and nitrogen species? J Pineal Res. 42, 28-42. 
Tan, D.X., Reiter, R.J., Manchester, L.C., Yan, M.T., El-Sawi, M., Sainz, R.M., 
Mayo, i.e., Kohen, R., Allegra, M., Hardeland, R. (2002). Chemical and physical 
176 
properties and potential mechanisms: melatonin as a broad spectrum antioxidant and 
free radical scavenger, Curr. Top. Med. Chem. 2,181-197. 
Taranova, N.P., Nilova, N.S., Polezhaeva, L.N., Shiriaeva, N.V., Kulagin, D.A.. 
Lopatina, N.G. (1994). Lipid peroxidation in the rat brain under neurotization 
conditions. Fiziol. Zh. Im. I.M. Sechenova. 80, 43-49. 
Temoshok, L., Fox, B.H. (1984). Coping styles and other psychological factors 
related to medical status and to prognosis in patients with cutaneous malignant 
melanoma, in: Fox, B.H., Newbery, B.H (eds), Impact of Psychoendocrine Systems 
in Cancer and Immunity, Hogrefe, New York. pp. 258-287. 
Terao, J., Piskula, M., Yao, Q. (1994). Protective effect of epicatechin,epicatechin 
gallate, and quercetin on lipid peroxidation in phospholipid bilayers. Arch. Biochem. 
Biophys. 308, 278-284 
Thirunavukkarasu, C, Sakthisekaran, CD., (2001). Effect of selenium on N-
nitrosodiethylamine-induced multistage hepatocarcinogenesis with reference to lipid 
peroxidation and enzymic antioxidants. Cell Biochem.Funct. 19 , 27-35. 
Till, M., Riebniger, D., Schmitz, H.J., Schrenk, D. (1999). Potency of various 
polycyclic aromatic hydrocarbons as inducers of CYPl Al in rat hepatocyte cultures. 
Chem.Biol. Inter. 117,135-150. 
Tisdale, M. J., Mahmoud, M. B. (1983). Activities of free radical metabolizing 
enzymes in tumours. Br. J. Cancer. 47, 809-812. 
Totsuka, Y., Fukutome, K., Takahashi, M., Takahashi, S., Tada, A., Sugimura, T., 
Wakabayashi, K. (1996). Carcinogenesis. 17, 1029. 
Travis,C.C., McClain,T.W., Birkner,P.D. (1991). Diethylnitrosamine- induced 
hepatocarcinogenesis in rats: a theroretical study. Toxicol. Appl. Pharmacol. 109, 
289-304. 
Tricker, A.R. (1997) N-nitroso compounds and man: sources of exposure, 
endogenous formation and occurrence in body fluids. Eur J Cancer Prev. 6: 226-
268. 
Tricker, A.R., Preussmann. R. (1991). Carcinogenic N-nitrosamines in the diet: 
occurrence, formation, mechanisms and carcinogenic potential. Mutat Res. 259: 
277-289. 
Trosko, J.E. (2001). Commentary: is the concept of "tumor promotion" a useful 
paradigm? .Mo! Carcinog. 30, 131-137. 
Trush, M.A., Kensler, T.W. (1991). An ovei-view of the relationship between 
oxidative stress and chemical carcinogenesis. Free Radic Biol Medicine. 10, 201-
209. 
Tsunematsu, S., Saito, H., Kagawa, T., Morizane, T., Hata, J.-l., Nakamura, T., Ishi, 
H., Tsuchiya, M., Nomura, T., Katsuki, M. (1994). Hepatic tumors induced by 
carbon tetrachloride in transgenic mice carrying a human c-H-ras proto-oncogene 
without mutations.Int. J. Cane. 59, 554-559. 
177 
(BiBGograpliy 
Urata, Y., Honma, S., Goto, S., Todoroki, S., lida, T., Cho, S., Honma, K., Kondo, 
T. (1999). Melatonin induces gamma-glutamylcysteine synthetase mediated by 
activator protein-1 in human vascular endothelial cells, Free Radical Bio!. Med. 27, 
838-847. 
Valko, M., Izakovic, M., Mazur, M., Rhodes, C. J., Telser, J. (2004). Role of oxygen 
radicals in DNA damage and cancer incidence. Mol. Cell. Biochem. 266, 37-56. 
Valko, M., Leibfritz, D., Moncol, J., Cronin, M.T.D., Mazur, M., Telser, J. (2007). 
Free radicals and antioxidants in normal physiological functions and human disease. 
Int. J. Biochem. Cell Biol. 39,44-84. 
Valko, M., Morris, H., Cronin, M.T.D. (2005). Metals, toxicity and oxidative stress. 
Curr. Med. Chem. 12,1161-1208. 
Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., Mazur, M. (2006). Free radicals, 
metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 
160, 1-40. 
Vijayalaxmi., Thomas, C.R., Reiter, R.J., Herman, T.S. (2002). Melatonin: from 
basic research to cancer treatment clinic, J. Clin. Oncol. 20, 2575-2601. 
Vineis, P., Pirastu, R. (1997). Aromatic amines and cancer. Cane. Caus. Control, 8, 
346-355. 
Visintainer, M.A., Volpicelli, J.R., Seligman, M.E.P. (1982). Tumor rejection in rats 
after inescapable or escapable shock. Science (Wash. DC). 216,437-439. 
Von Sonntag, C. (1987). New aspects in the free-radical chemistry of pyrimidine 
nucleobases. Free Radic. Res. Comm. 2, 217-24. 
von Sonntag, C. (1987). The Chemical Basis of Radiation Biology, Taylor & 
Francis, London 1987. 
Vuillaume, M. (1987). Reduced oxygen species, mutation, induction and cancer 
initiation. Mutat Res. 186, 43-72. 
Wakikawa, K.J., Utsuyama, M., Hirokawa, K. (1997). Effect of restraint stress on 
immune system and experimental B16 melanoma metastasis in aged mice. Mech. 
Ageing Dev. 93, 107-117. 
Walaszek, Z., Hanausek, M., Slaga, T.J. (2004). Mechanism of chemoprevention. 
Chest. 125, 128-133. 
Walaszek, Z., Hanausek, M., Slaga, T.J. (2005). Combined natural source inhibitors 
in skin cancer prevention. Cellscience Reviews. 1. 
Wang, D., Kreutzer, D.A., Esigmann, J.M. (1998). Mutagenicity and repair of 
oxidative DNA damage: insights from studies using defined lesions. Mutat. Res. 
Fundam. Mol. Mech. Mutagen. 400, 99-115. 
Wang, G., Reed, E., Li, Q.Q. (2004). Molecular basis of cellular response to 
cisplatin chemotherapy in non-small cell lung cancer. Oncol. Rep. 12, 955-965. 
Waris, G., Ahsan, H. (2006). Reactive oxygen species: role in the development of 
cancer and various chronic conditions. J. Carcinogenesis 5, 14. 
178 
(BiSSograpfiy 
Waris, G., Alam, K. (1998). Attenuated antigenicity of ribonucleoproteins modified 
by reactive oxygen species. Biochem. Mol Biol. Int. 45, 33-45. 
Wattenberg, L.W. (1978a). Inhibition of chemical carcinogenesis. J. Natl. Cancer 
Inst. 60, 11-18. 
Wattenberg, L.W. (1978b). Inhibitors of chemical carcinogenesis. Adv. Cancer Res. 
26, 197-226. 
Wattenberg, L.W. (1981). In inhibition of tumor induction and development. M.S. 
Zedeck and M. Lipkin (eds), Plenum, New York, pp, 1-22. 
Wattenberg, L.W. (1992). Inhibition of carcinogenesis by minor dietary constituents. 
Cancer Res. 52, 2085-2091. 
Waxier-Morrison, N., Hislop, T.G., Mears, B., Kan, L. (1991). Effects of social 
relationships on survival for women with breast cancer: a prospective study. Soc. 
Sci. med. 33, 177-183. 
Weijl N.I., Hopman G.D., Wipkink-Bakker A., Lentjes, E.G., Berger, H.M. (1998). 
Cleton FJ, Osanto S. Cisplatin combination chemotherapy induces a fall in plasma 
antioxidants of cancer patients. Ann Oncol. 12,1331-7. 
Weijl, N,I., Elsendoom, T.J., Lentjes, E.G., (2004). Supplementation with 
antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients 
treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-
controlled study. Eur J Cancer, 40, 1713-1723. 
Weijl, N.I., Hopman, G.D., Wipkink-Bakker, A. (1998). Cisplatin combination 
chemotherapy induces a fall in plasma antioxidants of cancer patients. Ann Oncol. 
9:1331-1337. 
Weiner, H. (1992). Perturbing the organism: the biology of stressful experience. 
Chicago University press, Chicago. 
Wiemels, J., Wiencke, J.K., Varykoni, A., Smith, M.T. (1999). Modulation of the 
toxicity and macromolecular binding of benzene metabolites by NAD(P)|-l:Quinone 
oxidoreductase in transfected HL-60 cells. Chem. Res. Toxicol. 12, 467-475. 
Willett, W.C, MacMahon, B. (1984). Diet and cancer-an overview. IM Engl J Med. 
310,633-638. 
Williams, G.M., Weisburger, J.H. (1983). Carcinogen risk assessment. Science 221, 
6. 
Willner, P., Towell, A., Sampson, D., Sophokleous, S., Muscat, R. (1987). 
Reduction of sucrose preference by chronic unpredictable mild stress, and its 
restoration by a tricyclic antidepressant. Psychopharmacol. 93, 358-364. 
Wing, R.R., Matthews, K.A., Kuller, L.H., Meilahn, E.N., Plantinga, P. (1991). 
Waist to hip ratio in middle-aged women.Associations with behavioral and 
psychosocial factors and with changes in cardiovascular risk factors. Arterioscler 
Thromb. 11, 1250-1257. 
179 
(BiBBograpfiy 
Witenberg, B., Kalir, H.H., Raviv, Z. (1999). Inhibition by ascorbic acid of 
apoptosis induced by oxidative stress in HL-60 myeloid leukemia cells. Biochem 
Pharmacol 57, 823-832. 
Witz, G. (1991). Active oxygen species as factors in multistage carcinogenesis. 
Proc. Soc. Exp. Biol. Med. 198, 675-82. 
Wu, L.L., Chiou, C.C, Chang, P.Y.,Wu, J.T. (2004). Urinary 8-OHdG: a marker of 
oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. 
Clinical Chimestry Acta. 339, 1-9. 
Yadav, A.S., Bhatnagar, D., (2007). Chemo-preventive effect of Star anise in N-
nitrosodiethylamine initiated and phenobarbital promoted hepato-carcinogenesis. 
Chem. Biol. Interact. 169, 207-214. 
Yang, J.H., Hsia, T.C., Kuo, H.M., Chao, P.D., Chou, C.C, Wei, Y.H., Chung, J.G. 
(2006). Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M 
arrest and induction of apoptosis. Drug Metab. Dispos. 34, 296-304. 
Yao, T., Esposti, S.D., Huang, L., Amon, R., Spangenberger, A., Zern, M.A. (1994). 
Inhibition of carbon tetrachloride-induced liver injury by liposomes containing 
vitamin E. Am. J. Physiol. 267, G476-G478. 
Yildirim, A., Oktay, M., Bulaloulu, V. (2001). The antioxidant activity of the leaves 
of Cydonia vulgaris, Turkish Journal of Medical Sciences, 31, 23-27. 
Yoshida, M., Fukuda, A., Hara, M., Terada, A., Kitanaka, Y. (2003). Owada S. 
Melatonin prevents the increase in hydroxyl radical-spin trap adduct formation 
caused by the addition of cisplatin in vitro. Life Sci. 72, 1773-80. 
Zaidi S.M., Banu, N., (2004) Antioxidant potential of vitamins A, E and C in 
modulating oxidative stress in rat brain. Clin Chim Acta, 340 (1-2), 229-233. 
Zaidi, S.M., Al-Qirim, T.M., Banu, N. (2005). Effects of antioxidant vitamins on 
glutathione depletion and lipid peroxidation induced by restraint stress in the rat 
liver. Drugs R D 6, 157-165. 
Zhang, D., Wen, X.S., Wang, X.Y., Shi, M., Zhao, Y. (2009). Antidepressant effect 
of Shudihuang on mice exposed to unpredictable chronic mild stress, J. 
Ethnopharmacol. 123, 55-60. 
Zhang e x . , Lippard. S.J. New metal complexes as potential therapeutics. Curr 
Opin Chem Biol. 2003 7,481-9. 
Zhang, H., Kamendulis, L.M., Xu, Y., Klaunig, J.E. (2000). The role of 8-hydroxy-
20 deoxyguanosine in morphological transformation of Syrian hamster embryo 
(SHE) Cells. Toxicological Sci. 56, 303-12. 
Zhao, Y., Oberly, T.D., Chaiswing, L. (2002). Manganese superoxide dismutase 
deficiency enhances cell turnover via tumor promoter induced alterations in AP-1 
and p53-mediated pathways in a skin cancer model. Oncogene 21, 3836-3846. 
Zhao, Y., Xue, Y., Oberley, T. D., Kiningham, K. K., Lin, S. M., Yen, H. C. 
Majima, H., Hines, J. & St. Clair, D. K. (2001) Overexpression of manganese 
superoxide dismutase suppresses tumor formation by modulation of activator 
180 
<Bi66ograp/iy 
protein-1 signaling in a multistage skin carcinogenesis model. Cancer Res 61, 6082-
6088. 
Zheng, W., Gustafson, D.R., Sinha, R., Cerhan, J.R., Moore, D., Hong, C.-P., 
Anderson, K.E., Kushi, L.H., Sellers, T.A., Folsom, A.R. (1998). Well-done meat 
intake and the risk of breast cancer. J. Natl. Cane. Inst. 90, 1724-1729. 
Zonios, G., Cothren, R., Crawford, J.M., Fitzmaurice, M., Manoharan, R.. Van Dam 
J. Feld M.S. Spectral pathology. Ann NY Acad Sci 838,108-115. 
Zorzet, S., Perissin, L., Rapozzi, V., Giraldi, T. (1998). Restraint stress reduces the 
antitumor efficacy of cyclophosphamide in tumor-bearing mice. Brain Behav. 
Immun. 12, 23-33. 
Zygmunt, S., Vagel, W.H., Hormoz, E., Gary, P., Mc Smith, J. (1985). Effects of 
restraint stress on inoculated tumor growth and immune response in rats. Cancer 
Res. 45, 5128-5133. 
181 
List of Publications 
Suhail N, Bilal N, Khan HY, Hasan S, Sharma S, Khan F, Mansoor T, Banu N. 
Effect of vitamins A and C on antioxidant status of breast-cancer patients 
undergoing chemotherapy. Journal of Clinical Pharmacy and Therapeutics. 
doi:!0.1111/j.l365-2710.2010.01237.x 
Hasan S, Bilal N, Naqvi S, Ashraf GM, Suhail N, Sharma S, Banu N. Multivitamin-
Mineral and Vitamins (E + C) Supplementation Modulate Chronic Unpredictable 
Stress-Induced Oxidative Damage in Brain and Heart of Mice. Biol Trace Eiem Res. 
DOl 10.1007/s 12011-010-8771 -5 
Ashraf GM, Bilal N, Suhail N, Hasan S, Banu N. Glycosylation of Purified Buffalo 
Heart Galectin-1 Plays Crucial Role in Maintaining Its Structural and Functional 
IntegrityBiochemistry(Moscow), 2010, Vol. 75,No. 12, pp. 1460-1467. 
Ashraf GM, Rizvi S, Naqvi S, Suhail N, Bilal N, Hasan S, Tabish M, Banu N. 
Purification, characterization, structural analysis and protein chemistry of a buffalo 
heart galectin-1. Amino Acids. 2010 Nov;39(5): 1321-32. 
Bilal N, Suhail N, Ashraf GM, Hasan S, Khan HY, Banu N. Exacerbation of N-
nitrosodiethylamine induced hepatotoxicity and DNA damage in mice exposed to 
chronic unpredictable stress. (Communicated) 
Bilal N, Suhail N, Ashraf GM, Hasan S, Khan HY, Banu N. Chronic unpredictable 
stress enhances NDEA induced lung toxicity through increased oxidative stress and 
DNA damage in mice (communicated) 
Suhail N, Bilal N, Hasan S, Ahmad A, Banu N. Enhancement of carcinogenic and 
genotoxic potential 7-12-dimethylbenz (a) anthracene (DMBA) following exposure 
to chronic unpredictable stress. (Communicated) 
Suhail N, Bilal N, Hasan S, Ahmad A, Banu N. Augmentation of DMBA-TPA 
induced hepatotoxicity and nephrotoxicity in Swiss albino mice by prior exposure to 
chronic unpredictable stress (CUS). (Communicated) 
Hasan S, Bilal N, Fatima S, Suhail N, Anwar K, Sharma S, Banu N. Multivitamin-
mineral supplement is more efficacious than vitamins (E+C) in the prevention of 
chronic unpredictable stress induced oxidative damage in mice. (Communicated) 
